Chicken embryo lethal (CELO) virus

ABSTRACT

A CELO virus obtained by in vitro manipulation of a plasmid-cloned CELO virus DNA is suitable for the production of vectors for gene therapy and as a vaccine against infectious diseases in humans and animals, particularly birds.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. application Ser. No. 09/171,461, §102(e) date Jan. 12, 1999, now U.S. Pat. No. 6,335,016, issued Jan. 1, 2002, which is the U.S. National Stage of International Application No. PCT/EP97/01944, filed Apr. 18, 1997, the disclosures of which are herein incorporated by reference.

The invention relates to adenoviruses. The large family of adenoviruses is subdivided according to its host into adenoviruses which infect mammals (the mastadenoviridae) and adenoviruses which infect birds (the aviadenoviridae). The CELO virus (Chicken Embryo Lethal Orphan; article by Mcferran, et al., 1977; McCracken and Adair, 1993) was identified as an infectious agent in 1957 (Yates and Fry, 1957). CELO virus is classified as a poultry adenovirus type 1 (FAV-1) and first aroused interest because of its property of being tumorigenic in baby hamsters. However, since infection with the CELO virus does not have any serious health and economic consequences, the interest in this virus disappeared in recent years. The FAV-1 adenoviruses can be isolated from healthy chickens and do not cause any disease when reintroduced experimentally into chickens (Cowen, et al., 1978). Their isolation from sick birds is presumably the result of adenovirus replication in a host which has an immune system weakened by other influences.

The general structural organisation of CELO virus, with an icosahedral capsid of 70-80 nm, made up of hexon and penton structures, is similar to that of the mammalian adenoviruses (Layer, et al., 1971). The CELO virus genome is a linear, double-stranded DNA molecule, the DNA being condensed inside the virion by virus-coded core proteins (Layer et al., 1971; Li, et al., 1984b). The CELO virus genome has covalently bound terminal proteins (Li, et al., 1983) and the genome has inverted terminal repeats (ITRs), although they are shorter than the mammalian ITRs (Aleström, et al., 1982b; Sheppard and Trist, 1992). The CELO virus codes a protease with 61-69% homology for the mammalian adenovirus proteases (Cai and Weber, 1993).

There are significant differences between CELO virus and the mastadenoviruses. CELO virus has a larger genome, with sequence homology with Ad5 which can only be detected in two short regions of the CELO virus genome (by hybridisation) (Aleström, et al., 1982a). The CELO virion has been reported to have two fibres of different lengths at each vertex. The CELO virus cannot complement the E1A functions of Ad5, and the replication of CELO virus is not made easier by the activity of Ad5E1 (Li, et al., 1984c).

Within the scope of the present invention, total sequence analysis of the CELO virus was carried out; on the one hand because it is useful for understanding the biology of adenoviruses to clarify the genomic organisation of an adenovirus which is very remote from the mammalian adenoviruses generally studied. Since the conditions for transmission and survival for a virus which infects a type of bird are presumably different than for mammalian viruses, it is possible that the bird adenoviruses have acquired new virus functions or exhibit a higher degree of variability than the mastadenoviridae. The complete CELO virus sequence also permits changes in the CELO virus genome with respect to functional analysis.

Since adenovirus vectors have proved highly effective vectors for gene transfer (see the summarising article by Graham, 1990; Kozarsky and Wilson, 1993; Trapnell and Gorziglia, 1994), the complete CELO virus sequence, on the other hand, is particularly interesting as the basis for preparing new recombinant vectors for gene transfer.

Sequence analysis has shown that the CELO virus genome has 43.8 kb, being more than 8 kb longer than the human subtypes Ad2 and Ad5. The genes for the main structural proteins (hexon, penton based, IIIa, fibres, pVI, pVII, pVIII) are on the one hand both present and also located at the corresponding sites in the genome. The genes of the early region 2 (E2; DNA binding protein, DNA polymerase and terminal protein) are also present. However, the CELO virus lacks sequences homologous to the regions E1, E3 and E4 of the mammalian adenoviruses.

There are approximately 5 kb at the left hand end and 15 kb at the right hand end of the CELO virus genome, where there is only restricted homology or no homology at all with the mastadenovirus genomes. These new sequences contain a number of open reading frames, and it can be assumed that these code for functions which replace the missing E1, E3 and possibly E4 regions.

Parts of the CELO virus sequence have already been published; they are listed in Table 1, as are the differences between the sequence known from the databank and the sequence determined within the scope of the present invention. From studies concentrating on specific viral genes, a homolog of the VA RNA gene of mastadenovirus was known (Larsson, et al., 1986) and part of the genome sequence which carries the endoprotease has been described (Cai and Weber, 1993). In addition, fragments of the CELO virus genome have been published (Akopian, et al., 1990; Akopian, et al., 1992; Hess, et al., 1995). The sequence of the penton base of the related virus FAV-10 has also been reported (Sheppard and Trist, 1992). Some other sequence fragments have been deposited in the databank and are also shown in Table 1. In all, about 50% of the CELO virus genome is available in the form of fragments (total about 24 kb). The sequence obtained within the scope of the present invention is complete and has the advantage of having been obtained from a single isolated material.

The total sequence of the CELO virus is shown in the sequence listing (in the sequence listing the word “complementary” indicates that the open reading frames are present in the reverse arrangement). It shows a large number of striking differences between Ad2 and the CELO virus. The organisation of the recognisable open reading frames (ORFs) of the CELO virus genome based on the sequence analysis, compared with Ad2, is shown in FIG. 1A: the Figure shows an overview of the genomic organisation of Ad2/5 and CELO virus. The arrows indicate the position of the coding regions but not the exact cleavage patterns of the gene products. The pattern of the CELO virus also (in the first 6,000 bp and in the last 13,000 bp) gives all the non-associated open reading frames which begin with a methionine and which code for more than 99 amino acid groups. The central region of the two genomes which show homology on the basis of dot matrix analysis (cf. FIG. 3) and the regions at the ends of the CELO virus genome which have no homology with other adenoviruses (“unique to CELO”) are given. The abbreviations in the Figure, which also correspond to those in the Tables, have the following meanings: PB, penton base; EP, endoproteinase; DBP, DNA binding protein; bTP, pre-terminal protein; pol, DNA polymerase.

The sequenced CELO virus genome has a length of 43,804 bp and has a content of G+C of 54.3%. It had already been presumed at an earlier stage that the CELO virus genome is much larger than the mastadenovirus genome with 34-36 kb; it has been found that the CELO virus DNA has a weight of 30×10⁶ Daltons, determined according to its sedimentation coefficient (Layer, et al., 1971), compared with 24×10⁶ Daltons for Ad2 (Green, et al., 1967). The size of the CELO virus genome determined by the addition of the restriction fragments is about 43 kb (Cai and Weber, 1993; Denisova, et al., 1979). A Pulsed Field Gel Analysis of the CELO virus genome isolated from purified virions is shown in FIG. 2A and is compared with the DNA isolated from Ads dl1014 (34,600 bp; Bridge and Ketner, 1989) or Wild-type Ad5-virions (35,935 bp; vt300; Chroboczek, et al., 1992; Jones and Shenk, 1978); a mixture of uncleaved bacteriophage λ-DNA and γ-DNA cleaved with five different restriction enzymes (Biorad) was used as the size marker (tracks 1 and 7 show the molecular weight markers, track 2 shows the DNA of Ad5 dl1014, track 3 shows the DNA of Ad5 wt300, track 4 shows the CELO virus DNA, track 5 shows the DNA of OTE, track 6 shows the DNA of Indiana C). FIG. 2A shows that the CELO virus genome has a length of 44 kb. From this analysis it is clear that the CELO virus genome is actually substantially larger than the genome of the mammalian virus. Calculations based on the migration of fragments of the lambda bacteriophage give a size of 43 kb for the CELO virus genome. The DNA extracted from two other FAV-1 isolates, Indiana C and OTE, co-migrates with the CELO virus species, which is further evidence of the size of the CELO virus genome. FIG. 2B shows that the CELO virus sequence contained in the bacterial plasmid pBR327 has the same size.

There is no identifiable E1 region. No significant homology could be found between the CELO virus genome and the first 4,000 bp of Ad2. There are a few small open reading frames in the first 5,000 bp of CELO virus which might possibly perform some of the E1 tasks. An open reading frame at the right hand end of the virus genome (GAM-1) may replace E1B 19K in functional assays without there being any significant homology between GAM-1 and E1B 19K. In order to confirm that the left hand end originates from the Wild type CELO virus genome and is not the sequence of a cloned variant, various tests were carried out; comparison of the direct sequence analysis of CELO virions at three different sites with the corresponding sites of the cloned sequences; Southern analyses with DNA from various virus isolates which yielded the same restriction fragments; pulsed field gel electrophoresis of various virus genomes which showed no heterogenicity.

There is no identifiable E3 region; the two small open reading frames in the corresponding region of the CELO virus have no significant homology with the E3 functions described.

There is a group of small open reading frames between 36,000 and 31,000 the position of which indicates the mammalian virus E4 region, but with additional 8 kb sequence at the right hand end of the CELO virus.

Nor was any sequence resembling protein IX identified (protein IX is essential for the hexon-hexon interactions and the stability of the mammalian adenovirus virions).

A protein V gene was not identified either.

The following regions are conserved between CELO virus and Ad2: the central part of the CELO virus genome, from the IVa2 gene (approximately from nucleotide (nt) 5,000) on the left hand strand up to the fibre genes on the right hand strand (approximately up to nt 33,000) is organised as in the mastadenoviruses, and the majority of the important viral genes can be identified both by their position and by sequence homology. Earlier studies on the homology between CELO and Ad2 (Aleström, et al., 1982a) showed two regions of the CELO virus which cross-hybridise with the Ad2 sequence. These two fragments are nt 5,626 to 8,877 (coding for IVa2 and the carboxy terminus of DNA polymerase) and nt 17,881 to 21,607 (coding for the hexon). The dot matrix analysis shown in FIG. 3 (carried out using the UWGCG program Compare with a window of 30 and a stringency of 20; summarised in FIG. 1A) shows that the total DNA sequence homology between CELO virus and Ads is mapped in the central region of the CELO virus genome. This is to be expected because the capsid proteins are coded in this central region and the coarse structure of the CELO virion is comparable with the capsid of the mammalian adenovirus (Layer, et al., 1971; Li, et al., 1984a). The genes which code for proteins corresponding to the human adenovirus proteins hexon, IIIa, penton base, protein VI and protein VIII, are present, and indeed in the expected sequence and position (FIG. 1A and Table 2A; Table 2B shows non-associated open reading frames which code for gene products with more than 99 amino acid groups). Each vertex of the mastadenovirus virion contains a pentamer of the penton base protein in conjunction with a single fibre consisting of three copies of the fibre polypeptide. Ad2, like most mastadenoviruses, has a single fibre gene, some adenovirus types have two fibre genes. The CELO virus genome codes for two fibre polypeptides of different lengths and sequences.

DNA binding proteins were identified in the region E2 (Li, et al., 1984c); four proteins with similar peptide maps were described, indicating a single precursor which is then cleaved or decomposed. The left hand open reading frame of the CELO virus genome, starting at nt 23,224, is located in the expected DNA binding protein region. The genes coding for DNA polymerase and pTP (pre-terminal protein) are present and in the expected positions (FIG. 1A, Table 2A).

With a view to the preparation of vectors based on the CELO virus it is useful to identify the mechanisms which the CELO virus uses in order to package almost 44 kb of DNA into a virion which is of a similar size to the human adenoviruses which are subjected to considerable restrictions on their packaging capacity (Bett, et al., 1993; Caravokyri and Leppard, 1995; Ghosh-Choudhury, 1987). One possibility is that the CELO virion, although virtually identical in size to Ad2 and Ad5, has a sufficiently widened structure in order to accommodate the larger genome. An alternative hypothesis is that CELO has a different mechanism for condensing DNA and therefore has differences in its provision of core proteins which are responsible for DNA packaging. Layer et al., in 1971 identified two proteins in the nucleus of the CELO virus and noted the absence of a molecule resembling protein V. Li, et al., 1984b, used electrophoresis with a higher resolution and reported a nuclear structure with three polypeptides (20 kD, 12 kD and 9.5 kD). These two findings lead one to conclude that the CELO virus must lack the larger basic nuclear protein V (41 kD) which occurs in mammalian adenoviruses. Perhaps the absence of protein V and/or the presence of smaller basic proteins is responsible for the additional packaging capacity of the CELO virion. The smallest of the CELO virus core proteins identified by Li, et al., 1984b (9.5 kD) is most closely associated with the virus DNA, similar to protein VII of the human adenovirus. An open reading frame which leads one to expect a protein with 8,597 D having 72 amino acids is located at nt 16,679; the coded protein is rich in arginine (32.9 mol %) and contains two cleavage sites for protease (pVII of Ad2 has only one cleavage site). An open reading frame which leads one to expect a protein with 19,777 D having 188 amino acid groups is located at nt 16,929. The protein has protease cleavage sites after groups 22, 128 and 145, and the carboxy-terminal groups have homology with pX of mastadenovirus. FIG. 4 shows the amino acid sequences of protein VII and pX of various mastadenoviruses compared with the CELO virus and the core proteins Core 2 and Core 1 of FAV-10. The sequences were arranged using the UWGCG Bestfit Program with a gap weight of 3.0 and a weight and gap length (“Gap Length Weight”) of 0.1. The protease cleavage sites of adenovinis are underlined, in connection .with this it is interesting that the mastadenovirus DNA binding protein designated “mu” consisting of 19 groups is formed by two protease cleavings of the pX precursor (Hosokava and Sung, 1976; Weber and Anderson, 1988; Anderson, et a!., 1989). Cleaving of the protein having 188 groups after groups 128 and 145 would produce a mu-like basic protein consisting of 17 groups (41% arginine, 12% lysine). The uncleaved form of the protein is also highly basic; the uncleaved copies of this protein could correspond to the 20 kD core protein observed by Li, et al., 1984b; a third 12 kD core protein identified by these authors could not yet be assigned.

Moreover, some new or non-assigned open reading frames were found in the CELO virus genome. A summary of these open reading frames is shown in Table 2A; these open reading frames are also given in FIG. 1A. This summary was restricted to the sequences from nt 0-6,000 and 31,000-43,804 and only ORFs which contain a methionine group and code for a protein >99 amino acid groups are mentioned. As already stated, there is an ORF at nt 1999 which codes for a protein having homology with parvovirus-REP, and an ORF at nt 794 having homology with dUTPase and Ad2 E4 ORF1. The objective of the present invention was to prepare a new CELO virus.

Thus, on the basis of the complete CELO virus genome sequence, the present invention relates to a CELO virus obtained by in vitro manipulation of a plasmid-cloned CELO virus DNA.

The CELO virus according to the invention derived from the genomic DNA contains, in a preferred embodiment, the left and right terminal repeat and the packaging signal and has modifications in the form of insertions and/or deletions and/or mutations in regions of the CELO virus DNA which are different therefrom.

The left or right terminal repeat (“Inverted Terminal Repeat”, ITR) extends from nucleotides 1-68 or from nucleotides 43734-43804, the packaging signal (also referred to as “Psi”) extends from nucleotides 70-200. Modifications-in DNA sections other than these ensures that the genes affected by the modification are non-functional or are deleted.

Preferably, modifications of the CELO virus genome are undertaken which are located on a section of the CELO virus DNA which includes the nucleotides from about 201 to about 5,000 (following the left terminal repeat of the section at the left hand end, hereinafter referred to as “Section A”) and/or on a section which includes the nucleotides from about 31,800-about 43,734 (the section at the right hand end located in front of the right terminal repeat, hereinafter referred to as “Section B”) and/or on a section which includes the nucleotides from about 28,114-30,495 (the region of the fibre 1 gene, hereinafter referred to as “Section C”).

A CELO virus in which certain genes are non-functional or are deleted, e.g. genes which affect the immune response of the host, such as antagonists to genes of the E3 region of mammalian adenoviruses, can be used as a vaccine.

In one embodiment of the invention the CELO virus contains one or more foreign DNA molecules, particularly a foreign DNA which is to be expressed in a host organism. In this embodiment the CELO virus acts as a vector which is capable of transporting the foreign DNA into higher eukaryotic cells, tissue or organisms, particularly mammals and birds, and expressing it therein.

Suitable insertion sites for the foreign DNA are the sections A and/or B and/or C.

The foreign DNA preferably replaces one or more sequences from these sections.

The CELO virus according to the invention is contained on a plasmid which is replicatable in bacteria or yeast and which yields virus particles after being introduced into suitable cells. Examples of suitable cells are bird embryo kidney or liver cells.

With a view to using a recombinant CELO virus vector for gene therapy, the foreign DNA may consist of one or more therapeutically active genes. Examples of these are genes coding for immunomodulators or modulators of inflammatory processes (cytokines such as IL-2, GM-CSF, IL-1, IL-6, IL-12; interferons, tumour antigens, 1 kB, and derivatives of 1 kB which lack serine phosphorylation sites (Traenckner, et al., 1995) or which lack lysine ubiquitinisation sites; glucocorticoid receptors; enzymes such as catalase, manganese superoxide dismutase, glutathione peroxidase, LIP members of the C/EBP family such as LIP or LAP (Descombes and Schibler, 1991), ADF (Tagaya, et al., 1989)), genes which influence apoptosis (members of the Bcl-2 family such as Bcl-2, adenovirus E1B19K, McI-2; BAX; IRF-2; members of the ICE protease family; variants of cJun, such as TAM-67 (Brown, et al., 1994); adenovirus E1A; p53) and genes which code for other therapeutic proteins (e.g. clotting factors such as factor VIII or IX; growth factors such as erythropoetin; cystic fibrosis transmembrane regulator gene (CFTR); dystrophin and derivatives thereof; globin; the LDL receptor; genes which are absent in lysosomal storage dysfunctions such as b-glucuronidase; etc.).

With regard to the production of cellular tumour vaccines or for pharmaceutical compositions with which the immune response to tumours is to be intensified, the foreign DNA codes for immunostimulating proteins or tumour antigens or fragments thereof.

The therapeutically active DNA may also code for antisense molecules which prevent the expression of genes or the transcription of specific RNA sequences in the target cell.

With regard to the use of the recombinant CELO virus vector as a vaccine, the foreign DNA codes for one or more antigens which bring about an immune response in the individual treated.

In one embodiment of the invention the foreign DNA codes for an antigen derived from a human pathogen, particularly a pathogen of infectious diseases.

Epitopes which can be expressed by recombinant CELO viruses include epitopes derived from all kinds of human viral pathogens such as HIV, hepatitis A, B, C, hanta virus, polio virus, influenza virus, respiratory syncytial virus, measles, mumps, rubella, papilloma and many other viruses. The non-viral pathogens include trypanosomes (the causal agents of sleeping sickness and Chagas' sickness), leishmania, Plasmodium falciparum (malaria), various bacterial pathogens such as the pathogens which cause tuberculosis, leprosy, Pseudomonas aeruginosa (complications in cystic fibrosis) and many others.

A summary of vaccines based on mastadenoviruses is given in Table 3; the epitopes mentioned therein by way of example can also be used for insertion in a vector based on the CELO virus.

With regard to the use of the recombinant CELO virus vector as a vaccine in the veterinary field, e.g. for birds, particularly poultry, the foreign DNA, in another preferred embodiment, codes for an antigen derived from a protein of a pathogen of animal diseases, particularly infectious diseases in birds.

Examples of pathogens of bird diseases are Avian Infectious Bronchitis Virus (IBV, a corona virus; Jia, et al., 1995; Ignjatovic and McWaters, 1991; Kusters, et al., 1990; Lenstra, et al., 1989; Cavanagh, et al., 1988; Cunningham, 1975), Avian Influenza Virus (Orthomyxovirus Type A; Kodihalli, et al., 1994; Treanor, et al., 1991; Tripathy and Schnitzlein, 1991), Fowlpox-Virus (McMillen, et al., 1994), Avian Infectious Laryngotracheitis Virus (Guo, et al., 1994; Scholz, et al., 1993; Keeler, et al., 1991), Mycoplasma Gallisepticum (Nascimento, et al., 1993), Avian Pasteurella Multocida (Wilson, et al., 1993; Lee, et al., 1991; Hertman, et al., 1980; Hertman, et al., 1979), Avian Reovirus (Ni and Kemp, 1992; Huang, et al., 1987), Marek's Disease Virus (MDV; Malkinson, et al., 1992; Scott, et al., 1989), Herpes virus of turkeys (HVT, Herpes virus of Turkeys), Newcastle Disease Virus (NDV; Cosset, et al., 1991; Morrison, et al., 1990), Avian Paramyxovirus Type 1 (Jestin, et al., 1989), Avipoxvirus Isolates (Schnitzlein, et al., 1988), such as Juncopox, Pigeon Pox, and Field—(Field) and vaccine strains of bird pox viruses, Avian Encephalomyelitis Virus (Shafren and Tannock, 1991; Nicholas, et al., 1987; Deshmukh, et al., 1974), Avian Sarcoma Virus, Rotavirus (Estes and Graham, 1985), Avian Reovirus (Haffer, 1984; Gouvea, et al., 1983; Gouvea and Schnitzer, 1982), H7 Influenza Virus (Fynan, et al., 1993).

Apart from DNA sequences which code for therapeutically active gene products or for antigens, the foreign DNA may code for proteins or protein fragments which change the behaviour of the CELO virus, particularly its ability to bind to cells, with regard to the use of mammals, particularly on mammalian cells. Examples of such proteins are fibre or penton base proteins from mammalian and other adenoviruses, surface proteins of other viruses and ligands which have the ability to bind to mammalian cells and transport the CELO virus into the cells. Suitable ligands include transferrin from various mammalian species, lectins, antibodies or antibody fragments, etc. The skilled person will be aware of ligands of this kind, other examples can be found in WO 93/07283.

The recombinant CELO virus may contain one or more foreign DNA molecules. These may be inserted either in tandem or spaced apart in different sections of the CELO virus sequence.

The foreign DNA is under the control of regulatory sequences; suitable promoters include for example the CMV immediate early promoter/enhancer, the Rous sarcoma virus LTR, the adenovirus major late promoter and the CELO virus major late promoter.

The suitability of the CELO virus for preparing vectors and the advantages of these vectors and their applications are based particularly on the following properties of the CELO virus:

i) Safety: Naturally, the CELO virus does not replicate in mammalian cells. Therefore, vectors based on this virus can be used in humans without any danger of a subsequent infection with a Wild type human adenovirus complementing the vector and possibly allowing replication. This is an advantage over the Ad2 and Ads vectors used at present.

ii) Increased packaging capacity: The CELO virus genome is about 44 kb long, compared with the 36 kb of the Ad5 genome. Both viruses have comparable virion sizes, so that with a CELO virus vector it is possible to expand the strict packaging limit of 35 kb which is available with Ads. On the basis of the sequencing carried out within the scope of the present invention, DNA-packaging core proteins of the CELO virus were identified, and striking differences were found from Ad2 which could be responsible for the increased packaging capacity. There are about 13 kb at both ends of the CELO virus which would appear not to code for structural proteins (e.g. capsid components) or for proteins required directly for the virus replication (e.g. DNA polymerase). For the production of vectors, these sequences on the CELO virus genome can be removed and if necessary replaced by complementing cell lines. These sequences can be assumed to code for the immune functions or the apoptotic functions (e.g. GAM-1) of the host cell or to be involved in the activation of the host cell for virus replication (antagonists to the E1, E3 and E4 regions of Ad2). These are the gene types which are either non-essential for virus growth in the cell culture, such as the E3 genes of Ad2 (Wold and Gooding, 1991; Gooding, 1992), or which are easily removed from the virus and can be expressed by a complementing cell line, such as the E1 region in 293 cells (Graham, et al., 1977) and the E4 region in W162 cells (Weinberg and Ketner, 1983).

iii) Stability: The CELO virion is remarkably stable. Its infectivity and its ability to transport DNA withstand a 30 minute treatment at 60° C. As a comparison, Ad5 loses two powers of ten of its infectivity at 48° C. and is completely inactivated at 52° C. Presumably, the CELO virus did not develop its heat stability naturally, rather this heat stability would indicate a reaction to another type of selective pressure on the virion. The natural route of CELO virus infection is a faecal-oral route, which requires the virion to survive contact with a chemically aggressive environment with extreme pH values and with proteases. For particular applications in gene therapy, a more resistant virus would be desirable which would survive, for example, in the digestive tract or in the lungs of a patient suffering from cystic fibrosis.

iv) Targeted use: The CELO virus binds only slightly to mammalian cells on its own and for efficient entry into the cell requires the addition of a ligand (transferrin or lectin; Cotten, et al., 1993). Therefore, recombinant CELO virions are unable to penetrate into human cells, resulting in the following possible applications:

The virus may be genetically modified as stated above in order to express, on its surface, ligands which enable targeted transportation, such as for example specific peptides or fibres and/or penton bases of human adenoviruses.

Another possibility is the chemical modification of the virus in order to couple specific ligands such as transferrin thereto, as proposed for example in WO 94/24299 and additionally the virus may be biotinylated (W93/07283) and bound via streptavidin to biotinylated ligands such as wheatgerm agglutinin or other lectins (WO 93/07283). CELO virus vectors thus do not have the disadvantages of human adenoviruses which have good binding ability to human cells but have to be masked for a specific, targeted use mediated by the ligand.

v) Possibility of use for vaccines: The CELO virus is seldom connected to diseases in birds, indicating that it provokes a strong protective immune response in bird hosts. The CELO virus vector can easily be adapted for the expression of new vaccine epitopes.

With regard to the removal of regions of the CELO virus DNA, it was concluded from the results obtained with the mastadenovirus that, when the central sections of the CELO genome are removed, these sections have to be made available in trans, e.g. by a packaging cell line. This restriction is based on the large quantity of virion components which are necessary for the assembly of the virus and the need to produce a cell line which is capable of producing the corresponding amounts of these proteins without any toxicity.

The approaches which have hitherto proved more successful in this respect with mastadenoviruses consisted of the production of cell lines which express regulatory proteins (E1 and E4 regions) or enzymatic proteins (DNA polymerase, DNA binding protein), because these proteins are not required in large amounts during a productive virus infection.

Starting from the analysis of the known CELO genes, the sections of the genome from nt about 12,000 to about 33,000 which code for structural components of the virus are preferably not interrupted. The region from about nt 5,000 to about 12,000 codes for the E2 genes IVa2 (a viral transcription factor), viral DNA polymerase (POL) and the terminal virus protein (viral terminal protein; pTP). These genes are essential for the function of mastadenoviruses; they ought therefore to be essential for the CELO virus as well. However, it is theoretically also possible to have deletions of essential genes of this kind provided that they can be produced in trans, e.g. by a packaging line. For example, a packaging cell line was prepared which produces Ad5 DNA polymerase, thus making it possible for this gene to be deleted from the virus genome. A similar procedure may be used in the construction of CELO virus vectors, by removing sections or the entire region from nt 5,000 to 12,000 from the CELO virus and having the corresponding functions controlled in trans by a packaging cell line.

Another possible restriction exists with regard to the presumed major late promoter, which was provisionally assigned to the region at about nt 7,000 (TATA box at nt 7,488). In the mastadenoviruses, this promoter is essential for driving late gene expression. Therefore, any change in the region at nt 7,000 of the CELO genome must be carried out in a way which maintains the promoter function of this region.

Table 4 lists the sequence elements of the CELO virus genome and is divided into various categories with regard to their deletion and/or mutation in the production of CELO virus vectors (in Table 4 L1, L2, etc. denote “late message 1, 2, etc., corresponding to the nomenclature normally used for mastadenoviruses):

Category 1 includes sequence elements which are required in cis and therefore cannot be made available in trans by a complementing cell line or by a complementing plasmid.

These sections are necessary and are therefore present on the CELO virus according to the invention; these are the left and right terminal repeats and the packaging signal.

Sequences of category 2 code for proteins which are required in large amounts for virion production. These proteins may optionally be produced by a gene contained in a complementing cell line or on a complementing plasmid. Other sequences of category 2 are the major later promoter, the tripartite leader sequence and also the splice acceptor sites (SA) or the polyadenylation sites (poly A sites) of genes which are essential and which cannot be made available in trans.

Fundamentally, care must be taken to ensure that, in modifications of the CELO virus DNA which are carried out at the boundaries of genes, any control signals present, e.g. polyA sites are not interrupted or affected in any other way if possible.

The genes deleted from the CELO virus or non-functional genes therein may be prepared in trans, e.g. by complementing cell lines.

Complementing cell lines (“helper cells”) can be prepared by the manner known from the literature, analogously to helper cells which complement the functions of mammalian adenoviruses. To do this, the relevant CELO virus gene on a plasmid, preferably combined with a selectable marker, is introduced into cells which permit the replication of CELO virus, preferably into immortalised cell lines such as LMH (Kawaguchi, et al., 1987) or immortalised quail cell lines, as described for example by Guilhot et al., 1993. In helper cells which express the relevant CELO virus genes, optionally stably integrated, the defective CELO viruses are able to replicate.

Instead of making the regions of the CELO virus deleted in the vector available by means of a cell line, the deletions may also be complemented by a copy of the relevant gene contained on a plasmid. For this, the method described in WO 96/03517, that described by Cotten et al., 1994a and 1994 b) or the one described by Wagner et al., 1992, may be used, for example, in which a CELO virus vector containing a deletion is inserted, as a component of a transfection complex, containing a conjugate of polylysine and a UV/psoralen-inactivated adenovirus (human or CELO) and optionally transferrin-polylysine, into embryonic chicken kidney cells or liver cells, embryonic or immortalised quail cells, e.g. liver or kidney cells, and the transfection complex also contains a plasmid which carries a copy of the gene or genes which lack the CELO virus vector. The combination of genes contained on the vector and genes carried by the plasmid results in a normal virus replication cycle. (Similar approaches were used in mastadenovirus systems in order to complement E1-deficient adenoviruses (Goldsmith, et al., 1994) and E4-deficient adenoviruses (Scaria, et al., 1995)). The subsequent amplification of the virus may be carried out by using the defective virus as a carrier which is dependent on the complementing plasmid using the methods described above.

Another possible way of replacing the genes missing from the CELO virus is by using helper viruses.

The helper virus used may be a CELO virus (Wild type or partly defective). In this embodiment the CELO plasmid carrying the mutation (e.g. a derivative of pCELO7), is introduced into chicken cells, e.g. using the method described in WO 96/03517 or described by Cotten et al., 1994, using as the carrier for the derivative, for example, psoralen/UV-inactivated adenovirus (human or CELO) together with an adenovirus (human or CELO) as a carrier for the plasmid or plasmids with the genes which complement the defect. Alternatively, a Wild type CELO virus may be used both as a carrier and as source for complementing gene functions. The subsequent amplification of the defective CELO viruses obtained is carried out by co-infection of the defective CELO virus with a complementing adenovirus (e.g. Wild-type CELO or a CELO which has mutations at other points of the genome).

CELO virus genes of category 3 include the sequences on Sections A, B and C. These are sequences which code for a protein or an RNA molecule which is necessary for the interaction with the host cell machinery or with the host immune system. These proteins should be required in fairly low concentrations or may be dispensable for cultivation of the virus in the tissue culture.

Thus, preferably, in the CELO virus vectors according to the invention the genes of category 3 are replaced by the gene in question; if necessary, complementary cell lines or plasmids or helper viruses can be prepared which produce the corresponding gene products.

In one embodiment of the invention the vectors according to the invention contain the gene in question instead of one of the fibre genes. The CELO virus has two fibre proteins (Layer, et al., 1971; Gelderblom and Maichle-Lauppe, 1982; Li, et al., 1984a). It can be assumed that one of the fibres of the CELO virus is not necessary for the assembly of the virion and the infectivity. This assumption is backed up by electron microscopic observations that the longer fibre (fibre 1) should associate with the penton base along the side of the complex, whilst the shorter fibre (fibre 2) projects out of the middle of the penton base, similarly to the penton/fibre complexes in the mastadenoviruses (Hess, et al., 1995). In adenoviruses with only a single fibre, the fibre molecule is required for the assembly of the virus; in the absence of fibres no stable mature viruses are formed. The CELO virion should therefore require fibre 2 for stability and as a ligand, whereas fibre 1 acts only as a ligand. Within the scope of the present invention the assumption that, of the two fibre genes of the CELO virus, fibre gene 1 located in region C is superfluous and can be replaced by the gene in question was proved correct by removing the fibre 1 gene and replacing it with a luciferase expression unit.

Other examples are inserts in region A and/or B.

Within the scope of the present invention it was found that destruction of the reading frame at nt 794 (region A) which codes for dUTPase yields viable viruses. The dUTPase gene is thus a gene which is not necessary for growth in cell culture.

In one embodiment of the invention, the recombinant CELO virus thus contains a foreign gene which is inserted in the region of the reading frame coding for dUTPase.

According to another aspect the present invention relates to a process for preparing recombinant CELO virus.

The process is characterised in that the CELO virus genome contained on a plasmid or sections thereof is or are genetically manipulated.

In one aspect of the invention the genetic manipulation consists of insertion and/or deletion. Insertions and/or deletions can be carried out by using restriction enzyme cutting sites which occur naturally in the CELO virus DNA in these sections, e.g. the FseI cutting site occurring at position 35,693 in Section B. The insertion may be carried out directly into this cutting site or beyond this cutting site or close to this cutting site, or this cutting site may be used to allow recombination in the surrounding area.

In one preferred embodiment the manipulation consists of carrying out insertions and/or deletions using standard methods of molecular biology (Maniatis, 1989). The naturally occurring restriction cutting sites can be used for this, e.g. sites located in regions of the genome which are non-essential for cultivation of the virus in the host cell, e.g. the FseI cutting site which occurs at position 35,693 in Section B. The insertion can be made directly into this cutting site or beyond this cutting site or in the vicinity of this cutting site, or the cutting site may be used to facilitate recombination in the surrounding area. Foreign DNA sequences can be inserted, e.g. marker genes or genes coding for therapeutically active proteins.

An alternative possibility is to remove CELO sequences which are flanked by two restriction sites and replace them with new sequences. (An example of this is dUTPase mutation as carried out in Example 7.) In these cases the manipulation is carried out with the entire CELO virus genome. In the event that restriction sites are present, the deletion/insertion can alternatively be carried out on a subfragment which is then re-incorporated in the entire genome by ligation and optionally recloning in bacteria.

Another possibility is to insert the foreign gene in artificial restriction enzyme cutting sites produced by conventional methods of recombinant DNA technology (Maniatis, 1989).

In one embodiment the process is characterised in that manipulations are carried out in a plasmid DNA which contains the CELO virus genome, in CELO DNA sequences, with the exception of the left and right inverted terminal repeats and the packaging signal.

In another preferred method, the manipulation of the CELO genome is carried out by recombination. For this, a subfragment of the CELO genome is manipulated in order to introduce mutations and/or new sequences. Subfragments can be prepared by various methods, specifically by PCR (polymerase chain reaction), by ligation between PCR products or between restriction fragments or by subcloning in bacteria (as described in the Examples of the previous invention; see also Chartier et al., 1996). Examples of suitable bacteria strains for recombination are BJ 5183 (Hanahan, 1983) or JC 8679 (Gillen et al., 1974) or JC 5176 (Capado-Kimball and Barbour, 1971).

For recombination using PCR products, the sequence to be inserted into the CELO genome is prepared by PCR (Oliner et al., 1993) using primers which flank the sequence plus about 15 nucleotides of the sequence complementary to the insertion site in the CELO genome. In a second round of PCR, another 15 nucleotides are hung from the sequence complementary to CELO, resulting in a PCR product which consists of the sequence to be inserted with 30 nucleotides of the CELO sequence at each end. This fragment is mixed with a plasmid which contains the CELO DNA (e.g. the plasmid pCELO7 prepared within the scope of the present invention) and which has been linearised with a restriction enzyme which cuts only between the two flanking sequences hung from the sequence by PCR.

For recombination using ligation reaction products (prepared by conventional techniques as described for example by Maniatis et al., 1989), in principle the same procedure is used as in the recombination with cloned fragments, except that the intermediate cloning step is omitted.

In every case, the manipulated product obtained is characterised and used to prepare virus by transfecting avian cells (e.g. using the method described by Wagner et al., 1992; Cotten et al., 1994; or Cotten et al., 1993) and then cultivating them, after which the virus is harvested.

For preparing recombinant CELO virus using cloned fragments, the method preferably comprises subcloning a small fragment from the relevant region of CELO virus into which the foreign gene is to be inserted on a bacterial plasmid in order to ensure that restriction sites which occur several times on the CELO virus genome occur only once on the plasmid. These restriction sites are used to remove a region from the small fragment. For preparing the CELO virus vector this region is replaced by foreign DNA. The foreign DNA may consist solely of a linker with a restriction site occurring only once or of a sequence coding for a protein or for an antigen. The sequence may also code for a reporter gene with a restriction site occurring only once. This makes further manipulation of the CELO virus easier by inserting the foreign DNA, which codes for a therapeutically active gene product or for an antigen, into this restriction site, and at the same time the reporter gene permits rapid information as to the efficiency of the vector, by introducing the plasmid into cells and monitoring the expression of the reporter gene.

SUMMARY OF THE FIGURES

FIG. 1A: Comparison of the genomic organisation of Ad2/5 with the CELO virus

FIG. 1B: Restriction map of the CELO virus genome

FIGS. 2A and B: Pulsed Field gel-electrophoretic analysis of the genome size of adenoviruses

FIG. 2C: Characterisation of plasmid-cloned copies of the CELO virus genome by means of restriction endonucleases

FIG. 3: Dot matrix analysis of the DNA sequence homology between CELO virus and Ad2

FIG. 4: Amino acid sequences of protein VII and pX from various mastadenoviruses compared with CELO virus and the core proteins core 2 and core 1

FIG. 5: Construction of a plasmid which contains the entire length of the CELO genome

FIG. 6: Preparation of a CELO vector from a copy of the CELO virus genome contained on a plasmid

FIG. 7: Identification of bacterial clones which contain a deletion in the dUTPase gene

FIG. 8: Comparison of Wild-type CELO and CELO containing a deletion in the dUTPase gene by Western blot analysis.

In the Examples, the following materials and methods were used unless otherwise specified:

a) Virus and Virus DNA

A plate-purified isolate from CELO virus (FAV-1, Phelps strain) which was used as starting material for the DNA both for direct sequencing and for the formation of bacterial plasmid clones, was grown in 9 day old pathogen-free chicken embryos, as described by Cotten, et al., 1993. The FAV-1 isolates OTE (Kawamura, et al., 1963) and Indiana C (Calnek and Cowen, 1975; Cowen, et al., 1978) were cultivated in chicken embryo kidney cells. The virus was purified from the allantoic fluid or from infected embryo kidney cells by separation in CsCl gradients, as described by Layer, et al., 1971, and Cotten, et al., 1993. Virus DNA was isolated by treating the purified virions with proteinase K (0.1 mg/ml) and SDS (0.2%) at 56° C. for 45 min and subsequent equilibrium centrifugation of the DNA in a CsCl gradient in the presence of ethidium bromide. After the second gradient, the ethidium bromide was removed by extraction with CsCl-saturated isopropanol and the virus DNA was exhaustively dialysed against 10 mM Tris, 0.1 mM EDTA, pH 8.

b) Chicken Embryo Kidney Cells

The kidneys of 14 day old chicken embryos were collected, washed in PBS and digested with pancreas trypsin (2.5 mg/ml in PBS) at 37° C. The dispersed cells were mixed with an equal volume of foetal calf serum, the cells were collected by centrifugation, washed once with FCK medium and taken up in the same medium again. (The FCK medium is medium 199 with Earle's salts (Sigma M2154) supplemented with 10% tryptose phosphate (Sigma T8159), with 10% foetal calf serum, 2 mM glutamine, 100 μg/ml streptomycin and 100 IU/ml penicillin.) The cells were plated out in 175 cm² tissue culture flasks (2 embryo kidneys per flask), stored at 37° C. under 5% CO₂ and infected 24 to 48 hours later. The cells were infected with about 1,000 virus particles per cell and harvested 3 to 4 days after infection when the cytopathic effect was complete.

c) Pulsed Field Electrophoresis

Aliquots of purified adenovirus DNA (10-20 ng) were loaded onto a 1% agarose gel (BioRad, PFC agarose) and separated using a BioRad CHEF Mapper Pulsed Field Electrophoresis system (FIGE mode) for 24 hours in 0.5×TBE cooled to 14° C. The switching time, both in the forward direction and in reverse, was changed logarithmically from 0.22 seconds to 0.92 seconds with a ramp factor of 0.357 (21%). The forward voltage gradient was 9 V/cm (300 V), the reverse voltage gradient was 6 V/cm (200 V). After the run the gel was stained for 25 minutes in 0.5 μg/ml of ethidium bromide solution in water and then destained for 1 hour before the DNA pattern was made visible under UV light.

d) Sequencing Methods, Data Analysis

For the sequencing, EcoRI and HindIII restriction fragments of CELO virus DNA were cloned in pBlueScript SK(−). Three of the EcoRI clones containing the EcoRI fragments C, D and E (see FIG. 1B) and five of the HindIII clones containing the HindIII fragments F, A, G, B and E (cf. FIG. 1B, were selected for the preparation of deletions in one direction using exonuclease III (in FIG. 1B the cleavage sites for the restriction enzymes EcoRI, HindIII, BamHI and BglII are given; the alphabetical names for the EcoRI and HindIII fragments, on the basis of their relative sizes, are also given). These deletion clones were sequenced using the Taq Dyedeoxy Terminator System with the automatic sequencing apparatus ABI 373 according to the manufacturer's instructions. The sequence analysis of the terminal 2,000 bp at the left hand end and the 1,000 bp at the right hand end of the CELO virus genome, the sequencing to close the gaps between the fragments EcoRI C/HindIII G and the fragments HindIII B/EcoRI D and the sequencing to confirm the sequence at various points of the genome were carried out by direct sequencing of the viral DNA. All the sequence data are the results of at least three sequence reactions. The sequence data were combined using the programs SeqEd (ABI) and SeqMan (Lasergene). The sequence analysis was carried out using the program GCG of the University of Wisconsin.

EXAMPLE 1

Preparation of a Recombinant Bacterial Plasmid Clone of the CELO Virus Genome

a) Preparation of a Plasmid Vector with a Low Copy Number for Cloning the CELO Virus

The bacterial vector pBR327 (ATCC No. 37516) was chosen for this because it is retained in bacterial host strains at relatively low copy numbers (instead of this plasmid any other plasmid with a low copy number such as pBR322 could be used equally well). It was essential to create on the vector a restriction site which occurs only once and which does not appear in the CELO virus sequence. As described hereinafter, the virus sequence has to be cut from the plasmid vector sequences in order to inject a productive infection; therefore, restriction sites which flank the CELO sequence (but which are not present within the CELO sequence) have to be incorporated in the vector.

In the experiments carried out, the restriction enzyme SpeI was used; however, any other enzymes which do not have recognition sites in the CELO sequence, such as AscI, PacI and SfiI, may be used instead.

The plasmid p327SpeI was prepared by ligating an SpeI linker (New England Biolabs) into the Klenow-treated EcoRI site of pBR327, thereby destroying the EcoRI site and creating an SpeI site which occurs only once.

b) Cloning the Ends of CELO

The two terminal HindIII fragments were cloned. In order to do this, CsCl-purified genomic CELO DNA was digested with HindIII and separated on a low-melting agarose gel (0.7% low melting agarose in TAE). The 1601 bp left hand end fragment and the 959 bp right hand end fragment were cut from the gel, and each gel fragment was suspended in 300 μl of 10 mM Tris, 1 mM EDTA pH 7.4 and heated to 70° C. for 10 min to melt the agarose. The terminal peptides were eliminated by the addition of NaOH to 0.3 N and heating to 37° C. for 90 min. (Hay, et al., 1984). The solutions were then cooled to ambient temperature, then Tris pH 7.4 (to 0.1 M) and HCl (to 0.3 M) were added in order to neutralise the NaOH. The fragments were heated to 56° C. for 20 min. and slowly cooled (over 1 hour) to ambient temperature in order to facilitate re-annealing. Then the DNA was purified over a Qiaquick column and ligated for 4 hours at 16° C. using a Pharmacia T4 ligase reaction (New England Biolabs) to an SpeI linker (New England Biolabs). The ligase was inactivated by heating to 70° C. for 10 minutes, excess linker was removed (and an overhang complementary to SpeI was formed) by digesting for 2 hours with restriction endonuclease SpeI. The DNA fragments were in turn purified by Quiquick column chromatography and ligated to p327SpeI treated with SpeI/HindIII/calf alkaline phosphatase. The ligation product was transformed into the bacterial strain DH5alpha, and plasmid clones were identified which carried either the 1601 bp left hand end fragment or the 959 bp right hand end fragment (both released by SpeI/HindIII digestion). In order to confirm the terminal 300 bp of both fragments, DNA sequence analysis was carried out.

c) Cloning of Both CELO Ends on the Same Plasmid

The 1601 bp left hand end and the 959 bp right hand end fragment were cut from their vectors by HindIII/SpeI digestion, separated by gel electrophoresis and purified by Qiaquick chromatography. The two fragments were mixed in approximately equimolar amounts and ligated for 30 minutes using the Pharmacia T4 ligase reaction. An aliquot of SpeI/CIP-treated p327SpeI was added and ligation was continued for 4 hours. The ligation mixture was transformed in DH5alpha and plasmid clones were identified which carried the correct double insert (pwu#1 and pWu#3).

The second HindIII site was removed by cleaving pWu#3 with Clal and BamHI, treating with Klenowenzyme, religation, transforming DH5alpha and selecting a clone which missed the ClaI/BamHI fragment (which had contained a HindIII site). The resulting plasmid designated pWu-H35 now contained a single HindIII site between the left and right hand CELO end fragments.

d) Cloning the Entire CELO Genome

The plasmid pWu-H35 obtained in c) was treated with HindIII and CIP and purified on a low melting agarose gel following by Qiaquick chromatography. The linearised vector pWu-H35 was mixed with 0.3 μg of purified CELO virus DNA, then 30 μl of electro-competent bacterial strain JC8679 (Gillen, et al., 1974; Oliner, et al., 1993) were added to the DNA mixture on ice. 10 Minutes later the mixture was transferred into a BioRad Electroporation chamber and pulsed with an electric charge of 2.4 kV (BioRad Gene Pulser; Oliner, et al., 1993). The bacteria were then plated onto LB ampicillin plates and the ampicillin-resistant colonies were investigated for their plasmid content. Recombination between the terminal CELO sequences on pWu-H35 and the ends of the genomic CELO DNA re-establishes the circularity of the linearised plasmid and allows growth on ampicillin. A plasmid which contains the CELO genome over its full length was identified, and this plasmid, referred to as pCELO7, was used for the subsequent investigations. FIG. 2C shows the characterisation of plasmid-cloned copies of the CELO virus genome. Plasmid DNA from clones designated pCELO7, 8, 9 and 13 or DNA isolated from purified CELO virus, was digested either with BglII (tracks 2-6) or HindIII (tracks 7-11) and separated on a 0.6% agarose gel, and the DNA was shown up by ethidium bromide staining. The molecular weight marker (tracks 1 and 12) was bacteriophage λ-DNA cut with HindIII and EcoRI. The sizes of some molecular weight fragments (in base pairs) are shown on the right of the Figure. For each enzyme, the two CELO end fragments which are bound to the bacterial plasmid during cloning (and which are therefore not released after restriction digestion) are given on the left of the Figure (in base pairs). These are the fragments with 5832 and 5102 bp with BglII or 1601 and 959 with HindIII.

The construction of pCELO7 is shown in FIG. 5.

e) Initiation of a CELO Virus Infection by a Cloned CELO Genome

pCELO7 was cleaved with SpeI (which cleaves at the sites flanking the adenovirus termini), extracted with phenol/chloroform and passed over an HBS-equilibrated gel filtration column (Pharmacia Nick column) to remove any impurities. The cleaved DNA was then incorporated in streptavidin-polylysine/transferrin-polylysine/biotin-adenovirus (UV/psoralen-inactivated) as described in WO 93/07283. Complexes containing 0.5 μg of SpeI-cleaved pCELO7 plus 5.5 μg of carrier DNA (pSP65; Boehringer Mannheim) were used to transfect primary embryonic chicken kidney cells (the complexes contain 4 mg of DNA per 180 cm² flask, containing about 3×10⁶ cells), and the cells were investigated for the cytopathic effect caused by virus replication. Five days after transfection, when the majority of the transfected cells had been rounded off and detached from the surface of the plate, the cells were obtained by centrifuging and the CELO virus was purified as described by Cotten, et al., 1993. The virus yield from plasmid cloned CELO virus is comparable with the yields obtained by using pure CELO virus DNA (purified from virions).

EXAMPLE 2

Preparation of a CELO Mutant Which Lacks the Sequences from nt 35,870 to 42,373 at the Right Hand End

There are no identifiable viral structural genes beyond the two fibre genes with the L5-polyadenylation site at position 31771. (There is a cryptic VA-gene at positions 39,841 to 39,751.) Investigations were therefore carried out to see whether the sequences between about 32,000 and the right ITR are necessary for the growth of the virus in cell culture. For this an accumulation of seven AseI sites were used at positions 35,870, 36,173, 38,685, 38,692, 39,015, 42,348 and 42,373, which does not appear anywhere else in the CELO virus genome. pCELO7 was digested with AseI, religated and a plasmid which lacked the inner AseI fragments was identified and designated pALMCELO_(—)35870-42373. In connection with this it should be noted that the plasmid vector also has an AseI site; however, this is located in the ampicillin resistance gene, and selection for ampicillin resistance requires that all positive colonies have at least the two fragments which carry the right and left hand halves of the amp gene.

To aid further manipulations of the virus with the missing left hand end of the genome, pALMCELO_(—)35870-42373 was digested with AseI (which cuts once in the ampicillin resistance gene of the plasmid and once at position 35,870) and ligated to a linker oligonucleotide TACCCTTAATTAAGGG which codes for a cutting site for the restriction endonuclease PacI and for ends which are complementary to those formed during AseI digestion. Religation, followed by selection for ampicillin resistance, identified plasmids which did not integrate the oligonucleotide at the AseI site of the ampicillin resistance gene. Restriction digestion identified a plasmid which carried a PacI site at the earlier AseI site of CELO at position 35,870. The plasmid was designated pALMCELO_(—)35870-42373P.

EXAMPLE 3

Preparation of a CELO Virus Vector in Which a Fibre Gene is Missing Which is Replaced by a Gene of Interest

The CELO fibre genes are contained on a HindIII fragment which extends from nt 27,060 to 33,920 (the HindIII B-fragment, cf. the restriction map in FIG. 1B). On this fragment the sequence coding for fibre 1 extends from nt 1,054 to 3,435. The 5H3 fragment was digested with BglII (which cuts at nt 1,168) and HpaI (which cuts at 3,440), the BglII end was filled with Klenow enzyme and ligated to a blunt CMV/luciferase/β-globin cleavage/polyadenylation signal fragment from the plasmid pCMVL (Plank et al., 1992) to form the plasmid p5H_(—)28227-30502(luc) which lacks almost the entire fibre 1 sequence which is replaced by a luciferase expression unit.

The relevant restriction cutting sites in CELO are as follows:

BglII A′GATC_T Cuts at: 0 5102 15979 23472 28227 37972 43804 Size  5102 10877 7493 4755 9745 5832 HindIII A′AGCT_T Cuts at: 0 1601 5626 17881 23327 27060 33920 38738 42845 42845 43804 Size:  1601 4025 12255 5446 3733 6860 4818 4107  959 HpaI GTT′AAC Cuts at: 0 5503 20673 23355 30502 43804 Size:  5503 15170 2682 7147 13302 NotI GC′GGCC_GC Cuts at: 0 17389 43804 Size:  17389 26415 XbaI T′CTAG_A Cuts at: 0 1659 1988 28608 39268 41746 43804 Size:  1659 329 26620 10660 2478 2058

The modifications which were carried out on p5H_(—)28227-30502(luc) were introduced into the entire CELO genome in the following manner: The CELO/luciferase/CELO fragment was cut from p5H_(—)28227-30502(luc) as a HindIII fragment. This fragment was recombined with the 26 kb XbaI fragment (CELO nucleotides 1988-28608) and the terminal HpaI fragments derived from pCELO7 (obtained by cutting with HpaI, containing the left hand end of the CELO virus and pBR327 sequences, defined by the HpaI sites). The three DNA fragments (each about 50 ng) were mixed in water and electroporated in JC8679 cells as described above.

EXAMPLE 4

Insertion of a Reporter Gene (Luciferase) in the CELO Genome

i) Preparation of a Left Hand End Fragment Containing a CMV Luciferase Construct

The EcoRI fragment designated 7R1 (nucleotides from positions 79 to 8877) was cloned into a pSP65 derivative designated pAAALM (described in WO 95/33062). The plasmid was transformed into the DAM methylase negative bacterial strain JM110 in order to allow cleavage of the ClaI sites in the fragment. The plasmid was purified, cut with ClaI (at position 1083) and NcoI (at position 4334), treated with Klenow enzyme to fill the overhanging ends and ligated to a blunt CMV/luciferase/β-globin cleavage/polyadenylation signal (Plank et al., 1992). The resulting plasmid was designated p7R1_(—)1083-4334Luc.

ii) Recombination of the Luciferase Left Hand End Fragment into a Complete (Full Length) CELO Sequence

The plasmid p7R1_(—)1083-4334Luc was cleaved with Eco47 III, which cleaves at the CELO nucleotides 937, 1292, 2300 and 8406 (the sites at nucleotide 1292 and 2300 are absent from p7R1_(—)1083-4334Luc) in order to release a large fragment containing the sequence CELOnt937-1083/CMVLusPA/CELOnt4334-8406.

This fragment was recombined in pCELO7. pCELO7 was cleaved at the single PmeI site at CELO nt7433 and exhaustively dephosphorylated with calf intestinal phosphatase. The linearised pCELO7 was mixed with an approximately 3 to 5 molar excess of CELOnt937-1083/CMVLucPA/CELOnt4334-8406. The mixture was electroporated into the bacterial strain JC8679 and ampicillin-resistant colonies were examined on plasmids which contain the desired recombinant DNA. The correct plasmid was identified, characterised by restriction enzyme analysis and designated pCELOLucI.

iii) A CELO Virus Expressing Luciferase was Prepared by Transfecting pCELOLucI into Primary Embryonic Chicken Kidney Cells as Described above.

EXAMPLE 5

Preparation of a CELO Vector from a Copy of the CELO Virus Genome Contained on a Plasmid

The region between the DraIII site (originally contained at nt 34,426 in the CELO virus genome) and the XhoI site (originally contained at nt 36,648 in CELO virus genome) were removed from the plasmid pAALMH3 which contains the HindIII fragment from nt 33,920 to nt 38,738, cloned in pAALM. Then it was treated with T4-DNA polymerase to produce blunt ends and ligated with the CMV/luciferase/β-globin fragment (cf. Example 4). In this way the plasmid p7H3Δ34426-36648 Luc was obtained. The CELO/luciferase/CELO fragment was cut on a HindIII fragment and inserted into the CELO genome of pCELO7 by recombination via the FseI site occurring only once at position 35,694. This yielded the plasmid PCELOΔ34426-36648Luc. Digestion with SpeI and transfection into embryonic chicken kidney cells yielded a virus CELOΔ34426-36648Luc. Then further insertions were carried out replacing the luciferase sequence with other genes of interest, using the once occurring PacI site which was introduced with the luciferase sequence.

FIG. 6 shows the cloning strategy used in this Example in general form: a small CELO fragment is subcloned into a plasmid (containing restriction site C); the restriction sites A and B which occur only once in this plasmid are used to replace the sequence with foreign DNA. As the next step, the entire fragment containing the foreign DNA between CELO sequence is cut from the plasmid and mixed with the plasmid which contains the entire CELO DNA and which has been cut with a restriction enzyme (D) which cleaves the CELO-DNA only once. With this mixture, bacteria (e.g. of the strain JC8679; Oliner et al., 1993; or another bacterial strain with a similar capacity for recombination) are transformed; recombination yields the desired plasmid containing the foreign DNA as an insert in the CELO virus genome.

EXAMPLE 6

Preparation of a Quail Cell Line Which Complements the 7R1 Deletions and/or the 9R1 Deletions in CELO

The plasmids pX7R1 and pX9R1 (described in WO 95/33062) were introduced into primary embryonic quail kidney or liver cells by transferrinfection as described in WO 93/07283. Four days after transfection the cells were trypsinised and seeded at ⅕ of the original density. The cells were fed twice a week with FCK medium. Clonal lines were expanded and clones which carried either the 7R1, 9R1 plasmid or both plasmids were identified by PCR analysis. The RNA expression of the integrated plasmids was determined by Northern analysis.

EXAMPLE 7

a) Preparation of a CELO Virus Genome with a Mutation in the ORF₇₉₄ DUTPase Gene

A plasmid designated pWuΔdut was produced by removing a 540 bp AflIII-SacI fragment from the ORF₇₉₄ in pWu-H35 (see Example 1 c). In order to product pCELOΔdut, pWuΔdut was linearised with HindIII and dephosphorylated using alkaline shrimp phosphatase. After gel purification the DNA was mixed with purified CELO DNA and used to transform E. coli BJ5183 (Degryse, 1996) to ampicillin resistance. From the ampicillin resistant bacterial colonies obtained the DNA was extracted and E. coli DH5a was transformed therewith. DNA extracted from these bacteria was analysed by restriction mapping in order to identify recombinant virus plasmids. The identity of the clones was determined by restriction mapping (FIG. 7; pWu-H35 is designated “pWu” in the Fig. ). The digestion of the Wild type plasmid pWu-H35 with HindIII and SpeI yields fragments of 2944 bp, 1607 bp and 961 bp (track 2). The deletion which changes the dUTPase converts the 1607 bp fragment into a 1071 bp fragment (track 3; the modified fragments are marked with an asterisk). The plasmids which contain the complete sequence coding for CELO or the complete CELO sequence plus the dUTPase mutation were analysed by SpeI/HindIII digestion and showed the same change of the 1607 bp fragment into a 961 bp fragment (tracks 4 and 5).

b) Preparation of Recombinant CELO Clones from Chicken Cells

Either 6 μg pCELO7 (see Example 1 d) or 6 μg of pCELOΔdut (see above, digested with SpeI) were used to transfect primary embryonic chicken kidney cells (approximately 500,000 cells in a 2.5 cm well) using polyethylene amine (PEI)/adenovirus complex. For this, the Qiagen-purified DNA was extracted with Triton X-114 in order to remove lipopolysaccharide as described by Cotten et al., 1994. Transfection complexes were prepared by diluting 6 μg of digested DNA in 250 μl of 20 mM HEPES, pH 7.4. 20 μl of 10 mM PEI (molecular weight 2,000, pH 7) were diluted in 250 μl of 20 mM HEPES, pH 7.4. The PEI solution was added dropwise to the DNA solution, incubated for 20 minutes at ambient temperature and then mixed with 1.5 μl of an adenovirus preparation (psoralen/UV-inactivated adenovirus type 5, cf. WO 1719, 1.5×10¹² particles/ml). After another 20 minutes the complex was added to the cells in DMEM without serum (250 μl of complex to 1.25 ml of medium). The medium was changed for normal growth medium (with serum) and 4 to 5 days later the cells were harvested, taken up again in 100 μl of HBS and sonicated for 2 minutes. A 10 μl aliquot of this sonicate (virus in passage 1) was used to infect the same number of primary embryonic chicken kidney cells in a 2.5 cm well in a cell culture plate. After another 4 to 5 days the cells were counted in order to determine the cytopathic effect (CPE end point assay or plaque assay, Precious and Russel, 1985). The cells were harvested (virus in passage 2) as in the first step and used to infect fresh chicken cells; harvesting these cells yielded viruses of the third passage, the analysis of which is shown in FIG. 8.

c) Western Blots

The virus infected cells were harvested, taken up in HBS and sonicated. Aliquots were mixed with 5×charging buffer (250 mM Tris-Cl, pH 6.8, 500 mM DTT, 10% SDS, 0.5% bromophenol blue, 50% glycerol), heated to 95° C. for 3 minutes and then allowed to run in a 10% polyacrylamide gel. The proteins were transferred onto nitrocellulose, blocked overnight in 5% skimmed milk/TBST (10 mM Tris-Cl, pH 7.4, 150 mM NaCl, 0.05% Tween 20). Viral proteins were shown up using anti-CELO-antisera from rabbits (1:1000) and anti-rabbit-horseradish peroxidase (DAKO; 1:20000) and made visible by ECL (Amersham). CELO virus (2.5×10¹² virus particles/ml) was used as the control. The rabbit serum was prepared using CsCl-purified CELO virus and heat-inactivated at 60° C. for 30 minutes.

d) Extraction of Virus DNA

Virus infected cells were harvested and taken up in 100 μl of HBS/0.1% SDS/1 g/ml proteinase K, incubated for 1 hour at 56° C. and extracted with phenol/chloroform. The DNA was precipitated with ethanol.

The analyses carried out showed that recombination between the linearised plasmid pWuΔdut and the CELO DNA yielded two types of plasmids. Recombination to the left hand end of the dUTPase mutation yielded a Wild type CELO genome; recombination on the right hand side of the dUTPase mutation yielded a CELO genome which carried the dUTPase mutation.

The infection of primary embryonic chicken cells both with CELO DNA and with CELO-Δdut-DNA produced cytopathic effects which took the form of swollen, detached cells after 36 hours, whereas control cells (treated with lysates of cells which had been transfected with an empty vector (Bluescript pBS, Stratagene)) remained healthy in their morphology.

Western blot analysis showed that CELO viruses and CELO Δdut viruses produced by plasmid DNA are indistinguishable from Wild type virus grown in fertilised, 9 day old hens eggs.

In all, the tests carried out in this example show that pCELO7 codes a viable CELO virus genome. After excision with SpeI and transfection into primary embryonic chicken kidney cells this DNA yields infectious, passagable virus. Lysates of viruses of the 1st and 2nd passage produce a cytopathic effect on primary embryonic chicken kidney cells. It should be noted that these lysates were produced by sonication, which rules out the possibility that the CPE in the secondary and tertiary infections can be put down to the expression of viral genes which originates from the residual plasmid DNA in the lysates; plasmid DNA cannot be expected to withstand the method used to produce the lysates. In addition, it was found that with each round of infection there is a 100 fold amplification of the agent which causes CPE; this conforms to the amplification of a virus but not to the single passage of residual plasmid DNA from the first transfection.

The deletion of 540 bp in the CELO genome with which sequences between an AflIII site at bp 609 and a SacI site at bp 1145 were removed and the open reading frame coding for dUTPase was destroyed, yielded a virus genome which is viable even in primary embryonic chicken cells. With the UTPase gene a virus gene was thus identified which is not necessary for growth in cell culture.

TABLE 1 CELO virus Sequences, published or from data banks differences between data bank published sequences and accession coordinates in new sequence (GenBank # authors, publication size the sequence Accession #U46933) remarks Aleström, et al, 1982b  101 bp  1-101 7 bases different 5′ITR K00939 Shinagawa, et al, 1983  68 bp  1-68 7 bases different 5′ITR Z17216, Akopian, et al., 1992 3576 bp   1-3576 3 bases different 92-100% labelled S61107 1 missing base slight differences in 3 additional bases these 2 versions Z48167 unpublished 3433 bp 13597-17033 6 bases different contains genes for 4 missing bases penton base and core 1 additional base proteins L13161 Cai, et al., 1993  900 bp 21023-21922 no differences contains protease gene X84724 Hess, et al., 1995 7359 b  27060-34299 2 bases different contains genes for 6 missing bases pVIII, fibre 1, fibre 2 3 additional bases 11 (GCA) repeats (new sequence shows 9) 6 doubtful bases M12738 Larsson, et al., 1986  440 bp 39584-40023 no differences contains VA gene Z22864 unpublished 3670 bp 35235-38905 2 bases different assigned by the 4 missing bases authors: 11.2-19.2% 2 additional bases X17217 Akopian, et al., 1990 4898 bp 38906-43804 2 bases different assigned by the authors: 11.2% K00940 Shinagawa, et al, 1983  68 bp 43741-43804 7 bases different 3′ITR Aleström, et al.,  124 bp 43680-43804 2 bases different 3′ITR 1982b 1 missing base

TABLE 2A Organisation of the CELO Virus Genome Cap, cleav- age, Amino poly A MW acid Protein ATG STOP sites Dalton groups Remarks L1 52K 12193 13329 42094 378 IIIa 13316 15043 63771 575 Protease cleavage site at amino acid 551 L2 15080 Penton base SA Penton 15110 16657 56719 515 no RGD base 16196 poly A-site pVII 16679 16897 8562 72 Protease cleavage sites at amino acids 27, 40 mu 16929 17495 19787 188 Protease (pX, cleavage sites 11K) at amino acids 125, 144 17526 poly A-site L3 pVI 17559 18230 23890 223 Protease cleavage sites at amino acids 28, 212 Hexon 18289 21117 106704 942 18261 Hexon SA Pro- 21134 21754 23763 206 tease 21102 Protease SA or 21123 21767, L3 poly A-site 21836 L4 23608 100K SA or 23649 100K 23680 26634 109905 984 pVIII 27149 27886 26876 245 Protease cleavage sites at amino acids 40, 115, 130, 141, 166 27920 L4 poly A-site L5 28315 fibre SA or 28341 fibre 1 28114 30495 81526 793 30509 [GCA]9 repeat 30511 fibre SA fibre 2 30536 31768 42939 410 31771 L5 poly A-site VA 39841 RNA to 39751 E2 and IVa2 IVa2 6685 5366 50366 439 E2b 10268 6501 144984 1255 pol E2b 11996 10269 66089 575 Protease pTP cleavage sites at amino acids 116, 141, 260, 264 DBP 23224 21899 49272 441 23292 DBP cap site 21824 DBP poly A or site 21882

TABLE 2B Non-assigned open reading frame, larger than 99 amino acid groups Right ORF's Left ORF's ATG STOP groups ATG STOP groups  794  1330 178  5094  4462 210  1999  2829 276  4568  3549 339  3781  4095 104  3374  2892 160  5963  6373 136  1514  1191 107 33030 33476 148 39705 39286 139 33169 33483 104 39256 38717 179 35629 36024 131 36144 35536 202 37391 38239 282 35599 34238 453 40037 41002 321 33707 32892 271 41002 41853 283 33058 32735 107 41958 42365 135 32429 31812 251

TABLE 3 Recombinant Adenovirus vaccines Pathogen Reference Comments Respiratory Hsu et al., (1994) Glycoprotein F and G, Syncytial inserted into the Virus E3 region of Ad 4, 5 or 7 Hepatitis B Chengalvalva et al., (1994) HBsAg, inserted into the E3 region of Ad 4 oder 7 Pseudorabies Eloit et al., (1990) Pseudorabies Glyco- protein gp50, inserted into the E1 region of Ad 5 Herpes Simplex Zheng et al., (1993) Tandem repeats of the epitope of gD Herpes Simplex Gallichan et al., (1993). Glycoprotein B Rotavirus Both et al., (1993) Rotavirus antigen, inserted into the E3 region HIV Natuk et al., (1993) Ad 4, 5 or 7, HIV env, or gag-protease gene SIV Cheng et al., (1992) SIV Env Rev, inserted into the E3 region of Ad 5 Rabies Kalicharran et al., (1992) Ad 5 with rabies glycoprotein Rabies Charlton et al., (1992) Ad 5 with rabies glycoprotein Human Marshall et al., (1990) gB in E3 region of Ad 5 Cytomegaloviras Measles virus Fooks et al., (1995) N protein in AdE1 Region

TABLE 4 Characteristics of the CELO Virus Genome. Coordinates Characteristics (Nucleotides) Category Left terminal  0-68 1 Repeat Packaging signal  70-200 1 unknown open   0-5365 3 reading frame L1 52K 12193-13329 2 IIIa 13316-15043 2 L2 penton base SA 15080 2 penton base 15110-16657 2 Poly A site 16196 2 pVII 16679-16897 2 mu 16929-17495 2 (pX, 11K) Poly A site 17526 2 L3 pVI 17559-18230 2 Hexon SA 18261 2 Hexon 18289-21117 2 Protease SA 21102 or 21123 2 Protease 21134-21754 2 L3 Poly A site 21767, 21836 2 L4 100K SA 23608 or 23649 2 100K 23680-26634 2 pVIII 27149-27886 2 L4 Poly A site 27920 2 L5 fibre SA 28315 oder 28341 2 or 3 fibre 1 28114-30495 2 or 3 Major Late 7350-7650 2 or 3 promoter (TATA box at 7488) Tripartite Leader  8651-8700,  8798-8857, 9682-9774 fibre SA 30511 2 fibre 2 30536-31768 2 L5 PolyA site 31771 2 VA RNA 39841 to 39751 3 E2 and IVa2 IVa2 6685-5366 3 E2b pol 10268-6501 3 E2b pTP 11996-10269 3 DBP 23224-21899 3 DBP cap site 23292 3 DBP PolyA site 21824 or 21882 3 right end open 31771 to 43804 3 reading frame (right end) right terminal 43734-43804 1 repeat (roughly the last 70 bp)

Bibliography

Akopian, T. A., et al., 1990, Nucleic Acids Res. 18: 2825. (Corrigendum: Nucleic Acids Res 19: 424).

Akopian, T. A., et al., 1992, Mol. Gen. Microbiol. Virol. 11: 19-23.

Aleström, P., et al., 1982a, J. Virology 42: 306-310.

Aleström, et al., 1982b, Gene 18: 193-197.

Anderson, J., et al., 1969a, J. Natl. Cancer Inst. 42: 1-7.

Anderson, J., et al., 1969b, J. Natl. Cancer Inst. 43: 575-580.

Anderson, C. W., et al., 1989, Virology 172: 506-512.

Bailey, A. and Mautner, V., 1994. Virology 205: 438-452.

Bennett, D. D. and Wrigth, S. E., 1987, Virus Res. 8: 73-7.

Bett, A. J., Prevec, L. and Graham, F. L., 1983, J. Virol. 67: 5911-5921.

Both et al., 1993, Virology 193: 940-950.

Boulanger, P., et al., 1979, J. Gen. Virol., 44: 783-800.

Bridge, E. and Ketner, G., 1989, J. Virol. 63: 631-638.

Brown, P. H., et al., 1993, Oncogene 9: 791-799.

Cai, F. and Weber, J., 1993, Virology 196: 358-362.

Calnek, B. W. and Cowen, B. S., 1975, Avian Dis. 19: 91-103.

Capado-Kimball and Barbour, 1997, J. Bacteriol. 106: 204-212

Caravokyri, C. and Leppard, K. N., 1995, J. Virol. 69: 6627-6633.

Cavanagh, D., et al., 1988, Virus Res. 11: 141-50.

Charlton et al., 1992, Arch. Virol. 123: 169-179.

Chartier, C., et al., 1996, J. Virol. 70: 4805-4810

Cheng et al., 1992, J. Virol. 66: 6721-6727.

Chengalvalva, et al., 1994, J. Gen. Virol. 75: 125-131.

Chiocca, S., et al., 1996, J. Virol. 70: 2939-2949

Chroboczek, J., Bieber, F. and Jacrot, B., 1992, Virology 186: 280-285.

Colby, W. W. and Shenk, T., 1981, J. Virol. 39: 977-980.

Cosset, F. L., et al., 1991, Virology 185: 862-6

Cotten, M., et al., 1993, J. Virol 67: 3777-3785.

Cotten, M., et al., 1994, Virology 205: 254-261

Cotten, M., et al., 1994, Gene Therapy 1: 239-246

Cowen, B., et al., 1978, Avian Diseases 22: 459-470.

Cunningham, C. H., 1975, Dev. Biol. Stand. 28: 546-62.

Davison, A. J., et al., 1993, J. Mol. Biol. 234: 1308-1316.

Degryse, E., 1996, Gene 170: 45-50

Denisova, T. S., Sitnikov, B. S. and Ghibadulin, R. A., 1979, Mol. Biol. (USSR) 13: 1021-1034.

Descombes, P., and Schibler, U., 1991, Cell 67: 569-579

Deshmukh, D. R., et al., 1974, Am. J. Vet. Res. 35: 1463-4.

Eloit et al., 1990, J. Gen. Virol. 71: 2425-2431.

Estes, M. K. and Graham, D. Y., 1985, Adv. Exp. Med. Biol. 185: 201-14.

Everitt, E., et al., 1973, Virology 52: 130-147.

Fooks et al., 1995, Virology 210: 456-465.

Furcinitti, P. S., van Oostrum, J. and Burnett, R. M., 1989, EMBO J. 8: 3563-3570.

Fynan, E. F., et al., 1993, DNA Cell Biol. 12: 785-9.

Gallichan et al., 1993, J. Infect. Dis. 168:622-629.

Gelderblom, H. and Maichle-Lauppe, I., 1982, Arch. Virol. 72: 289-298.

Ghosh-Choudhury, G., Haj-Ahmad, Y. and Graham, F. L., 1987, EMBO J. 6: 1733-1739.

Gillen, J. R., et al., 1974, Mechanisms in Genetic Recombination (R. F. Grell, ed.) Plenum, N.Y., pp. 123-135

Gooding, L. R., 1992, Cell 71: 5-7.

Gouvea, V. and Schnitzer, T. J., 1982, Infect. Immun. 38: 731-8.

Gouvea, V., et al., 1983, Virology 126: 240-7.

Gräble, M. and Hearing, P., 1990, J. Virol. 64: 2047-2056.

Gräble, M. and Hearing, P., 1992, J. Virol. 66: 723-731.

Graham, F. L., 1990, Trends in Biotechnology 8: 85-87.

Graham, F. L., et al., 1975, Cold Spring Harbor Symp. Quant. Biol. 39: 637-650.

Graham, F. L., et al., 1977, J. Gen. Virol. 36: 59-72.

Green, M., et al., 1967, Proc. Natl. Acad. Sci. USA 57: 1302-1309.

Green, N. M., et al., 1983, EMBO J. 2: 1357-1365.

Guilhot, C., et al., 1993, Oncogene 8: 619-624.

Haffer, K., 1984, Avian Dis. 28: 669-76.

Hanahan, D., 1983, J. Mol. Biol. 166: 557-580

Hertmann, I., et al., 1979, Avian Dis. 23: 863-9.

Hertmann, I., et al., 1980, Prog. Clin. Biol. Res. 47: 125-32.

Hess, M., et al., 1995, J. Mol. Biol. 252: 379-385.

Hosokawa, K. and Sung, M. T., 1976, J. Virol. 17: 924-934.

Hsu, et al., 1994, Vaccine 12: 607-612.

Huang, D. D., et al., 1987, Avian Dis. 31:446-54.

Ignjatovic, J. and McWaters, P. G., 1991, J. Gen. Virol. 72: 2915-22.

Javier, R., Raska, K. J. and Shenk, T., 1992, Science 257: 1267-1271.

Javier, R. T., 1994, J. Virol. 68: 3917-3924.

Jia, W., et al., 1995, Arch. Virol. 140: 259-271.

Johnson, D. C., et al., 1988, Virology 164: 1-14.

Jones, N., and Shenk, T., 1978, Cell 13: 181-188.

Jones, R. F., Asch, B. B. and Yohn, D. S., 1970, Cancer Res. 30: 1580-1585.

Kalicharran et al., 1992, Can J. Vet Res. 56: 28-33.

Kawamura, H., Sato, T., Tsubahara, H. and Isogai, S., 1963, Jap. Nat. Inst. Anim. Health Quart. 3: 1-10.

Keeler, C. L., et al., 1991, Avian Dis. 35: 920-9.

Kidd, A. H., et al., 1993 Virology 192: 73-84.

Kodihalli, S., et al., 1994, Vaccine 12: 1467-1472.

Kozarsky, K. F. and Wilson, J. M., 1993, Current Opinion in Genetics and Development 3: 499-503.

Kusters, J. G., et al., 1990, Vaccine 8: 605-8.

Larsson, S., Bellett, A. J. and Akusjarvi, G., 1986, J. Virol. 58: 600-609.

Layer, W. G., Younghusband, H. B. and Wrigley, N. G., 1971, J. A., et al., 1989, Mol. Immunol. 26: 7-15.

Li, P., Bellett, A. J. D., and Parish, C. R., 1983, J. Gen. Virol. 64: 1375-1379.

Li, P., Bellett, A. J. D. and Parish, C. R., 1984a, J. Gen. Virol. 65:1803-1815.

Li, P., Bellett, A. J. D. and Parish, C. R., 1984b, J. Virol. 52: 638-649.

Li, P., Bellett, A. J. D. and Parish, C. R., 1984c, J. Virol. 65: 1817-1825.

Maizel, J. V., et al., 1968, Virology 36: 126-136.

Malkinson, M., et al., 1992, Arch. Virol. 127: 169-84.

Mancini, L. O., et al., 1970a, Arch. für gesamte Virusforschung 30: 257-260.

Mancini, L. O., et all, 1970b, Arch. für gesamte Virusforschung 30: 261-262.

Mangel, W., et al., 1993, Nature 361: 274-275.

Maniatis, T., et al., 1989, Molecular cloning, A laboratory Manual, Second Edition. Cold Spring Harbor University Press, Cold Spring Harbor, N.Y.

Marshall, et al., 1990, J. Infect. Dis. 162: 1177-1181.

Mautner, V., 1989, Adenoviridae. in: Porterfield ed. Andrewes' Viruses of Vertebrates. pp. 249-282. London: Baillierre Tindall.

McFerran, J. B. and Adair, B. M., 1977, Avian Pathology 6: 189-217.

McCracken, R. M. and Adair, B. M., 1993, Avian adenoviruses. in “Viral Infections of Vertebrates” (volume 3. Viral Infections of Birds) Eds. J. B. McFerran and M. S. McNulty, Elsevier Scientific Publishers. Amsterdam.

Mittal, S. K., et al., 1995, J. Gen. Virol. 76: 93-102.

Moran, E., 1993, the FASEB J. 7: 880-885.

Moran, E., 1994, Seminars in Virology 5: 327-340.

Morrison, T, et al., 1990, Microb. Pathog. 9: 387-96

Moscovici, C., et al., 1977, Cell 11: 95-103.

Natuk, et al., 1993, AIDS Res. Hum Retroviruses. 9: 395-404

Ni, Y., and Kemp, M. C., 1992, J. Gen. Virol. 73: 3107-13.

Nicholas, R. A., et al., 1987, Arch. Virol. 96: 283-7.

Oliner, J. D., et al., 1993, Nucleic Acids Research 21: 5192-5197

Pieniazek, N. J., et al., 1990, Nucl. Acids Res. 18: 1901.

Plank, C., et al., 1992, Bioconjugate Chemistry 3: 533-539

Precious, B. and Russell, W. C., 1985, Virology, ed. Mahy, B. W. J., IRL Press, Oxford, Washington, D.C., 193-205.

Rao, L., et al., 1992, Proc. Natl. Acad. Sci. USA 89: 7742-7746.

Raviprakash, K. S., et al., 1989, J. Virol. 63: 5455-5458.

Roberts, R. J., et al., 1986, A consensus sequence for the adenovirus-2 genome. (in) Doerfler, W. (Ed.); Adenovirus DNA: 1-51; Martinus Nijhoff Publishing, Boston.

Ruley, H. E., 1983, Nature 304: 602-606.

Sarma, P. S., Huebner, R. J. and Lane, W. T., 1965, Science 149: 1108.

Schnitzlein, W. M., et al., 1988, Virus Res. 10: 65-75.

Scott, S. D., et al., 1989, J. Gen. Virol. 70: 3055-65.

Shafren, D. R. and Tannock, G. A., 1991, J. Gen. Virol. 72: 2713-9.

Sheppard, M. and Trist, H., 1992, Virology 188: 881-886.

Shinagawa, M., et al., 1983, Virology 125: 491-495.

Stouten, P. F. W., et al., 1992, J. Mol. Biol. 226: 1073-1084.

Tagaya, Y., et al., 1989, Embo J. 8: 757-764.

Taylor, J., et al., 1995, Vaccine 13: 539-549.

Traenckner, E., B-M., et al., 1995, Embo J. 14: 2876-2883.

Trapnell, B. C. and Gorziglia, M., 1994, Current Opinion in Biotechnology 5: 617-625.

Treanor, J. J., et al., 1991, Vaccine 9: 459-501.

Tripathy, D. N. and Schnitzlein, W. M., 1991, Avian Dis. 35: 186-91.

Van den Ende, M., Don, P. and Kipps, A., 1949, J. Gen. Microbiol. 3: 174-183.

Van der Eb, A. J., et al., 1980, Cold Spring Harbor Symp. Quant. Biol. 44: 383-399.

Vrati, S., et al., 1995, Virology 209: 400-408.

Wagner, E., et al., 1992, Proc. Natl. Acad. Sci. USA 89: 6099-6103.

Weber, J. M., 1995, Current Topics in Microbiology and Immunology 199/I. eds. W. Doerfler and P. Böhm. Springer-Verlag, Heidelberg-Berlin.

Weber, J. and Anderson, C. W., 1988, J. Virol. 62: 1741-1745.

Webster, A., Hay, R. and Kemp, G., 1993, Cell 72: 97-104.

Webster, A., Leith, I. R. and Hay, R. T., 1994, J. Virol. 68: 7292-7300.

Weinberg, D. H. and Ketner, G., 1983, Proc. Natl. Acad. Sci. USA 80: 5383-5386.

White, E., 1994, Seminars in Virology 5: 341-348.

Wold, W. S. M. and Gooding, L. R., 1991, Virology 184, 1-8.

Yates, V. J., and Fry, D. E., 1957, Amer. J. Vet. Res. 18: 657-660.

Zheng, et al., 1993, Vaccine 11: 1191-1198.

                   #             SEQUENCE LISTING <160> NUMBER OF SEQ ID NOS: 54 <210> SEQ ID NO 1 <211> LENGTH: 43804 <212> TYPE: DNA <213> ORGANISM: CELO Virus <220> FEATURE: <221> NAME/KEY: gene <222> LOCATION: (12193)..(15043) <223> OTHER INFORMATION: /gene: L1 <221> NAME/KEY: misc_feature <222> LOCATION: (15080) <223> OTHER INFORMATION: /note= L2 region pento #n base splice acceptor       site <221> NAME/KEY: gene <222> LOCATION: (15110)..(17495) <223> OTHER INFORMATION: /gene: L2 <221> NAME/KEY: polyA_site <222> LOCATION: (17526) <221> NAME/KEY: gene <222> LOCATION: (17559)..(21754) <223> OTHER INFORMATION: /gene: L3 <221> NAME/KEY: misc_feature <222> LOCATION: (18261) <223> OTHER INFORMATION: /gene: L3 /note= hexon # splice acceptor site <221> NAME/KEY: misc_feature <222> LOCATION: (21102) <223> OTHER INFORMATION: /gene: L3 /note= prote #ase splice acceptor site <221> NAME/KEY: misc_feature <222> LOCATION: (21123) <223> OTHER INFORMATION: /gene: L3 /note= prote #ase splice acceptor site <221> NAME/KEY: polyA_site <222> LOCATION: (21767) <221> NAME/KEY: polyA_site <222> LOCATION: (21824) <221> NAME/KEY: polyA_site <222> LOCATION: (21836) <221> NAME/KEY: polyA_site <222> LOCATION: (21882) <221> NAME/KEY: misc_feature <222> LOCATION: (23608) <223> OTHER INFORMATION: /note= 100K splice acc #eptor site <221> NAME/KEY: misc_feature <222> LOCATION: (23649) <223> OTHER INFORMATION: /note= 100K splice acc #eptor site <221> NAME/KEY: gene <222> LOCATION: (23680)..(27886) <223> OTHER INFORMATION: /gene: L4 <221> NAME/KEY: polyA_site <222> LOCATION: (27920) <221> NAME/KEY: misc_feature <222> LOCATION: (28315) <223> OTHER INFORMATION: /note= fibre splice ac #ceptor site <221> NAME/KEY: misc_feature <222> LOCATION: (28341) <223> OTHER INFORMATION: / note= fibre splice  #acceptor site <221> NAME/KEY: gene <222> LOCATION: (28363)..(31768) <223> OTHER INFORMATION: /gene: L5 <221> NAME/KEY: misc_feature <222> LOCATION: (30511) <223> OTHER INFORMATION: /gene: L5 /note= fibre # splice acceptor site <221> NAME/KEY: polyA_site <222> LOCATION: (31770) <400> SEQUENCE: 1 gatgatgtat aataacctca aaaactaacg cagtcataac cggccataac cg #cacggtgt     60 cactcgggta caaattatga attcgatctt tggacttttc gacgcgccca gt #gactgtac    120 tttattgcgc caattcacca cgcccgggag atttcgaaat tgctatttcc gt #gcagttcc    180 gcattccgaa gtacaattta accggtttta tgggtgttcg gtgtttttct ag #cttaatca    240 ttgtttttag acgacacagt gggtatctgt tttcgcttgg acttggctcc gc #tttgtgaa    300 aattcaactc gatccaacat tttccttatt gatggaaggc ttttattatt tg #cacaacag    360 acatcgcgct atttacacag aacgcaaagt gctgtctttt ttattccttg tt #ccgggtac    420 atcttttatt gctagtgcct cgcctatttt tagtcacgta tcttccttgt tc #tatagcta    480 tatattcacg cggttttcgg tctctcctca ctcggcagat gacttcggaa ga #gaagctgc    540 agagttcgtc tccggagacc ggcctcgccg ctgtcgtcct gcaaagcccc ct #tgaggtac    600 gtgtgcctgc cgttcttcct cctccagtgc gaattgacat ctaccgctac cc #aggctttc    660 cgccaacgga gaccatctgg cacggtctca tcacgcagac tgagttaaac ca #ggctttgg    720 agagcatcgt tgagcaattg tagtaagtgt cagtccctat ttttctgttt tt #tcttgtat    780 ttcctcttag acgatggacc cgttcggttc ttcttcagtc cctccgtgct ct #acatcaga    840 ccttcccgaa cccaagctct atttcgtccg cttgtcaccc catgcagtgc ct #ccagttag    900 ggctacgcac ggagctgcag gatacgattt gtttagcgct tacgacatta aa #gtgcctgc    960 tcgcggtcgg gcgctagttc ccacagattt agtttttcaa tttccgcccg gc #tgttacgg   1020 tcggattgct cctcgctcgg gcttggccgc caaatttttc attgacgtcg ga #gcgggtgt   1080 tatcgatccc gattaccgcg ggaacgttag cgtggttttg ttcaatttct cc #gagagctc   1140 gttcaacatc aggcgaggcg atagggtagc acagcttatt ctggagcgta tt #atggttcc   1200 ggagctgtcg gaactgacgc agctaggcga gacagaccgc ggggcgtcgg gt #ttcgggtc   1260 cacaggtatg ggtgctgtag accgcaatca gcgctctgtg ttggaatggc tg #acccctgg   1320 ttcccgttga taggaccctt gcgacgaagt cgacttcgct gtacgcttgc aa #gcagattt   1380 tgagggggac gacgacacat acggacattg tctgtgcgaa ggcagcacca gc #aagaggcc   1440 ctgctgtacg ctctgtaaca gttactgcgt gcttctttag gtatgattgt ga #gcgtgtgg   1500 cagctcgcga ccatcgcgat tgagttttgc gataagtggg tggggaaata ct #acagattc   1560 cgaccgtatc atgagagact tttgcttatg cagagtcggc aagctttgga aa #ggagcttg   1620 cgccgctgcg taagtgaagt tggacctccg ccagagcctc tagaatagcg at #ggagtccg   1680 gcgcacgtgg tgcttcctga ctttctgcac cattaccgtg gtgtttctgg cc #ttctttct   1740 gcagaaactt ctcaactaca tagatttcag agatagcgac tgcacagaat gt #ttttttgt   1800 gtagttgaca ggactatgga ccagacagca acccatacag ctttgattct tc #tgatcgtc   1860 ttgacggtgt tcacgggcgc ggtggtagct ttgatgttgt atattgcgat aa #ctggactt   1920 ccttgctcta tgctttgctc tcaataaaga ttttcagaat ggtgattcta tg #gtattttg   1980 tcttttttct agacagtcat gtcgcgtgag tctgaacgtt actggacttt gg #tgcacgct   2040 ctgattgatc ggggtgtagt cagccgtgaa cagtggcaaa tggttgaccc tg #cgcaatac   2100 cagttctacc accgctccaa acagaggggt tttaaggtcc gtcacattct tc #gtgatgtg   2160 attcgccaca tgtgttggtc tcggactctg ttagattata tgtcctcggc ct #cgacacct   2220 agtccggacg atgtattacg caatcccctg tatcagttgc tgttatgtaa tg #gatataac   2280 cccgctgttg tggggacagc gctgatccgg tgggcgggcc atcagagcaa cc #gtaacact   2340 gtttggattc gaggcacccc tatgtccgga gctccgtact tggcacaggc ta #tcgcgtac   2400 tgctctcccc tcgtagggag cgttgattgg cgcaacaagt ctaacccatt cg #aagggtgt   2460 ccagatagtc tggtgttttg gtgggacggc ggttatgttt atgattgttg tg #tgggtctg   2520 gtgaagcagg tgttccgggg agaacatgtt attttgcctc ctgagggctt gc #gtggcccc   2580 aacccgtgct ctgaactctt caggacccca gtcttgatgt acagccaggc gg #atatttgt   2640 atgactaggc tgagatcagg ggaactaagt gcagagcatg cggtgggcct ca #gggattgt   2700 atgtacctga tccgtttgac agaagatttt gactgcgcgg gtggtatatc gt #gtgcagat   2760 gtcaaacagt ttgtggcgtg gagccgcgaa caccctgggg aggttcgcga ga #cccacgaa   2820 ctcaaataaa aattcgggac ttctgtgtac gttccttttc atgtttatta aa #cactgttc   2880 tttcgagtga gtcatatcac gtggaagtta attgcgactg ggagccgcag aa #gcaggtgg   2940 taaaagcaag ctatgcaggg atagtttacg atgtcccttg gaagacagac at #agagtgtt   3000 tgtccttcca gtcgcgtgta ggcgccttgg cgccgcgcaa cggttactgc tg #tatatatt   3060 tgttcgaggg cagggttcaa gttgcataac ctgcagtgag tagcatatgt gt #ataagatg   3120 agattaagag ggagttgggg ctggtggtcg tgttgagcaa cgaaattgac ga #ccgttttg   3180 gcccagtgag ctgtaagcac tcggatgagg gataaacaaa agagggaacg gg #gtgtctcg   3240 cagctgcaga tgtactggat agtccagtcg gtacatcgca tctcaataac tc #ttatccag   3300 ctgcagaatg acctgagctg gaggtcacac tcttcgtccg taatgcagtg gg #gcgagtgc   3360 ttgaaggggt acatctgtct tttaaggaga aagagtagga aatcgggatc tg #tgattagg   3420 gtaatgccca cgcgcgtgaa caggggctcg atgtagatat gccaactgtg tt #ggggctcg   3480 tcctcatcgt tgtcactatc ccaaacaagg tcgcacgact cgaatgtctg ta #aaacatca   3540 aaagtttatt actgattttg aagaggggta cgtatacagg ggttacagag tt #tattatcg   3600 cgtttgcaat gcagtgtcat taagcaagca caagcggcag cattagcaac aa #agtcgcgt   3660 agctctttgc gcgggtggta gcatggaggg gtcttggtgt ggtctcctgt ga #ggaagaag   3720 acgaccgtgt tccgcgccgt gaactcgttg gcgagcgaga ggtccgcgca gt #ggattagc   3780 atgggggtcg aggggatgtg gaacgttttc ttattcagcc tgcaggtggc ag #cattgcct   3840 tccataaagt gcagcatcaa cgggtccggc ttctcgtcta cgaagggcag ac #agtataga   3900 gaggcgtggg gtgcgatttc gcccagtgat agtatggagt tgattcggct gt #cggagatc   3960 gcgagcggga aacacgcgca taaggcatta aagagactct tggcgttgga aa #gtcttcct   4020 ccgcagagca cgagggtgtt tagttctcct cggagccatc ggaggatggc gt #tagctgcc   4080 acttttccct cgtagccttc ggcttccatc atctgatgga accagttgtc gc #agacgttg   4140 tagaacgcag ccttgagggt gtcgggctct tcggagggta actggttaat ga #ggctctgt   4200 ccgggtccga accgttcctt gagggcttcg agtacacgct ctcgttcgta gg #tgggtatg   4260 aggttcttgg acgggaagtt ccactggact tcgtgtgcta caccttcgac aa #acaaccgt   4320 tcaaccaact gatccatggg ggacgtggac ggaaataagc agggtgaagg gg #tgtctgga   4380 atgcaggatg ctatttgctc ctcttcgcta cttaaagacg actgagactc gc #gtcgcctc   4440 ttggtgcact gtgggagaga attatatgtc atgtgatgag tgacaagcat tg #catgggga   4500 ggtccacgag cgggaacaga gcattccttt gttctcgcat aggagagcgc gc #aaggcgtc   4560 gttgtcatta tctgcctgta attggtgtat gcgatgaatg tagcgggaga gc #tctcccag   4620 aaagaacccg cagccgttgg cgggttcgta gaacctaata atgatatgtt cg #tcgggagc   4680 agtgggcaga tgttcgggat gggggagctg atataagcgg acgaggcatt tt #ttctcact   4740 gatgtccacg agaccgtcgc gggtcattgt ggtgaatgac ctgcctttca gc #agctggtt   4800 agcaacggga tctttgaacg tgttacaatg agctgtgcag gggaaataaa gc #atcttgac   4860 taaatcttgc tgtctggcgt actggccaaa gtcgaacgcg ttaatgttgg ca #gtgaggac   4920 aaattggaat aatctgagga tggatgcagt gaatatatct gcggcagagg aa #ggttctcc   4980 tacgacatag agcgtgttag tataatggca caggcgacta atgctcatgg ca #gacatcca   5040 cagataaatg gcgtagatgg ctaccggagc attgtaacct tcggcttcta gc #atggctcg   5100 gagatctctt tgtgaggaca gctcgaagcc ttgcagattg aaattgatcg tt #tgactgag   5160 cccgtagctg cagtataatt tgcgcgcttc ttccagaagc gcgggggcga cc #gattcgaa   5220 tagttcagca tcttggggat accgagtgag ccaatctttg taggtaaaga tg #ttgtttcg   5280 ctggagatcg aatattagcc tgtgtgtgac taaatcgtcg tcgtcttctc cc #gtgtggcg   5340 gttcctgagt ctcttaacgc tatccttaag tttcctgaaa cgttcctggg gg #agaaagtt   5400 tttcgagatc ggttagtttg gggtttctct ctaactgctt tctatgtgtt tc #gctaaatt   5460 tgatgataga tttggctgtt ttcaggaatc tctcctgaat gttaacattg ag #agggatga   5520 tcgagtactg ctgatctata ctgcaccacc taaaggactc ggatactggg tc #cggagtgt   5580 acatgaccca gctgaaccgc tggttctgct gcaggaagga aaagtaagct tt #gagaagga   5640 caacgaggtc cttcgagatg ttgtgtgcga acgcatagag gaacctagcg aa #ctggaatt   5700 ggggaatatg acaggatagg atgtgcattt tcgcgttcac tttgagggtg gg #aacgtttc   5760 ctatcgcggt gcgcggtgcc atgttgtgca agactacgaa aatgtagaag gc #tgtacagt   5820 gggcagagcg agcaaagagc ttagaaggaa gggcgtgaaa gaggacagag ac #gctggagc   5880 ctgaacagag cttatccatg cactcgtcca tgataatggc gacgggtccc cg #cttggaga   5940 ctttcacgta aatgttgtct ggatggtcga tgttgagatg ttcgggtgcg gt #ggcctcct   6000 cgtaagtcat ctccataaat tcgggacgga acgtgcttgt cttaggggcg at #ggtgccgt   6060 cttccctgca gtcgaaattg gcctcgacca gctgcaggtt ccaggacgtc tg #ttcgatgg   6120 gtggaatcat gttcttttcc ggagtgatga agatgaccgt ttcggggatc gg #gtccaaca   6180 tgttgcacga gatgagcgcc cgcagcagat gcgacttgcc ggatccggtg gg #tccgtaga   6240 tgaccccgat gatgggctgc ttgcccatgt tgatggacgg cagctgtccg tg #ttggaggt   6300 agcgactgtc catctgttcc tgggctttaa cttcttcgtg ggcttcgaga aa #cttctcat   6360 taacgccccc taggctgtag aactcgtcgt aggaggggaa gtgttgctcg cg #gaagagct   6420 gcggtgctag gtcgacagct ccgtcgtacc agctggtgac gcgctggtag aa #gtcccgcg   6480 aggcttcgta ctcttcttcc tcatactccc aggctttccg cttcctggga gc #tatcatct   6540 gcgaagagta ggtcgtgaac ttgcccgcat tcctcttcgg ataggaacgc gt #agggttcc   6600 catcgtaggg gtgcgagggg gtcttcgtgc ccgacgattg ggacgggtcg ta #cgtctcct   6660 gtcgtgcggg gatttgggtg ctcattgtcg taggggtaca ggtagtcccc gt #gctcgtat   6720 agggtgaggt ccttccacgg acgcagcact cgcgtgagct gctcgttgtg aa #tggtgaaa   6780 gggtcgtagc gactgacctt gttcagaagc gtggttttaa agatggttct cc #gcgtgtgt   6840 agctctggga tgttgctctg cgctccgaat tgcacgtcct cgtgtctacg cc #aacagcgc   6900 agcagcgtgt cgtagatgag ttcggactgc ctgtgtccct tcgatctgat tt #tcccgggt   6960 cctaccgtgc ggcactgttc gttgacgcag attgagtttt tcagtccgta ca #gttttggc   7020 gctaggaaga tggtttccga gctgtacgtg tcacttccgc aggctttgca ct #tgatgtcg   7080 caatcgcagg cccagtagag gccgggattt tctggatcga aagtcagtcg ag #tggattct   7140 gttttgattc ggtgcgcgcc gcggcttttc atgcgatgat agcctgtttc tg #tgacgaac   7200 aggctgtcgg tatcgccata gaggctgcgc ggctcctccc ttcgcaggat gt #gcactcct   7260 ctgtccggtc cgtacaggat gtcacaccac tcgctgaaga aggccctcga cc #agcccagc   7320 acgaagcagg cgatttgcgt ggcgtatctt ttgtttgcca cctgcttgtc ca #ggctttcc   7380 agatggagca cggttagggc ttctggtgtg gcttcgagga gacgcatagg tt #taaaccgg   7440 gtctcgttag cgcgagcgta gtgggcggag cttagctccc cctcgggtat at #aagggccc   7500 gtcgcgaggg tcgcctcgac ttccaggtct acggcgacga gaggatcgtc tt #cggtaagt   7560 gcgtttttcg gcttacgggc actctcgcga tcgctgtcgt ctccttcttc tt #ccccatcc   7620 tcttctgctt cgggctcttc ctgttcgggg tcgtctgcgt agcggaactg tt #gtcgtaga   7680 ctctcctcac tgaaggggtt aggcgcgttt tcgagggtga cttccgttcc gt #tgaacgag   7740 tcgtcattga gcagcgtgac gtgtttgacg atttcagtgc cttcgtagat gt #ttttctta   7800 tctgcttccg agaggtcctg ttcaaagatg atgcgcgtgg tgtccatgtt gg #tggcaaac   7860 gcaccgtaca gcgcgttgct cagcattttg gagatggatc gaatcacttc gt #tcttctcg   7920 cgatcggctt tttctttggc gaggatgttt ttcgtgacgt agtcggcaca ta #gcgttttc   7980 cattccggaa aaacaatgtt catctcgtca tggaggacct ggactcgcca tc #cccggttg   8040 tgcagcgtga ggatatctat gacggtgacc acctcgtcgt agagagcctc gt #tggtccag   8100 accagtctgc ctcccctccg ggagcagatg ggagggagtg ggtctaacat tt #cgggcggg   8160 ggagggtagg cttctatttt caggatggaa ggcttgatac gcgcatcgaa gt #agctcaga   8220 tgcgattcgt tggtcagcag ccggttgagc tcctccacgt gctgcgcggt aa #attttgga   8280 tctaggggca ttccgtgggg catggggtgg gtgagggcgg aagcgtacat gc #cgcagatg   8340 tcaaagacgt agacgggttt caggtaaggt ccgagcacgt tggggtagca tc #gtccgccg   8400 cggagcgctt ggcgtatgta tttgaacatg gggcggtggg gggcgtagac tt #cggccacg   8460 tagtcggggg agggttgttt tttctttttg gttcgacctt tctttttggg gg #gttcgggg   8520 acggagggag ggcatgtcgc acgctgttcg cggacgtaat tggaaaaggt aa #gttgcttc   8580 caaaaggcat gagtgttgct ggggatggtg ggccgcacga agatgttaaa at #ggccttcc   8640 atccctagtt ctcgttggaa ataggcgtcg tagctgtcgt gtaacgtgtg gg #ccagcttt   8700 tgggtgacgc ggacgtcctg catgcagtat tcgaggcacg cttggacgat gt #cgtactgc   8760 tggcccgggt gttctttctg ccatagattc ttctgttcag cgatgacgga tg #ggtcttcc   8820 cagtaccttt cgacaggaaa gccgtcggcg tccgcgtgaa agcgccccgt gg #aaatgaat   8880 tcgttgatgg cctcgtatgg gcaatgtccc ttgcagaggt ctagcgcgta gg #ctgccgcg   8940 gctttggaga gtttggcccc gctggtgagc tgtagagtgt ctcgcaccat ga #accgcaca   9000 aataccgagc gcgcatcctg atgggacacg atcccgcgag accagcgttc ta #cgcgggag   9060 gcgtctttct tcacgtagtt ggggtttggc atgcggaaaa tgatatcatt ga #acagaagg   9120 cgaccgacgc gaggcatgaa ggatcgatca catttgcacg cttccgggaa ta #ggtccctg   9180 cgctcgacga gttccgtggc taagaggagt tcatcgaact tacatatgtt gt #gacctagc   9240 actacgatgt ctacggaata aaagttatcc gggagggaga ggggggaggt gg #gtttctcg   9300 aagagctcgt acggtatttt gtgaacggag ccgtactttc cgtccttgac ta #gctggtcg   9360 caataatctc ggttggcagc cgcgtagcgg tcgactagat tttgggcaaa tt #ctatttgc   9420 agacgggacc tgaagttgcg aaaccttctg gcaacctcgc ccggatggct gt #ctagccaa   9480 tagaagcctt cgtcgagggc tttgagacgg tcgtcctgcc gtgctaagcg tt #cggcgcgg   9540 gagaccagct gggggtctcc gctgagcatg aagcacaaca taaacggatg ca #tgcgcttg   9600 cctttctttt cgaacacggt atacgtctcg atatcgtagg tgatgtacaa ct #gacgtatg   9660 tgggggtgtt gggctggaca ggagaagtgg acgtgctgcc acaaatcgct gc #ccgatccc   9720 tggacggcgt ggtagtagaa ggcagagcgg cgttcgttgc acgagtgtcg tc #tgacccag   9780 tgtcggccgc aggtgggaca ctgttgaacc ggagtgcggc tggtgatcca ga #cccattct   9840 ccggtgacgt ttttggcgat gagcatgggg ggaagggcgg gatgttcgga ga #tgtgcacg   9900 gtccgcaggc gcgctgtttt gcctttaaag ttgatgacgg tgacctgggc gg #gcttaaag   9960 tcggggaggg agcgttcggg gtctcgggca tagtgcagat agtctattcg gt #cgtagcct  10020 ctggctctct tagacagcag gaagcggtgg gtgcgtagga atttcttgag ac #ctatgggg  10080 aatacagtgg gttggaagcg gaagggctgt tcctcgatgt aatagacgtt tg #tgcgtagg  10140 gggttgcccc ggaagctctt gaagtacttt cgggtctctt ccagccgttt ag #cggaaatg  10200 gttcggatga cgtgcgaatc ggggcccagc acgctgtccg tgaggggagg cc #ccgcgtct  10260 gcttccattt acagaggctg acctcgtcgc gccgccgctt cgatgtcttc gc #ggcggtgg  10320 cggagcacgc gtctgaggtt ggctttgatc tcctcgttgg tagcgatggc ta #cgatgcct  10380 ttaaatttga tgcggaaact gatgtcgatg ctatcgatca gctcttcgct ga #ggttgagc  10440 tgcttcagca cttcttcgat gtcaccggag cggtctctgt attgaatatc ag #agagaaac  10500 agttgttggt ccgcatcgtc catgccttcg aattgacccg tccgttcgac ca #tcataaga  10560 aaatcgcgta atatacgttc ccacagggtt tcgaatatgg tggcggggtt gg #attgctcg  10620 ctccatatgc gtttaaaaac ctgctgcgcg ttgacgtccc atcccacgac ga #gtacttgt  10680 aaggtcagga cgtcgacgta ccggcggaac tcgcggttgg cgatgaagtg gc #tgtacagg  10740 tagtagagtg tagaggcgat atgttcggct aagaagaagt acagcaccca ct #tgcgcagg  10800 aacgactctc ccatgagtcc cgcgtcgcgc gcggtcagga gcatgcggta ga #agtcgttg  10860 gcaaacctga agagttcgtg tctccgggcg gccccgctga gctcgtcttg ca #gtgccccg  10920 atggcttcga gcgctgtgcg aatcacctcg tctaacagct cttcttcctc ct #cttctggt  10980 tcttctactt ccatggcggc ttcttctatt tcttcgggag ggggcgcggg gg #aggggggt  11040 ctccgtcgcc gccgcgtgac gcggggcagg cggtctacga aggcccgcac gg #cacggggc  11100 ctaatgcggc gcgcttcgga cgcggtgatg gctctgccgt ggcggtctct ag #ggcgcagg  11160 ccggtgcggt cggttacccg ccggctgcag agggtgatgg cgcctcctga ca #gacccgtt  11220 cctgctaagg aaacggcgtc gctcgctaga gtgctcatga aacatctcgc ca #ttgtttcc  11280 gtaggttcct ctacgtcccg tcttcctcga aacttgcgct cggcatcccg ca #ccagttgc  11340 tgggtgtcta gctccgcgaa ggcttccgcg aagtaggaga gccagtttgg tt #caaggaac  11400 acatcggatc caggtaagaa ccgatatctt tcttccgttt gaaatagatc at #atgcgtag  11460 cagaatagat agtggcagag ggcgactctt agttggcgga tggcggcgag ca #gttcggcg  11520 tcggcggcag aggccgttcg catgaggacg ccttcttgca agccacccgc tc #cgttgccc  11580 gacagtaggc tgtggtgttc ggcgtcgagc tgcggcaaca cttgtccgtg ac #ggcctacg  11640 tcgattcccc tacctcgcag atgcgcccgg cccatgtccg cggccacgcg gt #ccatgagt  11700 acggcgttgt gcatctgcgt gaacgtaccg tgaaagttgt cgagatcgag aa #atcgcatg  11760 tactgcccta cattgacggc gtaggagcag tcggtcagac aggtccaaaa ga #ggcgtctg  11820 ggtctttggg gtgggctatc gtaacctatc tgcataaaaa cgcggttgtc ga #aaaggtaa  11880 tcgttgagcg cgcggtgcat agcttggtac ccgaggagaa ggtgcggcgg cg #gcaatccg  11940 ttgtagggcg gcgcggcgac gttcggcgat cgcggcgcga ggtctcggag tt #gcattaaa  12000 cggtagtcgt acacccggct gacgagaaac acgcttcggg ggtggaccag gg #ctggttct  12060 tcccgaacga ggacatagtc agcggtgatg acgggttcgc agaagcggac gg #tggctaga  12120 ctctgtccgg tgagatccgc gaagactctg taagcctgaa attgagcccc tg #acgttttt  12180 agaccgctcg taatgcaccc cgtcctgcaa agcgttcgaa acgcgagcgt ga #gcgccgga  12240 ggaccccatc aacagcaacc gcagcagcaa cagcacggtg tgtcgtcggt cc #gtcgtcct  12300 ccttcaccac cccgatatcc cgcacaacat gcctatcccg gcgcgggcgc ga #cacccacg  12360 gcaggacgag gcgatttcga cggcgcgctt gatcccgatg aaggaccggt cg #cgtgcggg  12420 ctggcggccg gggccggtgt ggacgaagtt agaatgaggg agcgggacgc cg #cgcggcga  12480 gccacggtgc ccgagatcaa tctttttaag gctcgacgtg acgtggtgcc ca #atggggat  12540 tacgagaggg atctgatgta ccactcggga caggcaatcg atatcgatcg gc #aacgtgtg  12600 ctcactccgg aagactttaa ggggtccgag ccggctttca cgccggctgt ca #accatatg  12660 cgcgcggccg agttgaagag ggcggctgag cagacggcat ttggggagga at #tgaggaat  12720 acctgccatc agacccgcat ccgcacggct ctgttaaggc ccgagatcgg ag #cgggaatc  12780 tactatctgt acgatttcgt ccagacttat ctggagcatc cggacggtcg gg #tgaagctc  12840 aatcctcagc tggtgttggt ggctcagcac gcgggcaata ctatgctggc gc #agcgcttg  12900 tgggccatcg cagaggagaa gaatgcgtgg ttgagagatt tgatagagat gg #cgtacatg  12960 atcgtgaacg atccgtacct caatacggag cagcagctgt cggccatctg ca #cgacggtg  13020 gtcgagttga gcatgaaata cgccaagttg gccgccaaga acggttaccc gt #ccatggcg  13080 cagatggcta aggcgcagga atttttctac cgggtcatgc aagcggtgct cg #atttaggt  13140 gtccaagtgg gggtgtataa caaccgacca gctcggtacc gtcagaagcg ca #tgagcgag  13200 attccgcaga tgactgacgc cgagtacatg ttcggtttga cccaggcgct gg #agagcagg  13260 cctccgcagg gcgaatcttt tgccgacgag gggccgtcag aatcggacga cg #aggatgac  13320 ttcatctgat acgtttctgg ctcttgcgcc ctacgggcgt caggaggtgg cg #gacgccct  13380 cagttcgctc ccagatggca aggacgcgcg gtcgctacgt catgcaccct ac #gcaaatcg  13440 cctcatcaaa ctccagagcg ccatggtgcc tccaaaagtg gacggtactt cc #gagcgggt  13500 ggccgaaatc gtgaaagggc tagccgagca aggcgccatc taccccgatc ag #atgggcgc  13560 gatccactca gatttgctta atcgagctta cacgtggaat tccatggggg tg #caggagag  13620 catccaggcg ctggtcaacg acgtgatcca cggacagaac cggacattgc aa #gacgagct  13680 tgcgcggacg aaagaaatag cgaatgcttc gctcttgacc caatttttcg at #tccctgta  13740 caaaacggtg gatcgtgggc agcgaaattt tgagggcttt aagaaacttt tg #cgtctttt  13800 cgtgaataac gtgccgaatg ccgaagtgta cgggtcttcg gggtccttta gc #gtgcagat  13860 aaatcttggc ggatctagtc aaaacatcaa tctgaccaat gcgtttgaga at #ttgaagcc  13920 gatatggggc gcacggtggg acgcggtgaa taatcctcgc atcggggcgc tt #ctgacacc  13980 caacactcga gcgttgttgt ttttcgtgag ctctttttac gactacgggg ct #atggagcc  14040 cggtagttac ttggacaata tcatgaggct gtacaaggag gctatcagag cc #gatgtgga  14100 cgcggagggt gatgccatta tggagctcgg ggaggcgggc gcaaatctca ac #ttgcggtt  14160 caacgattac aaggacacac taaactacct cctgcaaaat cgagaggttg ta #cccgacac  14220 ggctccgctg gagctgagcg cggagcagga aatgctcttg aagtacctga tg #aggcaact  14280 acgacaggct cttaaggacg gggtcccggc ggacatttct atcagtacca tg #actcagta  14340 cctagatcct aggctgtatc agacgaacaa ggtgttcgtg gagaaattgc aa #aactacct  14400 gttggcggct caggcgcgca atcctgtgta ttaccgactg ttggtgctgg ac #cccaactg  14460 gcggcctccg gcaggcctat atacgggtaa ttacgtgata cccgaccgct ac #gactttga  14520 ggacgtgcag agcgagcttg aatacgcggg tccctccaga gacgagtatt tc #gatgattc  14580 tttgttcgca ccaggtcctc agcgccgctt aaattcggcc gaggaggctc aa #ttggagcg  14640 tgacatcgaa tctttgaccg gccacattga cgaagagctg ggcgtccaat ct #caggctgg  14700 ctggctcgcc gatcaccgcc tgcctgtcgc gttcgatggc gctctcagcc tt #accgaacg  14760 caacgcctac aacacgccgt tgccccccga ttcccacatg cgtagccgtt ct #agctccgt  14820 cgctagcgat cttgggctat tgaacctatc tgggacgggg ggaccgggct tt #ttcgctag  14880 tctgcggcct tccatcggca gccgtcaacc gaccggcacg gccgtgggcc tc #cgcccgac  14940 gacaccgtac agcggttcgg ggtgtatgag gggcaccggt ctggcgcgca aa #gttttaaa  15000 cccggccgcg tcgcgccggg ggcgcaagct acggttctac tgaaccctag ac #tctgacga  15060 agaaacttaa aaacgcttac cgccatttcg ccgcgcagaa gttggaagga tg #taccggag  15120 cctgcgaccg ccgacgtcga ttcctcctcc gcctccctct ggtccctcgc ct #tatccggc  15180 gatgatcaac ggatatcccc cggatgtgcc ggtggggtca cctgccaacg ga #gatgcgga  15240 gctgttcgtg ccgctccaga gggtgatgcc gcctacgggt ggacggaaca gc #attagata  15300 ccggaattat gcgccgtgcc aaaacaccac caagtttttt tacgtagaca at #aagctgag  15360 cgacttagac acctacaacg aggacgcgaa tcacagcaat tttaggacga ca #gtcattca  15420 taatcaggac ttagacccgt caacggccgc cacagagacc attcagctcg ac #aataggtc  15480 gtgttggggc ggagagctaa aaacagcggt gaaaaccaat tgcccgaaca tc #agctcgtt  15540 tttccaaagt gatacagtgc gcgtgcgtct gatgagcaag cgcgatccgg gg #ggtaccga  15600 cccagacgcg ggggtgaaca acccacccgg ggccgagtac aagtggtatg at #ctgaggat  15660 tcccgaaggt aactacgcgt tgaacgagat cattgacctt ttgaacgaag gc #atcgtcca  15720 gctgtacctg caggaggggc gccaaaacaa tgtgctcaag agcgatatcg gg #gttaagtt  15780 cgatacgcgg tatctggatt tgctgaagga ccccgtgacg gggctggtga cg #cccggcac  15840 ctacgtttac aaaggatacc atcccgacat catcctcctc cccggctgcg cg #gtcgactt  15900 tacgttcagc aggcttagtc ttctgctcgg tatcgcgaag cgcgagccct ac #tcgaaggg  15960 gtttacgatt acttacgaag atcttcaagg agggaacgtg cccgcgctgc tc #gatctgtc  16020 ctccgtgcag gtagacgatc aagacgagga cgtgatcgtg gtggcagacg ca #aggcctct  16080 tttaaaagac tccaagggcg tttcctataa cgtgatcacc actggcgtga ct #caaccgca  16140 aaccgcttat cggtcttggc tccttgccta ccacaccctg gactcccccg cg #cgcaataa  16200 aacgttattg actgttccgg atatggcagg tggtatcggc gctatgtaca ca #tcgatgcc  16260 ggacacgttt accgcacctg ccggatttaa ggaagacaat acgaccaacc tt #tgtcctgt  16320 ggtggccatg aacctgttcc cgagtttcaa taaggtattt taccagggcg cg #tccgccta  16380 cgtgcagcgc ttagaaaatg ccacgcaatc cgcaacggcc gctttcaacc gg #tttcccga  16440 aaacgaaatt ctaaagcagg ccccacccat gaatgtttcc tcggtgtgtg at #aaccaacc  16500 cgccgtcgtt cagcagggtg tgctaccgct gaagaattct ctgtctggcc ta #cagcgcgt  16560 gttgatcacc gacgaccggc gccgtcccat tccatacgtg tacaaaacca tc #gccaccgt  16620 gcaaccgcgc gttttgagca gttcaaccct gcagtgagga gcggaaggat tt #tcaaacat  16680 gtccattctg atttcaccca gtgataacag aggttgggga gcaaacatgc gt #taccgccg  16740 tagagcatcc atgcgcgggg tcggtcgccg tcgtctcacc ctgaggcagc ta #ttgggtct  16800 ggggtctcgc cggagacggc gatccaggcc cacgaccgtc agtaaccgtt tg #gtggttgt  16860 gagcacccgc cgccgctctt cccgaagacg ccgatgaagc aagcagctga tg #agatgttc  16920 ttctgactat gtgtgccgtc gctatacaca ggagcgacgt cgttatgcct tc #cgttcttt  16980 tgaccggcgg gcggaccgcc aagggcaaga agagagcctc tcgtcgtcga gt #gaaagtgc  17040 ctaagttgcc taagggagcg cgccgaaagc gtgcgtcggt gacgccggtc cc #taccgtag  17100 ctaccgcgac cgcttccgag cgcgcggctc tgacgaacct agccagacgg ct #ccagcgcg  17160 gcgactacgc cgcttggagg cccgccgact acacgtcacc ggccgtttcc ga #ggcggctc  17220 gcgcagccgc ctcgtccggc acccccgcga ccgcgaggga tctcgcgacg gg #aaccctcg  17280 ctcgcgccgt gcccatgacg ggtaccggcg gaaggcggcg caagcgcacc gc #tacccgcc  17340 gccgatctct gaaggggggc ttcctgccgg ctctgatacc tatcattgcg gc #cgctatcg  17400 gcgccattcc gggcatcgca ggcaccgccg tgggcatcgc caatctgaag ga #gcagcaga  17460 gacagtttaa taagatttac ggggacaaaa agtgatgctg actggacgca ct #aaaaggcc  17520 ctttcaataa acgcgttttt gtagaaccgg ctcgcgtcat ggactacgct gc #gctatcac  17580 cgcatctcgg tgggtgggcc ctgagagacc accacatcgg cgactctagc tt #gagagggg  17640 gagccatcaa ctggggcaac ctcgggtcgc gcataaccag cgcgctgaac tc #caccggtc  17700 gctggctgta taacaccggc aaccgcttcg tgcattcgaa cactttcaac ca #gattaaac  17760 aaggcataca agacagcggg gtcatacgca acgtggctaa tttggccgga ga #gacgctgg  17820 gggccctgac cgacatcggc cggttgaagt tgcaacagga tctggagaag ct #gcggcgta  17880 aagctttggg ggaggaaggt ccagcgaccc aggccgaact gcaggctctc at #tcaggccc  17940 tgcaggcgca agtggctgcc ggagagccgc ccgccgcacc cgcggcgccg gc #gccggccc  18000 cgccgctcgt gcccaccact cgtcctattc ccgaaatggt aacggaggtt aa #gcctcccg  18060 ttacgtcttc ggcgccagcc gtccccgtag acgtgccgac cacgctggaa at #gcgacctc  18120 cgccgcccaa gcgcaggcgc aagagggcac gaccgggaca atggagggca cg #cttggaca  18180 gcctctcggg taccggagta gcgaccgcca ctagacgtat gtgttactaa aa #ttccgtcg  18240 ttccgctatg tctaattttt agctcaccgg ttgtctcccg aaggcgtcat ga #ctgcgctt  18300 actcccgacc tgaccacggc gacgccgcgg ctgcagtact ttcatatcgc gg #gccctggc  18360 acccgagagt atctatccga ggatctccag cagtttatct cggccacggg ga #gctacttt  18420 gacttgaaaa acaaattcag gcagacggtc gtagctccca ctcgcaatgt ca #ccaccgaa  18480 aaggcacaac gtctgcagat cagattctac ccgatccaga cggatgacac gc #caaacagc  18540 tatcgcgtgc gctacagcgt caacgttggg gacagctggg tgttggacat gg #gggcgacc  18600 tacttcgaca taaagggtgt gctggaccgc ggaccttcct tcaagccgta cg #gcggaacg  18660 gcttataatc cccttgcgcc aagagaagct attttcaaca cctgggtgga ga #gcactggt  18720 cctcagacca atgtggtggg acagatgacc aacgtgtaca caaatcagac ca #ggaacgac  18780 aagacggcca cgcttcagca ggtcaatagc atctccgggg tggttcccaa cg #tcaacctg  18840 ggacccggcc tcagtcaact agcatcccgg gccgacgtgg ataatattgg cg #tggtggga  18900 cgtttcgcca aggtagactc agcgggcgtg aagcaggcgt acggagccta tg #tcaagccc  18960 gtgaaggacg acgggtctca gtctctgaac cagaccgcgt actggctgat gg #acaacgga  19020 ggtaccaact atctgggtgc cctggctgtg gaagactaca ctcagaccct ga #gttacccc  19080 gataccgtgc tcgtgacccc tcccaccgct taccagcaag tcaactccgg ca #ccatgcgg  19140 gcatgcaggc ccaactacat cggcttccga gacaacttta tcaacctact gt #accacgac  19200 tcgggcgtct gcagcggaac gctcaactcc gagcgctccg gcatgaacgt gg #tcgtggaa  19260 ctccaggaca gaaacacaga actgagttac cagtacatgc tggcggacat ga #tgtcccgt  19320 catcactact tcgcgctgtg gaaccaggcc gtcgaccagt acgaccacga cg #tgcgcgtc  19380 ttcaacaacg acggctacga agagggcgtg cctacttacg ccttcctgcc cg #acgggcac  19440 ggggcgggcg aagacaacgg tcccgacctc agcaatgtca aaatttacac ca #acggacag  19500 caagataagg gcaacgtggt ggccggaacg gtttccacac agctcaattt cg #gtaccatt  19560 ccctcctacg agatcgacat tgctgctgcc accaggcgca acttcatcat ga #gcaacatt  19620 gccgactacc tgcccgacaa atacaagttt agcattcgcg gtttcgaccc tg #ttacagac  19680 aacatcgacc ctaccaccta cttttacatg aatcgcaggg ttcccttgac ca #acgtggta  19740 gacctgttta ccaacattgg tgccagatgg tccgtggacc agatggacaa cg #tcaatccc  19800 ttcaaccacc accgtaactg ggggttgaag tacaggtctc agctgctcgg aa #acagcaga  19860 tactgccgtt tccatattca ggtgccgcag aaatactttg ccatcaagaa tc #tgctcctg  19920 ttgcccggca cctacactta cgagtgggtc ctcagaaagg atcccaacat ga #ttctgcag  19980 tccagccttg gcaacgactt gcgcgcggac ggcgcgcaga tcgtgtatac cg #aggtgaac  20040 cttatggcca atttcatgcc catggaccac aataccagca accagctgga gc #tgatgttg  20100 cgcaacgcta ccaacgacca gaccttcgcg gactacttgg gcgccaagaa cg #ctctctac  20160 aacgttccgg ccggctccac gctgctgacc atcaatattc ccgccagaac at #gggagggt  20220 atgcggggct ggtcttttac ccgcctcaag gcctcggaga cgccccagct gg #gcgctcag  20280 tacgacgtcg gtttcaagta ttcaggctcc attccctatt cggatggcac ct #tttacctg  20340 tcccacacgt tccgcagtat gagcgtgttg tttgatacct ctatcaactg gc #ctggcaac  20400 gaccgtctgc tcacacctaa cctgttcgag atcaagaggc cagtggccac cg #acagcgaa  20460 ggcttcacta tgtcgcagtg cgacatgacc aaggactggt tcctcgtgca ga #tggccacc  20520 aactacaact acgtgtacaa cggttatagg ttctggcctg acagacacta ct #tccactat  20580 gacttcctac gcaacttcga ccccatgtcg cgtcagggcc ccaacttcct gg #acaccacg  20640 ctgtacgacc tggtgtccag cactcccgtt gttaacgaca ccggctcaca gc #cgtctcag  20700 gacaacgtgc gtaacaactc cggctttatc gcccctcgca gctggcccgt at #ggaccgca  20760 cagcagggcg aagcctggcc cgctaactgg ccgtacccgc tgatcgggaa cg #acgccatc  20820 agttccaacc aaaccgtcaa ctacaagaag ttcctgtgcg ataactacct ct #ggaccgtg  20880 ccgttcagct cggactttat gtatatggga gagctgaccg atctgggtca ga #accccatg  20940 tacacaaaca actcccatag catggttatc aactttgagt tggaccccat gg #atgagaat  21000 acttacgtgt acatgctgta cggggtattt gataccgttc gcgtgaacca gc #ccgagcgt  21060 aacgtgctag ccatggctta cttccgtacg cctttcgcca caggcaacgc tg #tgtaaaaa  21120 aaagacggct gggatgtcgg gaaccaccga gacccaactg cgggacctgc tg #tcctctat  21180 gcacctgcgg caccgcttcc tgggtgtttt tgacaaaagt ttcccaggat tt #ctcgatcc  21240 gcacgtgccc gcctcagcta tcgtcaacac cggctcccgg gcctccggag gt #atgcactg  21300 gatcgggttc gcgttcgacc ctgccgcagg acgatgttac atgtttgacc ct #ttcgggtg  21360 gtcagaccag aagctgtggg agttatacag agtcaagtac aacgctttca tg #cgtcggac  21420 cggcttacgg cagcccgatc gctgttttac cctggtccgt tctaccgagg cc #gtgcagtg  21480 cccctgctcg gccgcttgtg ggctttttag tgcccttttt atcgtctctt tc #gaccgtta  21540 ccggtcgaag cccatggatg gcaatcccgt gatcgacacc gtagtcggtg tg #aagcacga  21600 aaatatgaat tctccgccct accgcgacat cctgcaccgt aaccaagagc gc #acctatta  21660 ctggtggacc aagaatagcg cctattttcg tgctcatcaa gaggaactcc ga #cgagaaac  21720 ggcccttaac gccctacctg aaaatcacgt ttaatgaccg actgtaaata aa #gaacgacg  21780 cacacacgta ctgtacatat ttgtgaatag agcaaccgtt tattagataa ac #gtcaataa  21840 atgccgaccg atagaccgac aaggctcttc actggcttta tttaaagaaa ca #aaaggatt  21900 aagcgaacgg gtcgtcactg gcgatgggcg agactggcgc caacacctcc gt #tttaaagg  21960 cgtacgactc gttccaacgg aactcaggca catgtgtggg ctctgaagaa cc #catcacgg  22020 cagtaaacag ctccgtagca aagacgtacg cgtagcgcag atccatggcc ga #cagacgcc  22080 aggcgcaggt tttttcggtc ttcttcagac cgcggcctgc tccgcccgac gc #cgcctgcg  22140 ggttgcagca ggtgaacacc atggtatgcg ggtttttctt gtgagccttc at #atcgggcc  22200 tgctctcgac catgtcgcga gtaatgtcgt ctgtgccgtt gagcttataa gg #agtcattt  22260 tacagaactg tctccctgaa atggctcgat cggaggcgta gttgcagttg ca #attggttg  22320 agatgaggac acattcctct gcccggcgct tgtccgcgtt ggggtaaagc gc #cttcgtcc  22380 agtctatgtc gtgacgcatc gcgctgaccg ccttggcggc gtcggaaaag ac #catggcgc  22440 aactgccgtg cgcgtgggga tgagggaagc cgctgtgctc ctgatccttg ta #gcacaccg  22500 cgttcgcgtc gaacctgagc accaccacct gtcgtccaaa ccggttcttc tc #gattacgc  22560 cgttctgttc ggccagagcc ctctttcccg cctcgctaga cgggttcaac tc #cacggtac  22620 gaggtttcgt caccatgtcc acaccgtgca tgcatttcgg gaagggctcc tg #gagcgctg  22680 ggaaccagcc atggcgccaa acgtgcgccc ctccgggcac gaacttgggc tc #cagacccg  22740 cgcggctgta gataacggct gccaggaacc gccctacctg agcgttgaaa ga #gtcgtagc  22800 tagaaaaggt caggcgaaat tcgggatgct ttttgcgaac gtatgtaccc cc #cattttgg  22860 tccaaatgga gtcgtcgggg cgcacgctgg ctccctgcca ctgtaggtcg ag #agcttcgc  22920 agatgctggc gacggtggcc atggcgcgtt gcgcgccgta gaccacgggg tc #tgacagag  22980 gggcctccgg ggattcctcg tcgctggcgt tttcttcgtc atcgacaacg gt #ttcccgcc  23040 ggcgggtaac tcgccttacg ggggatgggg actcctcgcg gcggctgacc tt #cttgcgag  23100 tcgcgcctcg gcccggggcg accacttcca cttcttcctc ctcctcttcc at #catgactt  23160 ctgccgttct cttgacaggc ttggtgctgc gaaagccatg agctcttttc gg #ggttcttt  23220 ccatgacttc tgcttcggtg acgggatctc gcgtttcaaa aagttcttgc tc #tccctcct  23280 cttcagagtc agggactact gccggagagg gtggaagcgt cttttgaagc tt #cctgggac  23340 ctatagggta aagttaacgc ccatcgtcag cgagaccacg cctcgctggc cg #atgggatc  23400 acgagacacg ataaaagacc gcgaccaaaa cactcttggg gctagtatcc ct #acccgggt  23460 gcgagcgtgg cagatcttcg ctcttctgct tctccagtgg attctcgggg tc #tttcggcc  23520 ccgtcggtct ctggggtggg agaggcctgc tcctccctct gtttgacttg at #taccgtcg  23580 acggcccggg ctcttcgagg tccacgaagt ccgccacgtc ttcgtcgctg ct #gatcgtct  23640 ctgggtgaag cgtttctgcc atcgtggctg tcatcgaaaa tggcagacaa ga #ttacccga  23700 gaggaaaaaa ccatagcgac gctggacctc gtgttacgcg tggtcgtcga tg #ctggtaac  23760 tgggacgtgt tctcgaaacg tttggttcgc tacacacgcg aacagtacgg aa #tcgagctg  23820 cccgaagata tcggggactt accggacaca tctgaggtct cgaaagtgct gt #tgagtcat  23880 ttgggggaag acaaggcggt actgtccgcg taccgaatcg cggaactgac gc #aaccttcc  23940 gaaatggacc gcgctaaggt cacagaggga ggcctggccg tacttaacgc ga #gtcgcgat  24000 gaaagcgaag ctcagaaccc ctcgaacccc gaacccgaga gcatcgagag cg #acgccgta  24060 gaggatctcg gcgttgcagc agagagcgac cctagcgatg acgaacccga cc #cagaaccc  24120 gagtatgacc atcgagaggc ggatcatgac tctgatgcgg atagcggata ct #attcggca  24180 gatgggggac gacctggaac accagtggac gaggagcccc aggacgattc tc #cctcttcc  24240 gaggagaccg catccactgt catcgaagaa gcgcagacta gcgctagcaa cg #attctcat  24300 gacgacgaca ctcaccgcga cgacggcagt gcttctgaag aggatctcga gc #gggacgcc  24360 ctcgtggccc cggccgatcc ttttcccaac ttgcggaagt gtttcgagcg cc #aagccatg  24420 atgctgaccg gggcgttaaa agacgccgcg gacacggctg atccgccaga aa #cgctctcc  24480 gtcgacagcg tgcaaaggca gctcgaacgc ttcgtcttta accccgaccg cc #gcgtgccc  24540 gccgaacact tggaggtacg ctacaatttc taccctcctt tcctcacccc ca #aggccatc  24600 gcgagctatc acatctttgc cgtcaccgct tccatccctc taagctgcaa ag #ccaaccgc  24660 agcggcagcg accttctagc caaagcaaaa gagagcactt tcttcaaacg ct #tacctaaa  24720 tggcgtctcg ggatagagat cgacgacggg ttgggaacgg aagtcacggc gg #taacagag  24780 ctggaagagg caaaaatggt tccgttaaag gacgacgtgt ctcgtctgca gt #gggcaaaa  24840 atgcgcggcg agcacattcg cttcttcagc tacccgtcgc tgcacatgcc tc #ccaaaatt  24900 tcccgcatgc tgatggaaac gctgttgcaa ccgttcgcgg acgaaaacca aa #aggcggaa  24960 gaggcacttc cctgtctgtc ggacgaggaa gtgctggcca tcgtggaccc ga #cagggcgc  25020 ctccacggcg aggacgcgct caaggccgtg gaaaagcgga gggccgcggt ca #ctatggcg  25080 gtacgctaca ccgcgaccct cgaactcatg gaacgcgtgt tccgcgaacc gt #ctatggtc  25140 aaaaagatgc aggaggtcct ccaccatacc ttccaccacg gcttcgtcgc cc #tggtacgc  25200 gaaaccgcaa aagtcaacct gagcaactat gcgaccttcc atgggcttac ct #acaacaac  25260 cccctgaaca actgcatcat gtccaagctc ctagaaggag cagacaagga gg #actatgtg  25320 gtggactcga tctacctttt cttggtcctg acgtggcaaa cggctatggg ta #tgtggcag  25380 caggccatag acgatatgac tatccagatg tacaccgagg tctttaccaa ga #ataagtac  25440 aggctgtact cgctgcccaa cccgaccgcc atcggcaagg ccatcgtgga ca #tcctcatg  25500 gactacgacc ggctcaccga ggaaatgcgg aaagcgctgc ccaacttcac ct #gtcagagc  25560 cagattactg ccttccgcca ttttctactg gaacggtcca acatcccagc gg #tcgccgcg  25620 cctttcatgc caagcgactt tgtgcctctg gcttacaagc agagccctcc cc #tcctctgg  25680 gaccaggtct atctgctgca gctggccttc tatctcacta agcacggagg ct #acctgtgg  25740 gaagccccgg aggaagaggc caacaacccg tccaaccgga cttactgtcc tt #gcaatctc  25800 tgcagtccgc accggatgcc aggtcacaat gcggcattgc acaacgagat tc #tggctatc  25860 ggaacgttcg agatccgcag tccggacggg aagaccttca agctcacgcc tg #agctgtgg  25920 accaacgcat acctcgacaa atttgacgcc gaggacttcc acccgttcac gg #tgttccac  25980 tatcccgaga acgcatcgcg gttcgcatcc actctaaaag catgcgtcac gc #agagcccc  26040 gaaatcttga gcctgattcg ccagattcag gaatcgaggg aggagtttct gc #tcaccaag  26100 ggcaaggggg tgtacaaaga cccgaacacc ggagaaacca tctccagaca gc #cccgggac  26160 actgcccgcg cgcagcacgc tggagacggt caagctctac cagcccctgg ag #cctatacc  26220 accggaggaa atagagcgga gacagcgcct gctggagctg tacggcttgc cc #cggactac  26280 caagacgggc agtttcctat cgcgaaagtc ggcccgcact accatggccc aa #agaatgtt  26340 agacgagaag accagggtta cagaggcggg cccggaggtg tacggggaga gc #gcgaggtc  26400 gtcctttcac gaagagcagg aggaagacgt ttcggacgga gaaacactag gc #agtcagga  26460 tacaacgaac gggctaaccg atatttcgga agaggaggag gaggatctgt tc #gagggcaa  26520 caaggagaac atcccaccac ctcgccgtcc gcctcggaac cgccggctcc ga #gccgcata  26580 ctcgctcgag gaacccctcc ttcccccgag cgccgcgacc gacaagaaga gt #aagaaagt  26640 cccaaaaagg cgaggtaaat atcgcagctg ggctaagcac cgcgtggcga ta #tgccaggc  26700 acttcgcgat gcggtctttg accgcaaaaa ggcgggcgaa atcctcaagc gg #ggtcaccg  26760 gctcttcgtg cccgctactg tcataggcta ctatgctcgc aaactctctc cc #tcatttct  26820 cgctcctctc tccagccaca ccgcacccct cctcccacca aaaaaacacc gg #cgctaagg  26880 ctgtgcgtct gcgccaagat ccggtgccgc agcacatcgc ggacctcaga gg #ggaaatac  26940 tcgacatcct gttggaaatc gagtcgtacg cccgccgccg tcccgaccgc ca #cgtgtcca  27000 ttcgcaacag aacgcgcgaa agcatcaccc gaaaactgca ttacgagaaa aa #tgaagata  27060 agcttacccg tatgaagagc gatgctatca agttgctcgc tctctggcag ac #cgtttaac  27120 tcgtgttcct ttatagccct tcggaaccat gaacctgatg aacgccacac cc #accgaata  27180 cgtatggaag tacaacccag tctccggcat tcccgccggc gcgcaacaga at #tacggcgc  27240 cactatagac tgggtgttgc caggaggaac cggtttcgca atagcaacca ac #gacattcg  27300 aagacaaacc cttaacccgg ccgtgacccg tgcaattacc gcgcgttttg aa #gctgagtc  27360 agaccagcaa ccgtacgcta gccctcacga gaccaatgtt atcgcggcca at #gtcctcga  27420 ctcgggttat cccaaatccg gtctctaccc attagagctc agcggcaatc ag #cgcgtaca  27480 gctggcaggc ggcctaatgg taggtcgcac tgagggcagg atgcaattag cg #ggcggttt  27540 aacagaagga agagtgcaac tttctggagg tttccacgga cggccgttgg tt #agagggcg  27600 gagcagaaga ccgcccagat ggtgcggcgc cgaactgact gggaacggac tg #cccgagca  27660 agccgaagtc acttctgaca cttacaagta cttcctgaga acacagggtc cc #agccaagt  27720 ggttgaagag cccggcgtct tttcgcaaag acaatttatg actaccttcc tc #ccctccgt  27780 tgtccctcat cccttcgaca gcaccaaccc cggcgatttc cccgcgcagt ac #agtgccat  27840 ctacaaaggc cgcacggcct tcgaagacac cttttgggac tggtgaagcg ca #ccttttgt  27900 tggcgatgct ccgtttcgca ataaatttct tccaattctc tgtcgttaaa cg #gctcccgt  27960 ctggtcactg tcacgcgctc gccgccctcg ctcgtcaccc gcgcgcggta cc #gtcgcctc  28020 agccagaata caaaaccggg gttcaggggt tcgtcgaacc gtaccacagc ct #ggtcgttt  28080 aatctcaacc aatattttct agggttcgac atcatgaacg aggaggttcc cc #taaagcgt  28140 gtcagccctg acgaaaccga gacggttccc aaaaaaccgc gaaccgacgt tc #gcgacacc  28200 gtcagggccg gcactgacga cacggtagat ctcgtgtacc ctttttggtg ga #atctcgga  28260 acgggagggg gcggaggagg aggaggcggg ggcggcggca gtggaacctc tc #tccagccc  28320 aatgacccgc tttacgccgc cagcgggacc atcaacctac gcatgacatc cc #cgctaacg  28380 ttgtcacaac gagccttggc tctcaaaacg gacagcaccc tcaccctcaa ca #cgcaaggc  28440 cagctgggcg tcagcctcac ccccggagac gggctcgtcc tcaacaccaa cg #ggctcagc  28500 atcaacgcag acccgcaaac cctcgcattc aacaacagcg gggcgctcga ag #tcaaccta  28560 gaccccgacg gaccctggtc taaaaccgcc acggggatcg atctgcgtct ag #atccgacg  28620 acgctcgaag tagacaattg ggaactagga gtcaagctcg atcccgacga ag #ccatcgat  28680 tccgggcccg acggtctctg cctcaacctg gacgagactc tgctgctcgc ca #ccaacagc  28740 acatccggca aaacggagct cggggtacac ctcaacacca gcggtcccat ta #ctgcggac  28800 gaccagggca tcgacctgga cgtcgatccc aacaccatgc aggtgaacac ag #gaccttcc  28860 ggaggcatgc tggccgtcaa actcaaatct ggcggcgggc tcaccgctga cc #ccgacggt  28920 atctcggtca cggccaccgt cgcgcctccg tccatcagtg cgacagctcc tc #tcacctac  28980 accagcggca ccattgcact cactacggat acgcaaacga tgcaagtcaa ca #gcaaccaa  29040 ctggccgtga agctcaaaac gggaggcggt ctgacggctg acgcggacgg aa #tctccgtt  29100 tcggttgcac cgaccccgac gatcagcgct tctcccccgc taacctacac ca #acgggcaa  29160 atagggctct ctatcggaga ccaaagcctc caagtcagct ctggacagct cc #aagtcaaa  29220 ctgaaaagcc agggcggtat tcaacagagc acgcaggggc tgggagtggc gg #ttgatcaa  29280 acccttaaga ttgtgtctaa cacgctcgag gtcaacacgg acccgagcgg ac #ccctcacc  29340 agcggcaaca acggtctcag cttagcggcc gtcacacccc tagcagtgtc tt #ccgccggc  29400 gtcaccctga actatcagtc ccctcttaca gtcacgagta actctctcgg gc #tctccata  29460 gccgcgccac tccaggcggg tgcgcaaggc ttgacggtaa acacgatgga ac #ccttgagc  29520 gcctcggcgc agggcatcca gctgcactac ggacagggat ttcaggtcgt cg #cgggcacg  29580 ctgcagctgc tcactaatcc ccccatcgtt gtctcatccc gcgggttcac ct #tactctac  29640 actcccgcct tcacggtgag caacaatatg ttggggttga atgtagacgg ca #ctgactgc  29700 gtggctatca gttcagccgg cctacagatc cgtaaggaag ccccgctgta cg #tgacctcg  29760 ggaagcactc cagcattagc ccttaagtac agctccgact ttaccattac ca #atggtgcg  29820 ctcgcgttag cgaacagcgg cggaggagga agttccacac ccgaggtggc ca #cctatcac  29880 tgcggggata acctactcga gtcctacgac atcttcgcct ctctacccaa ca #ccaacgcg  29940 gctaaggtgg cggcttactg ccgtttagct gctgcaggtg gcgtggtcag cg #ggaccatt  30000 caagtgacaa gctatgccgg acgatggcct aaagtgggca acagcgttac gg #acggcatc  30060 aaatttgcca tcgtcgtgtc tccccccatg gacaaagacc cacgatcgaa cc #tcagtcag  30120 tggctgggtg ccaccgtatt ccctgcgggc gcgactactg ctctcttctc ac #ccaacccg  30180 tacggctccc tcaacaccat caccacactg ccatccatcg cctcggactg gt #acgtgccc  30240 gagtccaacc tggtcacgta taccaagatc cattttaaac caacggggtc gc #agcagctg  30300 cagctcgcga gcggagaact cgttgttgca gcggcgaaat cgcccgtgca ga #cgacgaaa  30360 tacgaattga tctatctggg atttacgctt aagcagaact cctcgggtac ca #acttcttc  30420 gatcccaatg cctcctccga tctatccttt ctgacaccac cgattccgtt ta #cttatctg  30480 gggtactatc aatgaacttg ttaactcctg cagcagcagc agcagcagca gc #agcatggc  30540 tgaccagaaa aggaagctgg cggatccgga tgccgaggct ccgacgggca ag #atggcccg  30600 cgcgggtccg ggagaactgg acctcgtcta ccctttctgg taccaagtag cc #gctcccac  30660 ggaaatcaca cctccgttct tggacccgaa cggtcccctg tactccacgg ac #ggcttgtt  30720 gaacgtcagg ctcacggcac ccctcgttat catccgtcaa tctaacggca ac #gcgatcgg  30780 ggtcaagacc gacggaagca ttaccgtcaa tgcggacggc gcgctgcaga tc #ggaatcag  30840 cacggccgga cctctcacca ctaccgccaa cggcatcgat cttaatatcg at #cccaaaac  30900 cctggtcgtt gacggtagca gcggcaagaa cgtcttggga gtgcttctga aa #ggacaggg  30960 ggcgctacag agcagcgcgc aaggcatagg cgttgccgtc gacgagtctc ta #caaatcgt  31020 cgataacacc ttggaagtga aggtagatgc tgcaggtccg ctcgccgtca ca #gcagccgg  31080 cgtagggttg cagtacgaca acacccaatt taaagtcacg aatgggactt tg #caactgta  31140 ccaagcgccc actagcagcg tggccgcatt tacatccggg acgatcggct tg #tcctcccc  31200 tacgggcaat tttgtgagct ctagcaacaa cccgtttaac gggagctact tc #ctgcagca  31260 gatcaatacc atgggcatgc tgactacctc gctctacgtc aaagtcgaca ca #accaccat  31320 gggtacgcgt cccacgggcg cggtaaacga gaacgcgcga tactttaccg tc #tgggtgag  31380 ctccttcctc acgcagtgca acccctcgaa catcggtcaa gggaccctag ag #ccaagcaa  31440 catcagtatg acctcttttg aacccgccag aaaccccatc tcacctcccg tg #ttcaatat  31500 gaaccaaaac ataccctact acgcttcccg attcggggta ctggagtctt ac #cggcctat  31560 cttcaccggc tcgctcaaca cgggaagtat cgacgtacgg atgcaagtga cg #cccgtcct  31620 cgccaccaac aacacgacct acaatctcat cgcctttacc ttccaatgcg cc #agtgccgg  31680 actgttcaat cccaccgtga acggcaccgt ggccatcgga ccggtggtgc at #acctgtcc  31740 cgctgcccgc gcccccgtta cggtctgaac aataaagaca aggtgaacca tt #tatacagt  31800 ctcacgtctc tttattgcat acgctccgct aaatgtttcc attcgctcat tt #gccagtaa  31860 tacagcagat tcgcaaactc actgaaccaa tcttctgtat aaaaatgtac gc #gctgcgtg  31920 tccaaatcaa catcaatttt cctcatatac agacaggggc tgccacccgc ct #cccccaag  31980 cgcgacaccg caattaggaa tggtagcctg ctgtgcaggt ccacgtgaat ta #acatcccg  32040 cacacgttcc cgatcggtcg ctgcataaat actggagaga aatcgctaaa cc #ccggtgac  32100 gcccacatag ccacgaagta cacccctgcc acattcaagt catcctccaa cc #tggcccaa  32160 acataagtgg ccaaatcgga aggagccagg tggcaagccg ataaccccat ac #gatgcaaa  32220 ggtaacccgt ggcaagcgca tcccccgaaa tgaagttcga aagaatcgta ac #acagtagc  32280 tgataggcat gaagcggcgt cggcatctga agaccgtcat catcttcgtc gt #cttccatg  32340 tcatccccaa cttcctcctc gcgctccgct tcctgttggc ggcgctgctg gt #gctgcagc  32400 accatctcca ggatctgctc gtcgttcatc ttaatccgga attatcgcgt ac #ggatgttc  32460 ctcgtcgtcc gaactgacaa cagaaggcgg aggagctgtc agtggtgctg ta #gaggctaa  32520 cgatgctgca gcaccggtct cttgcaattc gaaataccaa gggttgctac tg #acggtcca  32580 gttcccgccc cgtgaaccag gccagcggga aatcggtgca ggtaggggat cc #ggtgaagg  32640 agaccgggaa tggagggaag gaactgcgag atccttatcc actcgataca aa #ccgtataa  32700 cagggagccc aacgccaggt acaccaggaa cgtactacaa acgaacacgc tg #attacaaa  32760 gtttaacgaa gacagatggt tctgtaggaa caggaagctg cacaggatga tg #ctgctgta  32820 ggacagggcg accaggaggg ccaagaactc gcgccaatag cgtccacaac ac #tgcaaaat  32880 caaacacgta attagctata cggacgttca ccagcgactc tcgcgcgtcg tt #ccataaac  32940 acattgcgca gataagccaa ctgagcagaa cagaacagag agagaggttg cc #gcgtcgaa  33000 cactgtttgc actgtccgaa acactcggga tgagactccc cgtacttccc gt #gcacatga  33060 aatacccact cttcgacgtt agcgtaggac aaccgacggt aaccggggaa gt #aacacagt  33120 ccctgcgaca cgatcggcca cagttccggc gacaccatca cgcggagcat gc #ttctcagg  33180 cagacgggtt gggtcacggc gctgctgcga gaaatagttt ccaccatgat gg #tggccgtc  33240 acggtcacgc gacacgcatt catgagaaca accggagacc gcacaaaagg aa #cagacgaa  33300 ggcacttgcg aaaaggacac ctcaaagctc atcgagcgga gagccatctt ta #cggatatc  33360 ttctccgcaa tcagaaagcc tgtggtgaaa aacttaaaat ctgtcttcct gc #gagcaagc  33420 atccacggtt ccaagtcgta cttcatccca ggtgtaataa aaagcaacct ac #gtgagagg  33480 tagtgcagca gggcggtctt ctctgcccgg ttcaggtgaa gggcactcac aa #tccggact  33540 atgcaattca tgagtacgta gtctcgccgt ttgaaacaca caaactttgc gc #tgcgtacc  33600 gtcactagca ccgtgacaga actatgcaat cgcctcatca gatcattatc ga #aacaccgc  33660 aagctagcca cggctctatt tatgcggtac tcgttcagtc tctccatttc ct #cctgtcga  33720 caagttggat cgtgacgtag gagaaaacta aaccatatta ctcctacttc gt #tatgaaag  33780 ccacaagctc tgctgacggt taaagactcc ttaagaaaga aaaggtagta ca #gtcaagct  33840 gacccataca ggtgaacccg ccccaagtca cgtaagtcaa ctcaccgaaa ga #ggacacag  33900 agccatatcc gctgcttcaa agctttattg acgggtctaa aggcgtaaag aa #aagaagaa  33960 tttaccgttc tgcatctcaa accccaccac cacgcgaaaa agtccgaacg at #gctgcagc  34020 accgttcacg caaaagtccc ggacgcgcac aaataaaccc ttaatcccga ta #acggtgct  34080 gcagcaccgt cacgctgctg cagcatcgtc agacgtttat gacatgcagc cg #attccgtg  34140 cggatttatg gtcccataac ggttccaggt cctttcgttg ctgcagcacc gt #ttcacgta  34200 aagaagctgt acaggtcaaa ctggtccgga ttactgatta ttcgggggag ag #ccacgtga  34260 cgtagactcg aacgacgtcc acttccgata caaaccacat ctctctggac ac #aggcttgt  34320 ccgccttgag ccaaaccatg tgattcttcc ggtccgttct gacgtcaatg cc #gacacgcc  34380 tcttggtgtt tgaacaggca tcccagtacg tagccaggac cactcggtga cg #tcgaggtt  34440 gaggtttaaa ggtcactacg gcctgtaacc cggtactcca gggccctaaa ct #aacatatt  34500 ctccggccct gcccactaca ttcgggtgat caaatatgac ataatcctta aa #caatttgg  34560 ggaacttcaa acagccacat ttgggcggga caggaagatg gtgcgcagaa ac #attgatat  34620 gagagcgcca tctagggaca tcaaagcggt gcccgcctgg atggcaatcg ta #cttcttag  34680 ttccggtaaa gtaataggtg tgagtccgga aacacgtaaa ctccgtcact tc #ctgtgtcg  34740 tcattgccct cgcccctagt gacgtcagag tgccacgccc cttgtacagt ct #aataaatt  34800 ttaatacacc cccgccccta gcatataaaa caatgggagc ctcgcccaca tt #cctatccc  34860 taataaaata ccatctgacc gaatacccgt gttccatccc tattgtttta gt #ataataag  34920 ggtcataagt ccacaactcc gcggcattgc cctctgtcac caccaacagc aa #ataggaag  34980 atgccatgtc atcctctcgt aaaagcatcc tccaatcagc tacctcttcc gt #gtagtact  35040 gagttggctg actgtaatca cgccccgtga cgtaggctga ccacgcggaa gg #aacacttc  35100 cgtgcatgct cagtagctgg tcagcctggt gagtatccag ggccttcata aa #ggtcaaag  35160 gcgccataat gtgataacac agtccatccg atcggaggaa atcaaaggga at #atgtacat  35220 cttcacaatg gcgcctccca gaataagacc atgcacagat ttgacctttc ca #ccaagcac  35280 gtgactcgca agcctcatgt ttttgaccag tcagatcgct ccgtatatac tc #gtctccta  35340 ttggtcgatc aaaaccgtac gaaccaatac tagacgcaat caccactacg ta #atccgcgt  35400 catccctaga gataacacta tccgcatccc tattggctga ccaatgacca cc #ggaagaca  35460 gcaaaaggtt taaccctttt gtgtgtaagt ccatcctata accctggaaa ct #ttccaatg  35520 ggggatctag cgccactatg cggccaacct tttttgaccc tctgtccgga ct #agaagttg  35580 gcgggacaaa gccgcgcata cagtgccccc tagcgacatc cctatgcaat ga #attcgatg  35640 gtccttgaac tccgtaaaaa aatgagcagt ggtcctgact gcgtaatagg cc #ggccccct  35700 cacatcctgc ccccacaaaa gggcgtctac cttcttacaa atatctctca gc #tgattggt  35760 ccagtccaac agaatgaccg gggactctgg cgtcataatg gtatgcatac gc #aaaatctt  35820 tctcatcatt tcactggtcc atttatatgt gccgtcatag cgcgccctat ta #ataagcgg  35880 acacacatcg ggatacatgt cctgaaccag aataatgagc tccccgctat ct #ttaccatc  35940 caataccccg agccgccgca tttgactgac aacccagggg ccgtccgaaa aa #gtcaaaaa  36000 agtctcattc caccatacaa ttaacttggg ccacgaagga aaatccggcg aa #taggtgcc  36060 catcaagcgc ctgacgtcag ccttaggata tggcggatcc catctggaat cc #gacccatt  36120 aaagcacgaa gatagggcag acatcggcca atggccagga gaatgggtag aa #ttaataag  36180 gactccgcct ccatttccga gcttttaaaa aaaagagaaa atggaaatca gc #caagagac  36240 caccaccccg tgattggatg attggtcatc agaagatcga taagggaatt ta #ttttctgg  36300 gagccccccc cccccctact cctatttaaa aaataaccct ttcctcacca ag #ctcagaag  36360 acagaggagg agagtagagc gccgctcaga ggtcatccgc cgagagaaaa tc #ccgcgcag  36420 agaacagagc tctcaggtag gggtctggag ctctctggaa aaatcgcggg ct #cttataca  36480 cttactctcc gcccattcga aagccgcgcc tgactagagt acacactata aa #ttccattc  36540 cggtgactta ctactaggcg ctggccactt atcaaaagaa acagttctaa ga #ataggaca  36600 aagtccaacc gcaataaaac acccttgtca aacatgataa gagtgttctc ga #gaaggtac  36660 tggaaaagca aacagtccaa ctcccaagtt aaatattacg caaagaggcg ta #acgagaaa  36720 agactagaaa gtgtaaacac acctctccta gttatatata aacccagcgg gg #cagtccct  36780 agaagaacac tacctcaatc cagttacaca ttaacccggg aacctattat tg #attaacta  36840 gacagtactt cctcattttc tactggaact ttccactgcc ctccggggat tt #tccattgg  36900 caatcattaa cttgactttg tactttatgt ttactctcca tagcaacgca cc #ttatatgg  36960 aaaatatgct cctccccgga ccgcccatcg taccacctga gcaggtaggc tg #tacctttt  37020 cctattggcc cattatgagc tcacctggtt aatcatatac ccgctccgcc ta #tataggta  37080 gcataccggg acaggttccc tcacagtcta ttgcagactg ccgaagagag ag #gagctccg  37140 cataggactg ggaccagaac cccgagactc tgccggtaat attttaattt ca #tttaatcg  37200 aatcaaataa atcaaaaatc aactcaaacc catgattctc aatggaaatt tc #ttgtgatt  37260 ttctttcgcg cgcgaccacc ccctatggca cccccctgta cacccccctg ta #cacccccc  37320 tgtacaaggg aacctacccc cctgtacagc gaccaccccc catggacacc cc #cctgtaca  37380 ttctacaggt atggcccgca acccattccg catgttccct ggggaccttc ca #tactacat  37440 ggggaccatt tcctttactt cggtggtccc tgtggaccct agccagcgga at #cccaccac  37500 tagccttaga gaaatggtga ccaccggcct gatttttaac cctaacctga cc #ggcgagca  37560 actgcgggaa tactcattca gccccctagt gtccatgggg agaaaggcaa tc #ttcgcaga  37620 ctacgagggt ccccagcgca ttatccacgt taccattagg gggcgctccg cg #gaacccaa  37680 gacccccagt gaggccctca ttatgatgga gaaggcggtc cgtggcgcgt tc #gcggttcc  37740 tgattgggtg gccagggaat actcggatcc cctcccccac ggcataaccc ac #gtggggga  37800 cctgggcttc cccattggtt ccgtgcatgc cctgaagatg gcgctagaca ca #ctgaagat  37860 ccatgtccct cgcggagtgg gggtccctgg ctatgagggt ctctgtggga cc #accaccat  37920 caaagccccc cgacaatatc ggctcctgac cactggagtt ttcaccaaaa aa #gatctgaa  37980 aagaacactt ccagaaccat tcttcagccg attttttaac caaactcccg aa #gtttgtgc  38040 catcaagact ggcaaaaatc cgttttctac agaaatttgg tgtatgactc tc #ggcgggga  38100 tagccccgcc cccgagagaa atgaacccag aaatccccat tctctccaag at #tgggcaag  38160 actgggtgtc atggaaacct gcctacgtat gagtaggcgg ggactcgggt ct #cggcacca  38220 cccctaccat tctctgtaac caatccctga ataaagattt gcataacaga ac #tttgactc  38280 ctccttttat gtgggtgggg taatgggcgg cacttggggg taatggcggt tc #ctattgga  38340 tgggtaacac cgactccgcc ctacaaagtt aatgattgat ttttcggact ta #gaaaaatt  38400 tcgactgtca cctggatgtt tttccccact taacctctag ggggagatag at #cgcgtcca  38460 aggggaggag ctcaataccg gaccgcctat taggtgtggc ttcgggctcc gc #ctagtggg  38520 aggagacagg aaaaccacgc ctagtgacgc tgggtcaaag tccaagggga gt #ggtttatg  38580 cgcaccgcct tggggcgtgg tttgggcggc gcaaggtaac ccttggactg gg #aggagact  38640 tctgtccctt gggcgtgtca aacaggtaaa ccccacccgc gcgattaatg at #taattttt  38700 cggacttaga aaattttcaa cctgatactt tattttcaag cttttcccgc cg #acgggcaa  38760 gcctcctatc tctccgtcta tgactccaca gagcctcatc tgaatatgta aa #tgtgctga  38820 accgcaaccc cgtagaccgc gcccacccca gcatcaaagg taacgccccc ga #tgccacaa  38880 tgtaattacc cactgttaaa ttaggatcct tacaccaatc atttctgtac aa #tttaaacc  38940 accgcccacg cgggactttc ccgtggtggt agaaaaaggt tttgaaaaac gc #gcgcatta  39000 ttttcgtggc ttcattaata gcggacatgc gcagatccag aaaggtcaga ca #caccacca  39060 cggtcacatg acatttgcat ggagacaggg attggatacc gacacaatac gc #catcggat  39120 actgaatgtc cacattggtc cgtgcatata cagtgtgcca cctcctcttg ac #cgcagcca  39180 cgaatcccca gaagagttct tcccgccaca aaatcgaaac cggggcggcg gc #cccaaagc  39240 acaaatacaa aggcatcctc ctgaggctct agaaaaaaca actcattaac ag #gcatcccg  39300 ctcataggta cattcgtgta aacagggctg catgccaacc aatgccccgc gt #tttacaaa  39360 gtgacgggcc accctattgg cggagggggt ccacgtattg cgcaccgcgt aa #atagaagc  39420 cacccctcgc ggaacctgtg tacattcaaa tctcctccaa atacattcgc gc #agtaaagc  39480 caccgccctt ttcaagaaag tccaatcaac cttatgcgtg ggcaaaaaaa ta #gaagctga  39540 atataccccc gcaaactcct ccaatcggaa caggtaatct acactatagt gg #gacagcat  39600 ctcaacagtt aaactttccc aggcatttat caccgtcaat ttcagatcat gg #aatacggc  39660 caagttaggc tccatcaagg tcacgcggag gtggaagtaa tacatcccga aa #taccctgt  39720 taaaaaaaat agaaaaatga actaaccgac aataagatcg gcagtaccca gt #ttcgatct  39780 ggggacctcc ggagtgcaag tccgacgctc ttacggctga gctacactgt cg #atcttgat  39840 ccgctagggt acgcagtccg gagaagaaat atactaagtg agacccggtc ct #atatatac  39900 aggttggttc aaaggaacct ttgtacccat taaaacaggt gcgtgactgt ag #aagccaca  39960 cccctacctg taccgataag gcacaccctg agcaaacaaa ccataaaggt at #acttcctt  40020 attcagacag gtataaatgg aacctccgca caacagtccg gtaccatttt cc #atcgcgaa  40080 aatgggcaac cctactctgc tccttctttc aggtctcctt tctctgaccc ag #gccatttc  40140 catcggagaa cacgaaaaca aaacccggca tgtgattgta tggcggcact cc #tcctccca  40200 ccaatgctct gattggagaa cagtcacgga atggttcccg ccccaaaaag gc #aacccggt  40260 gagaccaccc tacacccagc gggtttccct ggatacggca aacaataccc tc #acggtaaa  40320 acccttcgag acaaacaacg ggtgttggga aactacgtca caaggcatta ac #catccacc  40380 aaccaccatt cagtaccggg tatggaacat caccaccacg cccaccatac ag #acaatcaa  40440 cattaccaaa ataactgttc gggaggggga ggactttacc ttatacggac ct #gtgtccga  40500 aaccatgagt attatcgaat gggaattcat caaggatgtc acgccccagt tc #atcctcca  40560 atactatctc tccattaact ctactattgt gtacgcaagc taccaaggga ga #gttacctt  40620 taaccccggt aaaaacacac taaccttaaa aggcgcgaag accaccgaca gc #ggcaccta  40680 caagtccacg gtgaacctcg accaggtatc cgtccacaac ttccgagtag ga #gtcacgcc  40740 catcgagaaa aaagaagaag ctaccgcaga gacacctgcc agcaagccca cg #cccatacc  40800 acgtgtccga gcggatgctc gaagtactgc cctatgggtt ggacttgccc tt #tgcatcct  40860 gactgttata cccgccctta ttgggtggta cttcagagat aggctctgtg tt #cccgatcc  40920 aatcattgaa ctggaaatcc ccggacaacc ccatgtaaca atacacatat tg #aaaggtcc  40980 cgatgatgat tgcgaaactt aatgattgac aaacgtaata aaaaagctgt ga #cgcacata  41040 agtacgtgtc tgtgtcattc atccatacct atatatggtg atagcccctt cc #tcaataca  41100 caccgagccg cgatggaccc cagaccactt gttctgctcc tcctcctagc gt #cccatata  41160 agtacattcc ggcaaatgta ctttgaaggg gaaaccatcc atttccctat gg #gcatatat  41220 ggaaatgaga ccaccctcta tatgaatgac atcatcctgg aaggaacacg cg #ccaatacg  41280 accacccgta caatcagcct cacgaccacc aagaagaatg cgggaactaa cc #tgtacact  41340 gtgatctccg aaacgggaca caacgccacc tatctgataa ctgtacaacc gc #tgggacaa  41400 tcgatacacc acgcctacac ttgggctgga aatactttta ccttacaagg ac #aggtattt  41460 gaacacggta attatacacg atgggtgcgg ctggagaatg cggaaccgaa ac #tcattatc  41520 agctgggcat tgtccaacag aacaataaac aaaggaccgg cctatactgc aa #acatggac  41580 tttgatcccg gaaacaacac cctcactctc caccctgtgc tgataacaga tg #ccgggatt  41640 ttccaatgcg tcattgatca gcaaacaaac ctaaccctca ccataaactt ta #cagtctcc  41700 gagaatccac caatcgtagc acacctggat atccataaaa ctatttctag aa #caattgcc  41760 atttgtagct gtttgcttat cgcggtaatt gcggtcttgt gttgcctacg tc #agctcaat  41820 gtaaacgggc ggggaaattc cgaaatgata taaaacaata aagcagtgtg cg #tcatggaa  41880 acttttctca ggtgcttcct cattcacaca ggtatatata gggaatggaa aa #ttagacag  41940 atacccacac cggaacaatg ctacttctca cagtagttct gttggtgggg gt #caccctcg  42000 ctgcggacca tcctactcta tacgctccga aagggggcag tatagaattg gg #tgtggggg  42060 ctaaacagaa agggcaatac aaatttgaat ggcggtttgg aaatctaaaa at #tgtgatag  42120 ccgaaatgtc atccactaac caattagaaa tcaaatttcc cgataacggt tt #ccaaaatc  42180 gatccgagtt taaccccacc aaacataact taaccattca taatgccagc ta #cgaggaca  42240 gcggaaccta ctcactccac caggaagaaa atgatggcac ggaacacacg ga #caacttca  42300 aagtgattgt tcaaggtatg tcattatata catatttaca atatgcatta at #atcaccta  42360 tctaatagag cattaattat ccagacccga ttccacgccc tgaagtcaag gg #aaccacta  42420 tgcaaatcaa cgggaaaact ttcaccaata tatcctgcca tctaccggcc gg #ttcctacg  42480 gcaatgtctc ctggcattgg aattataccg acccaatcat agtcgggtac ga #aaatcaga  42540 gcatgctcgt tggaccttta ggggtaatgt attcatgtac ggcatccaat ca #agtctcaa  42600 aaaactccag tgcaataagt atggacaccg ccgaaccatc agagagtaag ta #gcgccctc  42660 tatagacatt atatagaata taactgaaca cattaagaaa cctctgtaat ta #tttatagg  42720 agcggagtgc gcatatacag gatacattgc gggcattata atcttaggag tg #ctttgcat  42780 attgttcatt tacctatatg caaatacccc tgaagtgcgg cagagaataa cc #gaccaatt  42840 agaaaagctt ctcggaacat tctgtgacgt cagtatagaa gacggaatac cg #gaacgcac  42900 cagaagaaac aaaaaaagaa tcatcttaaa ggagccctcc cataggtgga tc #tggattca  42960 gtcatttgca taatatgctg tgtcataacc gccaccatca ccatagcaat ca #ttgggcgt  43020 aagtattgtg acgtaagaaa aggcatgtct aaaaaaacgg tcactcacca ta #atgctgcc  43080 cccgataggt tgcgaccgcc ttccggagtt tgacgtagta tgcccgcgag ac #tggatcgg  43140 atttcaaagc aagtgctact acttttcgga gtcagagtcc aattggagtg aa #gccgaaaa  43200 attttgtaga cagcaagagg cggagctagc agttcggcgt tccgaggagg aa #aaggtaaa  43260 aagttaaatt ccaggaaact cctaattccc cgaaaaatta caaaaattaa cg #gagaccct  43320 ttacaggagt tccttctgcg ccaatgcgga acaggaacta actggctggg cg #taaccagg  43380 aagtcgaagg acggagctga ttgggtggat gcatcgtacg atgattacgt ac #catggtga  43440 gtcatgttat acgtcacatc cgggatgtga cgtatgcgga agttgatccg gg #agtgaaaa  43500 cccggaagta acctgttaat ttgcatacag gtatgaaatt cggggaggcg ga #gactgcgt  43560 gtatttaaat ggagaccgag tgacgtcagc ctactgtgat acccagaagc ta #tttgtctg  43620 ttcctgtcaa gattcgtatt cgtattggtt agaaaacaaa taaatcaata aa #ctaattta  43680 tgatatcatt catatttatg ggtgtggttt tattatgcgt cataaaacta tt #ttgcgtat  43740 agcgacacgc tgcggttatg gccggttatg actgcgttag tttttgaggt ta #ttatacat  43800 catc                  #                   #                   #          43804 <210> SEQ ID NO 2  211> LENGTH: 178 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 794..1330 /note= #ORF1 <400> SEQUENCE: 2 Met Asp Pro Phe Gly Ser Ser Ser Val Pro Pr #o Cys Ser Thr Ser Asp   1               5  #                 10  #                 15 Leu Pro Glu Pro Lys Leu Tyr Phe Val Arg Le #u Ser Pro His Ala Val              20      #             25      #             30 Pro Pro Val Arg Ala Thr His Gly Ala Ala Gl #y Tyr Asp Leu Phe Ser          35          #         40          #         45 Ala Tyr Asp Ile Lys Val Pro Ala Arg Gly Ar #g Ala Leu Val Pro Thr      50              #     55              #     60 Asp Leu Val Phe Gln Phe Pro Pro Gly Cys Ty #r Gly Arg Ile Ala Pro  65                  # 70                  # 75                  # 80 Arg Ser Gly Leu Ala Ala Lys Phe Phe Ile As #p Val Gly Ala Gly Val                  85  #                 90  #                 95 Ile Asp Pro Asp Tyr Arg Gly Asn Val Ser Va #l Val Leu Phe Asn Phe             100       #           105       #           110 Ser Glu Ser Ser Phe Asn Ile Arg Arg Gly As #p Arg Val Ala Gln Leu         115           #       120           #       125 Ile Leu Glu Arg Ile Met Val Pro Glu Leu Se #r Glu Leu Thr Gln Leu     130               #   135               #   140 Gly Glu Thr Asp Arg Gly Ala Ser Gly Phe Gl #y Ser Thr Gly Met Gly 145                 1 #50                 1 #55                 1 #60 Ala Val Asp Arg Asn Gln Arg Ser Val Leu Gl #u Trp Leu Thr Pro Gly                 165   #               170   #               175 Ser Arg <210> SEQ ID NO 3 <211> LENGTH: 276 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 1999..2829 /note= #ORF2 <400> SEQUENCE: 3 Met Ser Arg Glu Ser Glu Arg Tyr Trp Thr Le #u Val His Ala Leu Ile   1               5  #                 10  #                 15 Asp Arg Gly Val Val Ser Arg Glu Gln Trp Gl #n Met Val Asp Pro Ala              20      #             25      #             30 Gln Tyr Gln Phe Tyr His Arg Ser Lys Gln Ar #g Gly Phe Lys Val Arg          35          #         40          #         45 His Ile Leu Arg Asp Val Ile Arg His Met Cy #s Trp Ser Arg Thr Leu      50              #     55              #     60 Leu Asp Tyr Met Ser Ser Ala Ser Thr Pro Se #r Pro Asp Asp Val Leu  65                  # 70                  # 75                  # 80 Arg Asn Pro Leu Tyr Gln Leu Leu Leu Cys As #n Gly Tyr Asn Pro Ala                  85  #                 90  #                 95 Val Val Gly Thr Ala Leu Ile Arg Trp Ala Gl #y His Gln Ser Asn Arg             100       #           105       #           110 Asn Thr Val Trp Ile Arg Gly Thr Pro Met Se #r Gly Ala Pro Tyr Leu         115           #       120           #       125 Ala Gln Ala Ile Ala Tyr Cys Ser Pro Leu Va #l Gly Ser Val Asp Trp     130               #   135               #   140 Arg Asn Lys Ser Asn Pro Phe Glu Gly Cys Pr #o Asp Ser Leu Val Phe 145                 1 #50                 1 #55                 1 #60 Trp Trp Asp Gly Gly Tyr Val Tyr Asp Cys Cy #s Val Gly Leu Val Lys                 165   #               170   #               175 Gln Val Phe Arg Gly Glu His Val Ile Leu Pr #o Pro Glu Gly Leu Arg             180       #           185       #           190 Gly Pro Asn Pro Cys Ser Glu Leu Phe Arg Th #r Pro Val Leu Met Tyr         195           #       200           #       205 Ser Gln Ala Asp Ile Cys Met Thr Arg Leu Ar #g Ser Gly Glu Leu Ser     210               #   215               #   220 Ala Glu His Ala Val Gly Leu Arg Asp Cys Me #t Tyr Leu Ile Arg Leu 225                 2 #30                 2 #35                 2 #40 Thr Glu Asp Phe Asp Cys Ala Gly Gly Ile Se #r Cys Ala Asp Val Lys                 245   #               250   #               255 Gln Phe Val Ala Trp Ser Arg Glu His Pro Gl #y Glu Val Arg Glu Thr             260       #           265       #           270 His Glu Leu Lys         275 <210> SEQ ID NO 4 <211> LENGTH: 104 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 3781..4095 /note= #ORF3 <400> SEQUENCE: 4 Met Gly Val Glu Gly Met Trp Asn Val Phe Le #u Phe Ser Leu Gln Val   1               5  #                 10  #                 15 Ala Ala Leu Pro Ser Ile Lys Cys Ser Ile As #n Gly Ser Gly Phe Ser              20      #             25      #             30 Ser Thr Lys Gly Arg Gln Tyr Arg Glu Ala Tr #p Gly Ala Ile Ser Pro          35          #         40          #         45 Ser Asp Ser Met Glu Leu Ile Arg Leu Ser Gl #u Ile Ala Ser Gly Lys      50              #     55              #     60 His Ala His Lys Ala Leu Lys Arg Leu Leu Al #a Leu Glu Ser Leu Pro  65                  # 70                  # 75                  # 80 Pro Gln Ser Thr Arg Val Phe Ser Ser Pro Ar #g Ser His Arg Arg Met                  85  #                 90  #                 95 Ala Leu Ala Ala Thr Phe Pro Ser             100 <210> SEQ ID NO 5 <211> LENGTH: 136 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 5963..6373 /note= #ORF4 <400> SEQUENCE: 5 Met Val Asp Val Glu Met Phe Gly Cys Gly Gl #y Leu Leu Val Ser His   1               5  #                 10  #                 15 Leu His Lys Phe Gly Thr Glu Arg Ala Cys Le #u Arg Gly Asp Gly Ala              20      #             25      #             30 Val Phe Pro Ala Val Glu Ile Gly Leu Asp Gl #n Leu Gln Val Pro Gly          35          #         40          #         45 Arg Leu Phe Asp Gly Trp Asn His Val Leu Ph #e Arg Ser Asp Glu Asp      50              #     55              #     60 Asp Arg Phe Gly Asp Arg Val Gln His Val Al #a Arg Asp Glu Arg Pro  65                  # 70                  # 75                  # 80 Gln Gln Met Arg Leu Ala Gly Ser Gly Gly Se #r Val Asp Asp Pro Asp                  85  #                 90  #                 95 Asp Gly Leu Leu Ala His Val Asp Gly Arg Gl #n Leu Ser Val Leu Glu             100       #           105       #           110 Val Ala Thr Val His Leu Phe Leu Gly Phe As #n Phe Phe Val Gly Phe         115           #       120           #       125 Glu Lys Leu Leu Ile Asn Ala Pro     130               #   135 <210> SEQ ID NO 6 <211> LENGTH: 378 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 12193..13329 /gene #: L1 /Product: L1       52K <400> SEQUENCE: 6 Met His Pro Val Leu Gln Ser Val Arg Asn Al #a Ser Val Ser Ala Gly   1               5  #                 10  #                 15 Gly Pro His Gln Gln Gln Pro Gln Gln Gln Gl #n His Gly Val Ser Ser              20      #             25      #             30 Val Arg Arg Pro Pro Ser Pro Pro Arg Tyr Pr #o Ala Gln His Ala Tyr          35          #         40          #         45 Pro Gly Ala Gly Ala Thr Pro Thr Ala Gly Ar #g Gly Asp Phe Asp Gly      50              #     55              #     60 Ala Leu Asp Pro Asp Glu Gly Pro Val Ala Cy #s Gly Leu Ala Ala Gly  65                  # 70                  # 75                  # 80 Ala Gly Val Asp Glu Val Arg Met Arg Glu Ar #g Asp Ala Ala Arg Arg                  85  #                 90  #                 95 Ala Thr Val Pro Glu Ile Asn Leu Phe Lys Al #a Arg Arg Asp Val Val             100       #           105       #           110 Pro Asn Gly Asp Tyr Glu Arg Asp Leu Met Ty #r His Ser Gly Gln Ala         115           #       120           #       125 Ile Asp Ile Asp Arg Gln Arg Val Leu Thr Pr #o Glu Asp Phe Lys Gly     130               #   135               #   140 Ser Glu Pro Ala Phe Thr Pro Ala Val Asn Hi #s Met Arg Ala Ala Glu 145                 1 #50                 1 #55                 1 #60 Leu Lys Arg Ala Ala Glu Gln Thr Ala Phe Gl #y Glu Glu Leu Arg Asn                 165   #               170   #               175 Thr Cys His Gln Thr Arg Ile Arg Thr Ala Le #u Leu Arg Pro Glu Ile             180       #           185       #           190 Gly Ala Gly Ile Tyr Tyr Leu Tyr Asp Phe Va #l Gln Thr Tyr Leu Glu         195           #       200           #       205 His Pro Asp Gly Arg Val Lys Leu Asn Pro Gl #n Leu Val Leu Val Ala     210               #   215               #   220 Gln His Ala Gly Asn Thr Met Leu Ala Gln Ar #g Leu Trp Ala Ile Ala 225                 2 #30                 2 #35                 2 #40 Glu Glu Lys Asn Ala Trp Leu Arg Asp Leu Il #e Glu Met Ala Tyr Met                 245   #               250   #               255 Ile Val Asn Asp Pro Tyr Leu Asn Thr Glu Gl #n Gln Leu Ser Ala Ile             260       #           265       #           270 Cys Thr Thr Val Val Glu Leu Ser Met Lys Ty #r Ala Lys Leu Ala Ala         275           #       280           #       285 Lys Asn Gly Tyr Pro Ser Met Ala Gln Met Al #a Lys Ala Gln Glu Phe     290               #   295               #   300 Phe Tyr Arg Val Met Gln Ala Val Leu Asp Le #u Gly Val Gln Val Gly 305                 3 #10                 3 #15                 3 #20 Val Tyr Asn Asn Arg Pro Ala Arg Tyr Arg Gl #n Lys Arg Met Ser Glu                 325   #               330   #               335 Ile Pro Gln Met Thr Asp Ala Glu Tyr Met Ph #e Gly Leu Thr Gln Ala             340       #           345       #           350 Leu Glu Ser Arg Pro Pro Gln Gly Glu Ser Ph #e Ala Asp Glu Gly Pro         355           #       360           #       365 Ser Glu Ser Asp Asp Glu Asp Asp Phe Ile     370               #   375 <210> SEQ ID NO 7 <211> LENGTH: 575 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 13316..15043 /gene #: L1 /product: L1       IIIa <400> SEQUENCE: 7 Met Thr Ser Ser Asp Thr Phe Leu Ala Leu Al #a Pro Tyr Gly Arg Gln   1               5  #                 10  #                 15 Glu Val Ala Asp Ala Leu Ser Ser Leu Pro As #p Gly Lys Asp Ala Arg              20      #             25      #             30 Ser Leu Arg His Ala Pro Tyr Ala Asn Arg Le #u Ile Lys Leu Gln Ser          35          #         40          #         45 Ala Met Val Pro Pro Lys Val Asp Gly Thr Se #r Glu Arg Val Ala Glu      50              #     55              #     60 Ile Val Lys Gly Leu Ala Glu Gln Gly Ala Il #e Tyr Pro Asp Gln Met  65                  # 70                  # 75                  # 80 Gly Ala Ile His Ser Asp Leu Leu Asn Arg Al #a Tyr Thr Trp Asn Ser                  85  #                 90  #                 95 Met Gly Val Gln Glu Ser Ile Gln Ala Leu Va #l Asn Asp Val Ile His             100       #           105       #           110 Gly Gln Asn Arg Thr Leu Gln Asp Glu Leu Al #a Arg Thr Lys Glu Ile         115           #       120           #       125 Ala Asn Ala Ser Leu Leu Thr Gln Phe Phe As #p Ser Leu Tyr Lys Thr     130               #   135               #   140 Val Asp Arg Gly Gln Arg Asn Phe Glu Gly Ph #e Lys Lys Leu Leu Arg 145                 1 #50                 1 #55                 1 #60 Leu Phe Val Asn Asn Val Pro Asn Ala Glu Va #l Tyr Gly Ser Ser Gly                 165   #               170   #               175 Ser Phe Ser Val Gln Ile Asn Leu Gly Gly Se #r Ser Gln Asn Ile Asn             180       #           185       #           190 Leu Thr Asn Ala Phe Glu Asn Leu Lys Pro Il #e Trp Gly Ala Arg Trp         195           #       200           #       205 Asp Ala Val Asn Asn Pro Arg Ile Gly Ala Le #u Leu Thr Pro Asn Thr     210               #   215               #   220 Arg Ala Leu Leu Phe Phe Val Ser Ser Phe Ty #r Asp Tyr Gly Ala Met 225                 2 #30                 2 #35                 2 #40 Glu Pro Gly Ser Tyr Leu Asp Asn Ile Met Ar #g Leu Tyr Lys Glu Ala                 245   #               250   #               255 Ile Arg Ala Asp Val Asp Ala Glu Gly Asp Al #a Ile Met Glu Leu Gly             260       #           265       #           270 Glu Ala Gly Ala Asn Leu Asn Leu Arg Phe As #n Asp Tyr Lys Asp Thr         275           #       280           #       285 Leu Asn Tyr Leu Leu Gln Asn Arg Glu Val Va #l Pro Asp Thr Ala Pro     290               #   295               #   300 Leu Glu Leu Ser Ala Glu Gln Glu Met Leu Le #u Lys Tyr Leu Met Arg 305                 3 #10                 3 #15                 3 #20 Gln Leu Arg Gln Ala Leu Lys Asp Gly Val Pr #o Ala Asp Ile Ser Ile                 325   #               330   #               335 Ser Thr Met Thr Gln Tyr Leu Asp Pro Arg Le #u Tyr Gln Thr Asn Lys             340       #           345       #           350 Val Phe Val Glu Lys Leu Gln Asn Tyr Leu Le #u Ala Ala Gln Ala Arg         355           #       360           #       365 Asn Pro Val Tyr Tyr Arg Leu Leu Val Leu As #p Pro Asn Trp Arg Pro     370               #   375               #   380 Pro Ala Gly Leu Tyr Thr Gly Asn Tyr Val Il #e Pro Asp Arg Tyr Asp 385                 3 #90                 3 #95                 4 #00 Phe Glu Asp Val Gln Ser Glu Leu Glu Tyr Al #a Gly Pro Ser Arg Asp                 405   #               410   #               415 Glu Tyr Phe Asp Asp Ser Leu Phe Ala Pro Gl #y Pro Gln Arg Arg Leu             420       #           425       #           430 Asn Ser Ala Glu Glu Ala Gln Leu Glu Arg As #p Ile Glu Ser Leu Thr         435           #       440           #       445 Gly His Ile Asp Glu Glu Leu Gly Val Gln Se #r Gln Ala Gly Trp Leu     450               #   455               #   460 Ala Asp His Arg Leu Pro Val Ala Phe Asp Gl #y Ala Leu Ser Leu Thr 465                 4 #70                 4 #75                 4 #80 Glu Arg Asn Ala Tyr Asn Thr Pro Leu Pro Pr #o Asp Ser His Met Arg                 485   #               490   #               495 Ser Arg Ser Ser Ser Val Ala Ser Asp Leu Gl #y Leu Leu Asn Leu Ser             500       #           505       #           510 Gly Thr Gly Gly Pro Gly Phe Phe Ala Ser Le #u Arg Pro Ser Ile Gly         515           #       520           #       525 Ser Arg Gln Pro Thr Gly Thr Ala Val Gly Le #u Arg Pro Thr Thr Pro     530               #   535               #   540 Tyr Ser Gly Ser Gly Cys Met Arg Gly Thr Gl #y Leu Ala Arg Lys Val 545                 5 #50                 5 #55                 5 #60 Leu Asn Pro Ala Ala Ser Arg Arg Gly Arg Ly #s Leu Arg Phe Tyr                 565   #               570   #               575 <210> SEQ ID NO 8 <211> LENGTH: 515 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 15110..16657 /gene #: L2 /product:       penton base <400> SEQUENCE: 8 Met Tyr Arg Ser Leu Arg Pro Pro Thr Ser Il #e Pro Pro Pro Pro Pro   1               5  #                 10  #                 15 Ser Gly Pro Ser Pro Tyr Pro Ala Met Ile As #n Gly Tyr Pro Pro Asp              20      #             25      #             30 Val Pro Val Gly Ser Pro Ala Asn Gly Asp Al #a Glu Leu Phe Val Pro          35          #         40          #         45 Leu Gln Arg Val Met Pro Pro Thr Gly Gly Ar #g Asn Ser Ile Arg Tyr      50              #     55              #     60 Arg Asn Tyr Ala Pro Cys Gln Asn Thr Thr Ly #s Phe Phe Tyr Val Asp  65                  # 70                  # 75                  # 80 Asn Lys Leu Ser Asp Leu Asp Thr Tyr Asn Gl #u Asp Ala Asn His Ser                  85  #                 90  #                 95 Asn Phe Arg Thr Thr Val Ile His Asn Gln As #p Leu Asp Pro Ser Thr             100       #           105       #           110 Ala Ala Thr Glu Thr Ile Gln Leu Asp Asn Ar #g Ser Cys Trp Gly Gly         115           #       120           #       125 Glu Leu Lys Thr Ala Val Lys Thr Asn Cys Pr #o Asn Ile Ser Ser Phe     130               #   135               #   140 Phe Gln Ser Asp Thr Val Arg Val Arg Leu Me #t Ser Lys Arg Asp Pro 145                 1 #50                 1 #55                 1 #60 Gly Gly Thr Asp Pro Asp Ala Gly Val Asn As #n Pro Pro Gly Ala Glu                 165   #               170   #               175 Tyr Lys Trp Tyr Asp Leu Arg Ile Pro Glu Gl #y Asn Tyr Ala Leu Asn             180       #           185       #           190 Glu Ile Ile Asp Leu Leu Asn Glu Gly Ile Va #l Gln Leu Tyr Leu Gln         195           #       200           #       205 Glu Gly Arg Gln Asn Asn Val Leu Lys Ser As #p Ile Gly Val Lys Phe     210               #   215               #   220 Asp Thr Arg Tyr Leu Asp Leu Leu Lys Asp Pr #o Val Thr Gly Leu Val 225                 2 #30                 2 #35                 2 #40 Thr Pro Gly Thr Tyr Val Tyr Lys Gly Tyr Hi #s Pro Asp Ile Ile Leu                 245   #               250   #               255 Leu Pro Gly Cys Ala Val Asp Phe Thr Phe Se #r Arg Leu Ser Leu Leu             260       #           265       #           270 Leu Gly Ile Ala Lys Arg Glu Pro Tyr Ser Ly #s Gly Phe Thr Ile Thr         275           #       280           #       285 Tyr Glu Asp Leu Gln Gly Gly Asn Val Pro Al #a Leu Leu Asp Leu Ser     290               #   295               #   300 Ser Val Gln Val Asp Asp Gln Asp Glu Asp Va #l Ile Val Val Ala Asp 305                 3 #10                 3 #15                 3 #20 Ala Arg Pro Leu Leu Lys Asp Ser Lys Gly Va #l Ser Tyr Asn Val Ile                 325   #               330   #               335 Thr Thr Gly Val Thr Gln Pro Gln Thr Ala Ty #r Arg Ser Trp Leu Leu             340       #           345       #           350 Ala Tyr His Thr Leu Asp Ser Pro Ala Arg As #n Lys Thr Leu Leu Thr         355           #       360           #       365 Val Pro Asp Met Ala Gly Gly Ile Gly Ala Me #t Tyr Thr Ser Met Pro     370               #   375               #   380 Asp Thr Phe Thr Ala Pro Ala Gly Phe Lys Gl #u Asp Asn Thr Thr Asn 385                 3 #90                 3 #95                 4 #00 Leu Cys Pro Val Val Ala Met Asn Leu Phe Pr #o Ser Phe Asn Lys Val                 405   #               410   #               415 Phe Tyr Gln Gly Ala Ser Ala Tyr Val Gln Ar #g Leu Glu Asn Ala Thr             420       #           425       #           430 Gln Ser Ala Thr Ala Ala Phe Asn Arg Phe Pr #o Glu Asn Glu Ile Leu         435           #       440           #       445 Lys Gln Ala Pro Pro Met Asn Val Ser Ser Va #l Cys Asp Asn Gln Pro     450               #   455               #   460 Ala Val Val Gln Gln Gly Val Leu Pro Leu Ly #s Asn Ser Leu Ser Gly 465                 4 #70                 4 #75                 4 #80 Leu Gln Arg Val Leu Ile Thr Asp Asp Arg Ar #g Arg Pro Ile Pro Tyr                 485   #               490   #               495 Val Tyr Lys Thr Ile Ala Thr Val Gln Pro Ar #g Val Leu Ser Ser Ser             500       #           505       #           510 Thr Leu Gln         515 <210> SEQ ID NO 9 <211> LENGTH: 72 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 16679..16897 /gene #: L2 /product:       L2pVII <400> SEQUENCE: 9 Met Ser Ile Leu Ile Ser Pro Ser Asp Asn Ar #g Gly Trp Gly Ala Asn   1               5  #                 10  #                 15 Met Arg Tyr Arg Arg Arg Ala Ser Met Arg Gl #y Val Gly Arg Arg Arg              20      #             25      #             30 Leu Thr Leu Arg Gln Leu Leu Gly Leu Gly Se #r Arg Arg Arg Arg Arg          35          #         40          #         45 Ser Arg Pro Thr Thr Val Ser Asn Arg Leu Va #l Val Val Ser Thr Arg      50              #     55              #     60 Arg Arg Ser Ser Arg Arg Arg Arg  65                  # 70 <210> SEQ ID NO 10 <211> LENGTH: 188 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 16929..17495 /gene #: L2 /product: L2       mu (pX, 11K) <400> SEQUENCE: 10 Met Cys Ala Val Ala Ile His Arg Ser Asp Va #l Val Met Pro Ser Val   1               5  #                 10  #                 15 Leu Leu Thr Gly Gly Arg Thr Ala Lys Gly Ly #s Lys Arg Ala Ser Arg              20      #             25      #             30 Arg Arg Val Lys Val Pro Lys Leu Pro Lys Gl #y Ala Arg Arg Lys Arg          35          #         40          #         45 Ala Ser Val Thr Pro Val Pro Thr Val Ala Th #r Ala Thr Ala Ser Glu      50              #     55              #     60 Arg Ala Ala Leu Thr Asn Leu Ala Arg Arg Le #u Gln Arg Gly Asp Tyr  65                  # 70                  # 75                  # 80 Ala Ala Trp Arg Pro Ala Asp Tyr Thr Ser Pr #o Ala Val Ser Glu Ala                  85  #                 90  #                 95 Ala Arg Ala Ala Ala Ser Ser Gly Thr Pro Al #a Thr Ala Arg Asp Leu             100       #           105       #           110 Ala Thr Gly Thr Leu Ala Arg Ala Val Pro Me #t Thr Gly Thr Gly Gly         115           #       120           #       125 Arg Arg Arg Lys Arg Thr Ala Thr Arg Arg Ar #g Ser Leu Lys Gly Gly     130               #   135               #   140 Phe Leu Pro Ala Leu Ile Pro Ile Ile Ala Al #a Ala Ile Gly Ala Ile 145                 1 #50                 1 #55                 1 #60 Pro Gly Ile Ala Gly Thr Ala Val Gly Ile Al #a Asn Leu Lys Glu Gln                 165   #               170   #               175 Gln Arg Gln Phe Asn Lys Ile Tyr Gly Asp Ly #s Lys             180       #           185 <210> SEQ ID NO 11 <211> LENGTH: 223 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 17559..18230 /gene #: L3 /product: L3       pVI <400> SEQUENCE: 11 Met Asp Tyr Ala Ala Leu Ser Pro His Leu Gl #y Gly Trp Ala Leu Arg   1               5  #                 10  #                 15 Asp His His Ile Gly Asp Ser Ser Leu Arg Gl #y Gly Ala Ile Asn Trp              20      #             25      #             30 Gly Asn Leu Gly Ser Arg Ile Thr Ser Ala Le #u Asn Ser Thr Gly Arg          35          #         40          #         45 Trp Leu Tyr Asn Thr Gly Asn Arg Phe Val Hi #s Ser Asn Thr Phe Asn      50              #     55              #     60 Gln Ile Lys Gln Gly Ile Gln Asp Ser Gly Va #l Ile Arg Asn Val Ala  65                  # 70                  # 75                  # 80 Asn Leu Ala Gly Glu Thr Leu Gly Ala Leu Th #r Asp Ile Gly Arg Leu                  85  #                 90  #                 95 Lys Leu Gln Gln Asp Leu Glu Lys Leu Arg Ar #g Lys Ala Leu Gly Glu             100       #           105       #           110 Glu Gly Pro Ala Thr Gln Ala Glu Leu Gln Al #a Leu Ile Gln Ala Leu         115           #       120           #       125 Gln Ala Gln Val Ala Ala Gly Glu Pro Pro Al #a Ala Pro Ala Ala Pro     130               #   135               #   140 Ala Pro Ala Pro Pro Leu Val Pro Thr Thr Ar #g Pro Ile Pro Glu Met 145                 1 #50                 1 #55                 1 #60 Val Thr Glu Val Lys Pro Pro Val Thr Ser Se #r Ala Pro Ala Val Pro                 165   #               170   #               175 Val Asp Val Pro Thr Thr Leu Glu Met Arg Pr #o Pro Pro Pro Lys Arg             180       #           185       #           190 Arg Arg Lys Arg Ala Arg Pro Gly Gln Trp Ar #g Ala Arg Leu Asp Ser         195           #       200           #       205 Leu Ser Gly Thr Gly Val Ala Thr Ala Thr Ar #g Arg Met Cys Tyr     210               #   215               #   220 <210> SEQ ID NO 12 <211> LENGTH: 942 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 18289..21117 /gene #: L3 /product: L3       hexon <400> SEQUENCE: 12 Met Thr Ala Leu Thr Pro Asp Leu Thr Thr Al #a Thr Pro Arg Leu Gln   1               5  #                 10  #                 15 Tyr Phe His Ile Ala Gly Pro Gly Thr Arg Gl #u Tyr Leu Ser Glu Asp              20      #             25      #             30 Leu Gln Gln Phe Ile Ser Ala Thr Gly Ser Ty #r Phe Asp Leu Lys Asn          35          #         40          #         45 Lys Phe Arg Gln Thr Val Val Ala Pro Thr Ar #g Asn Val Thr Thr Glu      50              #     55              #     60 Lys Ala Gln Arg Leu Gln Ile Arg Phe Tyr Pr #o Ile Gln Thr Asp Asp  65                  # 70                  # 75                  # 80 Thr Pro Asn Ser Tyr Arg Val Arg Tyr Ser Va #l Asn Val Gly Asp Ser                  85  #                 90  #                 95 Trp Val Leu Asp Met Gly Ala Thr Tyr Phe As #p Ile Lys Gly Val Leu             100       #           105       #           110 Asp Arg Gly Pro Ser Phe Lys Pro Tyr Gly Gl #y Thr Ala Tyr Asn Pro         115           #       120           #       125 Leu Ala Pro Arg Glu Ala Ile Phe Asn Thr Tr #p Val Glu Ser Thr Gly     130               #   135               #   140 Pro Gln Thr Asn Val Val Gly Gln Met Thr As #n Val Tyr Thr Asn Gln 145                 1 #50                 1 #55                 1 #60 Thr Arg Asn Asp Lys Thr Ala Thr Leu Gln Gl #n Val Asn Ser Ile Ser                 165   #               170   #               175 Gly Val Val Pro Asn Val Asn Leu Gly Pro Gl #y Leu Ser Gln Leu Ala             180       #           185       #           190 Ser Arg Ala Asp Val Asp Asn Ile Gly Val Va #l Gly Arg Phe Ala Lys         195           #       200           #       205 Val Asp Ser Ala Gly Val Lys Gln Ala Tyr Gl #y Ala Tyr Val Lys Pro     210               #   215               #   220 Val Lys Asp Asp Gly Ser Gln Ser Leu Asn Gl #n Thr Ala Tyr Trp Leu 225                 2 #30                 2 #35                 2 #40 Met Asp Asn Gly Gly Thr Asn Tyr Leu Gly Al #a Leu Ala Val Glu Asp                 245   #               250   #               255 Tyr Thr Gln Thr Leu Ser Tyr Pro Asp Thr Va #l Leu Val Thr Pro Pro             260       #           265       #           270 Thr Ala Tyr Gln Gln Val Asn Ser Gly Thr Me #t Arg Ala Cys Arg Pro         275           #       280           #       285 Asn Tyr Ile Gly Phe Arg Asp Asn Phe Ile As #n Leu Leu Tyr His Asp     290               #   295               #   300 Ser Gly Val Cys Ser Gly Thr Leu Asn Ser Gl #u Arg Ser Gly Met Asn 305                 3 #10                 3 #15                 3 #20 Val Val Val Glu Leu Gln Asp Arg Asn Thr Gl #u Leu Ser Tyr Gln Tyr                 325   #               330   #               335 Met Leu Ala Asp Met Met Ser Arg His His Ty #r Phe Ala Leu Trp Asn             340       #           345       #           350 Gln Ala Val Asp Gln Tyr Asp His Asp Val Ar #g Val Phe Asn Asn Asp         355           #       360           #       365 Gly Tyr Glu Glu Gly Val Pro Thr Tyr Ala Ph #e Leu Pro Asp Gly His     370               #   375               #   380 Gly Ala Gly Glu Asp Asn Gly Pro Asp Leu Se #r Asn Val Lys Ile Tyr 385                 3 #90                 3 #95                 4 #00 Thr Asn Gly Gln Gln Asp Lys Gly Asn Val Va #l Ala Gly Thr Val Ser                 405   #               410   #               415 Thr Gln Leu Asn Phe Gly Thr Ile Pro Ser Ty #r Glu Ile Asp Ile Ala             420       #           425       #           430 Ala Ala Thr Arg Arg Asn Phe Ile Met Ser As #n Ile Ala Asp Tyr Leu         435           #       440           #       445 Pro Asp Lys Tyr Lys Phe Ser Ile Arg Gly Ph #e Asp Pro Val Thr Asp     450               #   455               #   460 Asn Ile Asp Pro Thr Thr Tyr Phe Tyr Met As #n Arg Arg Val Pro Leu 465                 4 #70                 4 #75                 4 #80 Thr Asn Val Val Asp Leu Phe Thr Asn Ile Gl #y Ala Arg Trp Ser Val                 485   #               490   #               495 Asp Gln Met Asp Asn Val Asn Pro Phe Asn Hi #s His Arg Asn Trp Gly             500       #           505       #           510 Leu Lys Tyr Arg Ser Gln Leu Leu Gly Asn Se #r Arg Tyr Cys Arg Phe         515           #       520           #       525 His Ile Gln Val Pro Gln Lys Tyr Phe Ala Il #e Lys Asn Leu Leu Leu     530               #   535               #   540 Leu Pro Gly Thr Tyr Thr Tyr Glu Trp Val Le #u Arg Lys Asp Pro Asn 545                 5 #50                 5 #55                 5 #60 Met Ile Leu Gln Ser Ser Leu Gly Asn Asp Le #u Arg Ala Asp Gly Ala                 565   #               570   #               575 Gln Ile Val Tyr Thr Glu Val Asn Leu Met Al #a Asn Phe Met Pro Met             580       #           585       #           590 Asp His Asn Thr Ser Asn Gln Leu Glu Leu Me #t Leu Arg Asn Ala Thr         595           #       600           #       605 Asn Asp Gln Thr Phe Ala Asp Tyr Leu Gly Al #a Lys Asn Ala Leu Tyr     610               #   615               #   620 Asn Val Pro Ala Gly Ser Thr Leu Leu Thr Il #e Asn Ile Pro Ala Arg 625                 6 #30                 6 #35                 6 #40 Thr Trp Glu Gly Met Arg Gly Trp Ser Phe Th #r Arg Leu Lys Ala Ser                 645   #               650   #               655 Glu Thr Pro Gln Leu Gly Ala Gln Tyr Asp Va #l Gly Phe Lys Tyr Ser             660       #           665       #           670 Gly Ser Ile Pro Tyr Ser Asp Gly Thr Phe Ty #r Leu Ser His Thr Phe         675           #       680           #       685 Arg Ser Met Ser Val Leu Phe Asp Thr Ser Il #e Asn Trp Pro Gly Asn     690               #   695               #   700 Asp Arg Leu Leu Thr Pro Asn Leu Phe Glu Il #e Lys Arg Pro Val Ala 705                 7 #10                 7 #15                 7 #20 Thr Asp Ser Glu Gly Phe Thr Met Ser Gln Cy #s Asp Met Thr Lys Asp                 725   #               730   #               735 Trp Phe Leu Val Gln Met Ala Thr Asn Tyr As #n Tyr Val Tyr Asn Gly             740       #           745       #           750 Tyr Arg Phe Trp Pro Asp Arg His Tyr Phe Hi #s Tyr Asp Phe Leu Arg         755           #       760           #       765 Asn Phe Asp Pro Met Ser Arg Gln Gly Pro As #n Phe Leu Asp Thr Thr     770               #   775               #   780 Leu Tyr Asp Leu Val Ser Ser Thr Pro Val Va #l Asn Asp Thr Gly Ser 785                 7 #90                 7 #95                 8 #00 Gln Pro Ser Gln Asp Asn Val Arg Asn Asn Se #r Gly Phe Ile Ala Pro                 805   #               810   #               815 Arg Ser Trp Pro Val Trp Thr Ala Gln Gln Gl #y Glu Ala Trp Pro Ala             820       #           825       #           830 Asn Trp Pro Tyr Pro Leu Ile Gly Asn Asp Al #a Ile Ser Ser Asn Gln         835           #       840           #       845 Thr Val Asn Tyr Lys Lys Phe Leu Cys Asp As #n Tyr Leu Trp Thr Val     850               #   855               #   860 Pro Phe Ser Ser Asp Phe Met Tyr Met Gly Gl #u Leu Thr Asp Leu Gly 865                 8 #70                 8 #75                 8 #80 Gln Asn Pro Met Tyr Thr Asn Asn Ser His Se #r Met Val Ile Asn Phe                 885   #               890   #               895 Glu Leu Asp Pro Met Asp Glu Asn Thr Tyr Va #l Tyr Met Leu Tyr Gly             900       #           905       #           910 Val Phe Asp Thr Val Arg Val Asn Gln Pro Gl #u Arg Asn Val Leu Ala         915           #       920           #       925 Met Ala Tyr Phe Arg Thr Pro Phe Ala Thr Gl #y Asn Ala Val     930               #   935               #   940 <210> SEQ ID NO 13 <211> LENGTH: 206 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 21134..21754 /gene #: L3 /product: L3       protease <400> SEQUENCE: 13 Met Ser Gly Thr Thr Glu Thr Gln Leu Arg As #p Leu Leu Ser Ser Met   1               5  #                 10  #                 15 His Leu Arg His Arg Phe Leu Gly Val Phe As #p Lys Ser Phe Pro Gly              20      #             25      #             30 Phe Leu Asp Pro His Val Pro Ala Ser Ala Il #e Val Asn Thr Gly Ser          35          #         40          #         45 Arg Ala Ser Gly Gly Met His Trp Ile Gly Ph #e Ala Phe Asp Pro Ala      50              #     55              #     60 Ala Gly Arg Cys Tyr Met Phe Asp Pro Phe Gl #y Trp Ser Asp Gln Lys  65                  # 70                  # 75                  # 80 Leu Trp Glu Leu Tyr Arg Val Lys Tyr Asn Al #a Phe Met Arg Arg Thr                  85  #                 90  #                 95 Gly Leu Arg Gln Pro Asp Arg Cys Phe Thr Le #u Val Arg Ser Thr Glu             100       #           105       #           110 Ala Val Gln Cys Pro Cys Ser Ala Ala Cys Gl #y Leu Phe Ser Ala Leu         115           #       120           #       125 Phe Ile Val Ser Phe Asp Arg Tyr Arg Ser Ly #s Pro Met Asp Gly Asn     130               #   135               #   140 Pro Val Ile Asp Thr Val Val Gly Val Lys Hi #s Glu Asn Met Asn Ser 145                 1 #50                 1 #55                 1 #60 Pro Pro Tyr Arg Asp Ile Leu His Arg Asn Gl #n Glu Arg Thr Tyr Tyr                 165   #               170   #               175 Trp Trp Thr Lys Asn Ser Ala Tyr Phe Arg Al #a His Gln Glu Glu Leu             180       #           185       #           190 Arg Arg Glu Thr Ala Leu Asn Ala Leu Pro Gl #u Asn His Val         195           #       200           #       205 <210> SEQ ID NO 14 <211> LENGTH: 984 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 23680..26634 /gene #: L4 /product: L4       100K <400> SEQUENCE: 14 Met Ala Asp Lys Ile Thr Arg Glu Glu Lys Th #r Ile Ala Thr Leu Asp   1               5  #                 10  #                 15 Leu Val Leu Arg Val Val Val Asp Ala Gly As #n Trp Asp Val Phe Ser              20      #             25      #             30 Lys Arg Leu Val Arg Tyr Thr Arg Glu Gln Ty #r Gly Ile Glu Leu Pro          35          #         40          #         45 Glu Asp Ile Gly Asp Leu Pro Asp Thr Ser Gl #u Val Ser Lys Val Leu      50              #     55              #     60 Leu Ser His Leu Gly Glu Asp Lys Ala Val Le #u Ser Ala Tyr Arg Ile  65                  # 70                  # 75                  # 80 Ala Glu Leu Thr Gln Pro Ser Glu Met Asp Ar #g Ala Lys Val Thr Glu                  85  #                 90  #                 95 Gly Gly Leu Ala Val Leu Asn Ala Ser Arg As #p Glu Ser Glu Ala Gln             100       #           105       #           110 Asn Pro Ser Asn Pro Glu Pro Glu Ser Ile Gl #u Ser Asp Ala Val Glu         115           #       120           #       125 Asp Leu Gly Val Ala Ala Glu Ser Asp Pro Se #r Asp Asp Glu Pro Asp     130               #   135               #   140 Pro Glu Pro Glu Tyr Asp His Arg Glu Ala As #p His Asp Ser Asp Ala 145                 1 #50                 1 #55                 1 #60 Asp Ser Gly Tyr Tyr Ser Ala Asp Gly Gly Ar #g Pro Gly Thr Pro Val                 165   #               170   #               175 Asp Glu Glu Pro Gln Asp Asp Ser Pro Ser Se #r Glu Glu Thr Ala Ser             180       #           185       #           190 Thr Val Ile Glu Glu Ala Gln Thr Ser Ala Se #r Asn Asp Ser His Asp         195           #       200           #       205 Asp Asp Thr His Arg Asp Asp Gly Ser Ala Se #r Glu Glu Asp Leu Glu     210               #   215               #   220 Arg Asp Ala Leu Val Ala Pro Ala Asp Pro Ph #e Pro Asn Leu Arg Lys 225                 2 #30                 2 #35                 2 #40 Cys Phe Glu Arg Gln Ala Met Met Leu Thr Gl #y Ala Leu Lys Asp Ala                 245   #               250   #               255 Ala Asp Thr Ala Asp Pro Pro Glu Thr Leu Se #r Val Asp Ser Val Gln             260       #           265       #           270 Arg Gln Leu Glu Arg Phe Val Phe Asn Pro As #p Arg Arg Val Pro Ala         275           #       280           #       285 Glu His Leu Glu Val Arg Tyr Asn Phe Tyr Pr #o Pro Phe Leu Thr Pro     290               #   295               #   300 Lys Ala Ile Ala Ser Tyr His Ile Phe Ala Va #l Thr Ala Ser Ile Pro 305                 3 #10                 3 #15                 3 #20 Leu Ser Cys Lys Ala Asn Arg Ser Gly Ser As #p Leu Leu Ala Lys Ala                 325   #               330   #               335 Lys Glu Ser Thr Phe Phe Lys Arg Leu Pro Ly #s Trp Arg Leu Gly Ile             340       #           345       #           350 Glu Ile Asp Asp Gly Leu Gly Thr Glu Val Th #r Ala Val Thr Glu Leu         355           #       360           #       365 Glu Glu Ala Lys Met Val Pro Leu Lys Asp As #p Val Ser Arg Leu Gln     370               #   375               #   380 Trp Ala Lys Met Arg Gly Glu His Ile Arg Ph #e Phe Ser Tyr Pro Ser 385                 3 #90                 3 #95                 4 #00 Leu His Met Pro Pro Lys Ile Ser Arg Met Le #u Met Glu Thr Leu Leu                 405   #               410   #               415 Gln Pro Phe Ala Asp Glu Asn Gln Lys Ala Gl #u Glu Ala Leu Pro Cys             420       #           425       #           430 Leu Ser Asp Glu Glu Val Leu Ala Ile Val As #p Pro Thr Gly Arg Leu         435           #       440           #       445 His Gly Glu Asp Ala Leu Lys Ala Val Glu Ly #s Arg Arg Ala Ala Val     450               #   455               #   460 Thr Met Ala Val Arg Tyr Thr Ala Thr Leu Gl #u Leu Met Glu Arg Val 465                 4 #70                 4 #75                 4 #80 Phe Arg Glu Pro Ser Met Val Lys Lys Met Gl #n Glu Val Leu His His                 485   #               490   #               495 Thr Phe His His Gly Phe Val Ala Leu Val Ar #g Glu Thr Ala Lys Val             500       #           505       #           510 Asn Leu Ser Asn Tyr Ala Thr Phe His Gly Le #u Thr Tyr Asn Asn Pro         515           #       520           #       525 Leu Asn Asn Cys Ile Met Ser Lys Leu Leu Gl #u Gly Ala Asp Lys Glu     530               #   535               #   540 Asp Tyr Val Val Asp Ser Ile Tyr Leu Phe Le #u Val Leu Thr Trp Gln 545                 5 #50                 5 #55                 5 #60 Thr Ala Met Gly Met Trp Gln Gln Ala Ile As #p Asp Met Thr Ile Gln                 565   #               570   #               575 Met Tyr Thr Glu Val Phe Thr Lys Asn Lys Ty #r Arg Leu Tyr Ser Leu             580       #           585       #           590 Pro Asn Pro Thr Ala Ile Gly Lys Ala Ile Va #l Asp Ile Leu Met Asp         595           #       600           #       605 Tyr Asp Arg Leu Thr Glu Glu Met Arg Lys Al #a Leu Pro Asn Phe Thr     610               #   615               #   620 Cys Gln Ser Gln Ile Thr Ala Phe Arg His Ph #e Leu Leu Glu Arg Ser 625                 6 #30                 6 #35                 6 #40 Asn Ile Pro Ala Val Ala Ala Pro Phe Met Pr #o Ser Asp Phe Val Pro                 645   #               650   #               655 Leu Ala Tyr Lys Gln Ser Pro Pro Leu Leu Tr #p Asp Gln Val Tyr Leu             660       #           665       #           670 Leu Gln Leu Ala Phe Tyr Leu Thr Lys His Gl #y Gly Tyr Leu Trp Glu         675           #       680           #       685 Ala Pro Glu Glu Glu Ala Asn Asn Pro Ser As #n Arg Thr Tyr Cys Pro     690               #   695               #   700 Cys Asn Leu Cys Ser Pro His Arg Met Pro Gl #y His Asn Ala Ala Leu 705                 7 #10                 7 #15                 7 #20 His Asn Glu Ile Leu Ala Ile Gly Thr Phe Gl #u Ile Arg Ser Pro Asp                 725   #               730   #               735 Gly Lys Thr Phe Lys Leu Thr Pro Glu Leu Tr #p Thr Asn Ala Tyr Leu             740       #           745       #           750 Asp Lys Phe Asp Ala Glu Asp Phe His Pro Ph #e Thr Val Phe His Tyr         755           #       760           #       765 Pro Glu Asn Ala Ser Arg Phe Ala Ser Thr Le #u Lys Ala Cys Val Thr     770               #   775               #   780 Gln Ser Pro Glu Ile Leu Ser Leu Ile Arg Gl #n Ile Gln Glu Ser Arg 785                 7 #90                 7 #95                 8 #00 Glu Glu Phe Leu Leu Thr Lys Gly Lys Gly Va #l Tyr Lys Asp Pro Asn                 805   #               810   #               815 Thr Gly Glu Thr Ile Ser Arg Gln Pro Arg As #p Thr Ala Arg Ala Gln             820       #           825       #           830 His Ala Gly Asp Gly Gln Ala Leu Pro Ala Pr #o Gly Ala Tyr Thr Thr         835           #       840           #       845 Gly Gly Asn Arg Ala Glu Thr Ala Pro Ala Gl #y Ala Val Arg Leu Ala     850               #   855               #   860 Pro Asp Tyr Gln Asp Gly Gln Phe Pro Ile Al #a Lys Val Gly Pro His 865                 8 #70                 8 #75                 8 #80 Tyr His Gly Pro Lys Asn Val Arg Arg Glu As #p Gln Gly Tyr Arg Gly                 885   #               890   #               895 Gly Pro Gly Gly Val Arg Gly Glu Arg Glu Va #l Val Leu Ser Arg Arg             900       #           905       #           910 Ala Gly Gly Arg Arg Phe Gly Arg Arg Asn Th #r Arg Gln Ser Gly Tyr         915           #       920           #       925 Asn Glu Arg Ala Asn Arg Tyr Phe Gly Arg Gl #y Gly Gly Gly Ser Val     930               #   935               #   940 Arg Gly Gln Gln Gly Glu His Pro Thr Thr Se #r Pro Ser Ala Ser Glu 945                 9 #50                 9 #55                 9 #60 Pro Pro Ala Pro Ser Arg Ile Leu Ala Arg Gl #y Thr Pro Pro Ser Pro                 965   #               970   #               975 Glu Arg Arg Asp Arg Gln Glu Glu             980 <210> SEQ ID NO 15 <211> LENGTH: 245 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 27149..27886 /gene #: L4 /product: L4       pVIII <400> SEQUENCE: 15 Met Asn Leu Met Asn Ala Thr Pro Thr Glu Ty #r Val Trp Lys Tyr Asn   1               5  #                 10  #                 15 Pro Val Ser Gly Ile Pro Ala Gly Ala Gln Gl #n Asn Tyr Gly Ala Thr              20      #             25      #             30 Ile Asp Trp Val Leu Pro Gly Gly Thr Gly Ph #e Ala Ile Ala Thr Asn          35          #         40          #         45 Asp Ile Arg Arg Gln Thr Leu Asn Pro Ala Va #l Thr Arg Ala Ile Thr      50              #     55              #     60 Ala Arg Phe Glu Ala Glu Ser Asp Gln Gln Pr #o Tyr Ala Ser Pro His  65                  # 70                  # 75                  # 80 Glu Thr Asn Val Ile Ala Ala Asn Val Leu As #p Ser Gly Tyr Pro Lys                  85  #                 90  #                 95 Ser Gly Leu Tyr Pro Leu Glu Leu Ser Gly As #n Gln Arg Val Gln Leu             100       #           105       #           110 Ala Gly Gly Leu Met Val Gly Arg Thr Glu Gl #y Arg Met Gln Leu Ala         115           #       120           #       125 Gly Gly Leu Thr Glu Gly Arg Val Gln Leu Se #r Gly Gly Phe His Gly     130               #   135               #   140 Arg Pro Leu Val Arg Gly Arg Ser Arg Arg Pr #o Pro Arg Trp Cys Gly 145                 1 #50                 1 #55                 1 #60 Ala Glu Leu Thr Gly Asn Gly Leu Pro Glu Gl #n Ala Glu Val Thr Ser                 165   #               170   #               175 Asp Thr Tyr Lys Tyr Phe Leu Arg Thr Gln Gl #y Pro Ser Gln Val Val             180       #           185       #           190 Glu Glu Pro Gly Val Phe Ser Gln Arg Gln Ph #e Met Thr Thr Phe Leu         195           #       200           #       205 Pro Ser Val Val Pro His Pro Phe Asp Ser Th #r Asn Pro Gly Asp Phe     210               #   215               #   220 Pro Ala Gln Tyr Ser Ala Ile Tyr Lys Gly Ar #g Thr Ala Phe Glu Asp 225                 2 #30                 2 #35                 2 #40 Thr Phe Trp Asp Trp                 245 <210> SEQ ID NO 16 <211> LENGTH: 710 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 28363..30495 /gene #: L5 /product: L5       fibre 1 <400> SEQUENCE: 16 Met Thr Ser Pro Leu Thr Leu Ser Gln Arg Al #a Leu Ala Leu Lys Thr   1               5  #                 10  #                 15 Asp Ser Thr Leu Thr Leu Asn Thr Gln Gly Gl #n Leu Gly Val Ser Leu              20      #             25      #             30 Thr Pro Gly Asp Gly Leu Val Leu Asn Thr As #n Gly Leu Ser Ile Asn          35          #         40          #         45 Ala Asp Pro Gln Thr Leu Ala Phe Asn Asn Se #r Gly Ala Leu Glu Val      50              #     55              #     60 Asn Leu Asp Pro Asp Gly Pro Trp Ser Lys Th #r Ala Thr Gly Ile Asp  65                  # 70                  # 75                  # 80 Leu Arg Leu Asp Pro Thr Thr Leu Glu Val As #p Asn Trp Glu Leu Gly                  85  #                 90  #                 95 Val Lys Leu Asp Pro Asp Glu Ala Ile Asp Se #r Gly Pro Asp Gly Leu             100       #           105       #           110 Cys Leu Asn Leu Asp Glu Thr Leu Leu Leu Al #a Thr Asn Ser Thr Ser         115           #       120           #       125 Gly Lys Thr Glu Leu Gly Val His Leu Asn Th #r Ser Gly Pro Ile Thr     130               #   135               #   140 Ala Asp Asp Gln Gly Ile Asp Leu Asp Val As #p Pro Asn Thr Met Gln 145                 1 #50                 1 #55                 1 #60 Val Asn Thr Gly Pro Ser Gly Gly Met Leu Al #a Val Lys Leu Lys Ser                 165   #               170   #               175 Gly Gly Gly Leu Thr Ala Asp Pro Asp Gly Il #e Ser Val Thr Ala Thr             180       #           185       #           190 Val Ala Pro Pro Ser Ile Ser Ala Thr Ala Pr #o Leu Thr Tyr Thr Ser         195           #       200           #       205 Gly Thr Ile Ala Leu Thr Thr Asp Thr Gln Th #r Met Gln Val Asn Ser     210               #   215               #   220 Asn Gln Leu Ala Val Lys Leu Lys Thr Gly Gl #y Gly Leu Thr Ala Asp 225                 2 #30                 2 #35                 2 #40 Ala Asp Gly Ile Ser Val Ser Val Ala Pro Th #r Pro Thr Ile Ser Ala                 245   #               250   #               255 Ser Pro Pro Leu Thr Tyr Thr Asn Gly Gln Il #e Gly Leu Ser Ile Gly             260       #           265       #           270 Asp Gln Ser Leu Gln Val Ser Ser Gly Gln Le #u Gln Val Lys Leu Lys         275           #       280           #       285 Ser Gln Gly Gly Ile Gln Gln Ser Thr Gln Gl #y Leu Gly Val Ala Val     290               #   295               #   300 Asp Gln Thr Leu Lys Ile Val Ser Asn Thr Le #u Glu Val Asn Thr Asp 305                 3 #10                 3 #15                 3 #20 Pro Ser Gly Pro Leu Thr Ser Gly Asn Asn Gl #y Leu Ser Leu Ala Ala                 325   #               330   #               335 Val Thr Pro Leu Ala Val Ser Ser Ala Gly Va #l Thr Leu Asn Tyr Gln             340       #           345       #           350 Ser Pro Leu Thr Val Thr Ser Asn Ser Leu Gl #y Leu Ser Ile Ala Ala         355           #       360           #       365 Pro Leu Gln Ala Gly Ala Gln Gly Leu Thr Va #l Asn Thr Met Glu Pro     370               #   375               #   380 Leu Ser Ala Ser Ala Gln Gly Ile Gln Leu Hi #s Tyr Gly Gln Gly Phe 385                 3 #90                 3 #95                 4 #00 Gln Val Val Ala Gly Thr Leu Gln Leu Leu Th #r Asn Pro Pro Ile Val                 405   #               410   #               415 Val Ser Ser Arg Gly Phe Thr Leu Leu Tyr Th #r Pro Ala Phe Thr Val             420       #           425       #           430 Ser Asn Asn Met Leu Gly Leu Asn Val Asp Gl #y Thr Asp Cys Val Ala         435           #       440           #       445 Ile Ser Ser Ala Gly Leu Gln Ile Arg Lys Gl #u Ala Pro Leu Tyr Val     450               #   455               #   460 Thr Ser Gly Ser Thr Pro Ala Leu Ala Leu Ly #s Tyr Ser Ser Asp Phe 465                 4 #70                 4 #75                 4 #80 Thr Ile Thr Asn Gly Ala Leu Ala Leu Ala As #n Ser Gly Gly Gly Gly                 485   #               490   #               495 Ser Ser Thr Pro Glu Val Ala Thr Tyr His Cy #s Gly Asp Asn Leu Leu             500       #           505       #           510 Glu Ser Tyr Asp Ile Phe Ala Ser Leu Pro As #n Thr Asn Ala Ala Lys         515           #       520           #       525 Val Ala Ala Tyr Cys Arg Leu Ala Ala Ala Gl #y Gly Val Val Ser Gly     530               #   535               #   540 Thr Ile Gln Val Thr Ser Tyr Ala Gly Arg Tr #p Pro Lys Val Gly Asn 545                 5 #50                 5 #55                 5 #60 Ser Val Thr Asp Gly Ile Lys Phe Ala Ile Va #l Val Ser Pro Pro Met                 565   #               570   #               575 Asp Lys Asp Pro Arg Ser Asn Leu Ser Gln Tr #p Leu Gly Ala Thr Val             580       #           585       #           590 Phe Pro Ala Gly Ala Thr Thr Ala Leu Phe Se #r Pro Asn Pro Tyr Gly         595           #       600           #       605 Ser Leu Asn Thr Ile Thr Thr Leu Pro Ser Il #e Ala Ser Asp Trp Tyr     610               #   615               #   620 Val Pro Glu Ser Asn Leu Val Thr Tyr Thr Ly #s Ile His Phe Lys Pro 625                 6 #30                 6 #35                 6 #40 Thr Gly Ser Gln Gln Leu Gln Leu Ala Ser Gl #y Glu Leu Val Val Ala                 645   #               650   #               655 Ala Ala Lys Ser Pro Val Gln Thr Thr Lys Ty #r Glu Leu Ile Tyr Leu             660       #           665       #           670 Gly Phe Thr Leu Lys Gln Asn Ser Ser Gly Th #r Asn Phe Phe Asp Pro         675           #       680           #       685 Asn Ala Ser Ser Asp Leu Ser Phe Leu Thr Pr #o Pro Ile Pro Phe Thr     690               #   695               #   700 Tyr Leu Gly Tyr Tyr Gln 705                 7 #10 <210> SEQ ID NO 17 <211> LENGTH: 410 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 30536..31768 /gene #: L5 /product: L5       fibre 2 <400> SEQUENCE: 17 Met Ala Asp Gln Lys Arg Lys Leu Ala Asp Pr #o Asp Ala Glu Ala Pro   1               5  #                 10  #                 15 Thr Gly Lys Met Ala Arg Ala Gly Pro Gly Gl #u Leu Asp Leu Val Tyr              20      #             25      #             30 Pro Phe Trp Tyr Gln Val Ala Ala Pro Thr Gl #u Ile Thr Pro Pro Phe          35          #         40          #         45 Leu Asp Pro Asn Gly Pro Leu Tyr Ser Thr As #p Gly Leu Leu Asn Val      50              #     55              #     60 Arg Leu Thr Ala Pro Leu Val Ile Ile Arg Gl #n Ser Asn Gly Asn Ala  65                  # 70                  # 75                  # 80 Ile Gly Val Lys Thr Asp Gly Ser Ile Thr Va #l Asn Ala Asp Gly Ala                  85  #                 90  #                 95 Leu Gln Ile Gly Ile Ser Thr Ala Gly Pro Le #u Thr Thr Thr Ala Asn             100       #           105       #           110 Gly Ile Asp Leu Asn Ile Asp Pro Lys Thr Le #u Val Val Asp Gly Ser         115           #       120           #       125 Ser Gly Lys Asn Val Leu Gly Val Leu Leu Ly #s Gly Gln Gly Ala Leu     130               #   135               #   140 Gln Ser Ser Ala Gln Gly Ile Gly Val Ala Va #l Asp Glu Ser Leu Gln 145                 1 #50                 1 #55                 1 #60 Ile Val Asp Asn Thr Leu Glu Val Lys Val As #p Ala Ala Gly Pro Leu                 165   #               170   #               175 Ala Val Thr Ala Ala Gly Val Gly Leu Gln Ty #r Asp Asn Thr Gln Phe             180       #           185       #           190 Lys Val Thr Asn Gly Thr Leu Gln Leu Tyr Gl #n Ala Pro Thr Ser Ser         195           #       200           #       205 Val Ala Ala Phe Thr Ser Gly Thr Ile Gly Le #u Ser Ser Pro Thr Gly     210               #   215               #   220 Asn Phe Val Ser Ser Ser Asn Asn Pro Phe As #n Gly Ser Tyr Phe Leu 225                 2 #30                 2 #35                 2 #40 Gln Gln Ile Asn Thr Met Gly Met Leu Thr Th #r Ser Leu Tyr Val Lys                 245   #               250   #               255 Val Asp Thr Thr Thr Met Gly Thr Arg Pro Th #r Gly Ala Val Asn Glu             260       #           265       #           270 Asn Ala Arg Tyr Phe Thr Val Trp Val Ser Se #r Phe Leu Thr Gln Cys         275           #       280           #       285 Asn Pro Ser Asn Ile Gly Gln Gly Thr Leu Gl #u Pro Ser Asn Ile Ser     290               #   295               #   300 Met Thr Ser Phe Glu Pro Ala Arg Asn Pro Il #e Ser Pro Pro Val Phe 305                 3 #10                 3 #15                 3 #20 Asn Met Asn Gln Asn Ile Pro Tyr Tyr Ala Se #r Arg Phe Gly Val Leu                 325   #               330   #               335 Glu Ser Tyr Arg Pro Ile Phe Thr Gly Ser Le #u Asn Thr Gly Ser Ile             340       #           345       #           350 Asp Val Arg Met Gln Val Thr Pro Val Leu Al #a Thr Asn Asn Thr Thr         355           #       360           #       365 Tyr Asn Leu Ile Ala Phe Thr Phe Gln Cys Al #a Ser Ala Gly Leu Phe     370               #   375               #   380 Asn Pro Thr Val Asn Gly Thr Val Ala Ile Gl #y Pro Val Val His Thr 385                 3 #90                 3 #95                 4 #00 Cys Pro Ala Ala Arg Ala Pro Val Thr Val                 405   #               410 <210> SEQ ID NO 18 <211> LENGTH: 148 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 33030..33476 /note #=ORF5 <400> SEQUENCE: 18 Met Arg Leu Pro Val Leu Pro Val His Met Ly #s Tyr Pro Leu Phe Asp   1               5  #                 10  #                 15 Val Ser Val Gly Gln Pro Thr Val Thr Gly Gl #u Val Thr Gln Ser Leu              20      #             25      #             30 Arg His Asp Arg Pro Gln Phe Arg Arg His Hi #s His Ala Glu His Ala          35          #         40          #         45 Ser Gln Ala Asp Gly Leu Gly His Gly Ala Al #a Ala Arg Asn Ser Phe      50              #     55              #     60 His His Asp Gly Gly Arg His Gly His Ala Th #r Arg Ile His Glu Asn  65                  # 70                  # 75                  # 80 Asn Arg Arg Pro His Lys Arg Asn Arg Arg Ar #g His Leu Arg Lys Gly                  85  #                 90  #                 95 His Leu Lys Ala His Arg Ala Glu Ser His Le #u Tyr Gly Tyr Leu Leu             100       #           105       #           110 Arg Asn Gln Lys Ala Cys Gly Glu Lys Leu Ly #s Ile Cys Leu Pro Ala         115           #       120           #       125 Ser Lys His Pro Arg Phe Gln Val Val Leu Hi #s Pro Arg Cys Asn Lys     130               #   135               #   140 Lys Gln Pro Thr 145 <210> SEQ ID NO 19 <211> LENGTH: 104 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 33169..33483 /note #=ORF6 <400> SEQUENCE: 19 Met Leu Leu Arg Gln Thr Gly Trp Val Thr Al #a Leu Leu Arg Glu Ile   1               5  #                 10  #                 15 Val Ser Thr Met Met Val Ala Val Thr Val Th #r Arg His Ala Phe Met              20      #             25      #             30 Arg Thr Thr Gly Asp Arg Thr Lys Gly Thr As #p Glu Gly Thr Cys Glu          35          #         40          #         45 Lys Asp Thr Ser Lys Leu Ile Glu Arg Arg Al #a Ile Phe Thr Asp Ile      50              #     55              #     60 Phe Ser Ala Ile Arg Lys Pro Val Val Lys As #n Leu Lys Ser Val Phe  65                  # 70                  # 75                  # 80 Leu Arg Ala Ser Ile His Gly Ser Lys Ser Ty #r Phe Ile Pro Gly Val                  85  #                 90  #                 95 Ile Lys Ser Asn Leu Arg Glu Arg             100 <210> SEQ ID NO 20 <211> LENGTH: 131 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 35629..36024 /note #= ORF7 <400> SEQUENCE: 20 Met Asn Ser Met Val Leu Glu Leu Arg Lys Ly #s Met Ser Ser Gly Pro   1               5  #                 10  #                 15 Asp Cys Val Ile Gly Arg Pro Pro His Ile Le #u Pro Pro Gln Lys Gly              20      #             25      #             30 Val Tyr Leu Leu Thr Asn Ile Ser Gln Leu Il #e Gly Pro Val Gln Gln          35          #         40          #         45 Asn Asp Arg Gly Leu Trp Arg His Asn Gly Me #t His Thr Gln Asn Leu      50              #     55              #     60 Ser His His Phe Thr Gly Pro Phe Ile Cys Al #a Val Ile Ala Arg Pro  65                  # 70                  # 75                  # 80 Ile Asn Lys Arg Thr His Ile Gly Ile His Va #l Leu Asn Gln Asn Asn                  85  #                 90  #                 95 Glu Leu Pro Ala Ile Phe Thr Ile Gln Tyr Pr #o Glu Pro Pro His Leu             100       #           105       #           110 Thr Asp Asn Pro Gly Ala Val Arg Lys Ser Gl #n Lys Ser Leu Ile Pro         115           #       120           #       125 Pro Tyr Asn     130 <210> SEQ ID NO 21 <211> LENGTH: 282 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position:  37391..38239 / #note=ORF8 <400> SEQUENCE: 21 Met Ala Arg Asn Pro Phe Arg Met Phe Pro Gl #y Asp Leu Pro Tyr Tyr   1               5  #                 10  #                 15 Met Gly Thr Ile Ser Phe Thr Ser Val Val Pr #o Val Asp Pro Ser Gln              20      #             25      #             30 Arg Asn Pro Thr Thr Ser Leu Arg Glu Met Va #l Thr Thr Gly Leu Ile          35          #         40          #         45 Phe Asn Pro Asn Leu Thr Gly Glu Gln Leu Ar #g Glu Tyr Ser Phe Ser      50              #     55              #     60 Pro Leu Val Ser Met Gly Arg Lys Ala Ile Ph #e Ala Asp Tyr Glu Gly  65                  # 70                  # 75                  # 80 Pro Gln Arg Ile Ile His Val Thr Ile Arg Gl #y Arg Ser Ala Glu Pro                  85  #                 90  #                 95 Lys Thr Pro Ser Glu Ala Leu Ile Met Met Gl #u Lys Ala Val Arg Gly             100       #           105       #           110 Ala Phe Ala Val Pro Asp Trp Val Ala Arg Gl #u Tyr Ser Asp Pro Leu         115           #       120           #       125 Pro His Gly Ile Thr His Val Gly Asp Leu Gl #y Phe Pro Ile Gly Ser     130               #   135               #   140 Val His Ala Leu Lys Met Ala Leu Asp Thr Le #u Lys Ile His Val Pro 145                 1 #50                 1 #55                 1 #60 Arg Gly Val Gly Val Pro Gly Tyr Glu Gly Le #u Cys Gly Thr Thr Thr                 165   #               170   #               175 Ile Lys Ala Pro Arg Gln Tyr Arg Leu Leu Th #r Thr Gly Val Phe Thr             180       #           185       #           190 Lys Lys Asp Leu Lys Arg Thr Leu Pro Glu Pr #o Phe Phe Ser Arg Phe         195           #       200           #       205 Phe Asn Gln Thr Pro Glu Val Cys Ala Ile Ly #s Thr Gly Lys Asn Pro     210               #   215               #   220 Phe Ser Thr Glu Ile Trp Cys Met Thr Leu Gl #y Gly Asp Ser Pro Ala 225                 2 #30                 2 #35                 2 #40 Pro Glu Arg Asn Glu Pro Arg Asn Pro His Se #r Leu Gln Asp Trp Ala                 245   #               250   #               255 Arg Leu Gly Val Met Glu Thr Cys Leu Arg Me #t Ser Arg Arg Gly Leu             260       #           265       #           270 Gly Ser Arg His His Pro Tyr His Ser Leu         275           #       280 <210> SEQ ID NO 22 <211> LENGTH: 321 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 40037..41002 /note #=ORF9 <400> SEQUENCE: 22 Met Glu Pro Pro His Asn Ser Pro Val Pro Ph #e Ser Ile Ala Lys Met   1               5  #                 10  #                 15 Gly Asn Pro Thr Leu Leu Leu Leu Ser Gly Le #u Leu Ser Leu Thr Gln              20      #             25      #             30 Ala Ile Ser Ile Gly Glu His Glu Asn Lys Th #r Arg His Val Ile Val          35          #         40          #         45 Trp Arg His Ser Ser Ser His Gln Cys Ser As #p Trp Arg Thr Val Thr      50              #     55              #     60 Glu Trp Phe Pro Pro Gln Lys Gly Asn Pro Va #l Arg Pro Pro Tyr Thr  65                  # 70                  # 75                  # 80 Gln Arg Val Ser Leu Asp Thr Ala Asn Asn Th #r Leu Thr Val Lys Pro                  85  #                 90  #                 95 Phe Glu Thr Asn Asn Gly Cys Trp Glu Thr Th #r Ser Gln Gly Ile Asn             100       #           105       #           110 His Pro Pro Thr Thr Ile Gln Tyr Arg Val Tr #p Asn Ile Thr Thr Thr         115           #       120           #       125 Pro Thr Ile Gln Thr Ile Asn Ile Thr Lys Il #e Thr Val Arg Glu Gly     130               #   135               #   140 Glu Asp Phe Thr Leu Tyr Gly Pro Val Ser Gl #u Thr Met Ser Ile Ile 145                 1 #50                 1 #55                 1 #60 Glu Trp Glu Phe Ile Lys Asp Val Thr Pro Gl #n Phe Ile Leu Gln Tyr                 165   #               170   #               175 Tyr Leu Ser Ile Asn Ser Thr Ile Val Tyr Al #a Ser Tyr Gln Gly Arg             180       #           185       #           190 Val Thr Phe Asn Pro Gly Lys Asn Thr Leu Th #r Leu Lys Gly Ala Lys         195           #       200           #       205 Thr Thr Asp Ser Gly Thr Tyr Lys Ser Thr Va #l Asn Leu Asp Gln Val     210               #   215               #   220 Ser Val His Asn Phe Arg Val Gly Val Thr Pr #o Ile Glu Lys Lys Glu 225                 2 #30                 2 #35                 2 #40 Glu Ala Thr Ala Glu Thr Pro Ala Ser Lys Pr #o Thr Pro Ile Pro Arg                 245   #               250   #               255 Val Arg Ala Asp Ala Arg Ser Thr Ala Leu Tr #p Val Gly Leu Ala Leu             260       #           265       #           270 Cys Ile Leu Thr Val Ile Pro Ala Leu Ile Gl #y Trp Tyr Phe Arg Asp         275           #       280           #       285 Arg Leu Cys Val Pro Asp Pro Ile Ile Glu Le #u Glu Ile Pro Gly Gln     290               #   295               #   300 Pro His Val Thr Ile His Ile Leu Lys Gly Pr #o Asp Asp Asp Cys Glu 305                 3 #10                 3 #15                 3 #20 Thr <210> SEQ ID NO 23 <211> LENGTH: 283 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 41002..41853 /note #=ORF10 <400> SEQUENCE: 23 Met Ile Asp Lys Arg Asn Lys Lys Ala Val Th #r His Ile Ser Thr Cys   1               5  #                 10  #                 15 Leu Cys His Ser Ser Ile Pro Ile Tyr Gly As #p Ser Pro Phe Leu Asn              20      #             25      #             30 Thr His Arg Ala Ala Met Asp Pro Arg Pro Le #u Val Leu Leu Leu Leu          35          #         40          #         45 Leu Ala Ser His Ile Ser Thr Phe Arg Gln Me #t Tyr Phe Glu Gly Glu      50              #     55              #     60 Thr Ile His Phe Pro Met Gly Ile Tyr Gly As #n Glu Thr Thr Leu Tyr  65                  # 70                  # 75                  # 80 Met Asn Asp Ile Ile Leu Glu Gly Thr Arg Al #a Asn Thr Thr Thr Arg                  85  #                 90  #                 95 Thr Ile Ser Leu Thr Thr Thr Lys Lys Asn Al #a Gly Thr Asn Leu Tyr             100       #           105       #           110 Thr Val Ile Ser Glu Thr Gly His Asn Ala Th #r Tyr Leu Ile Thr Val         115           #       120           #       125 Gln Pro Leu Gly Gln Ser Ile His His Ala Ty #r Thr Trp Ala Gly Asn     130               #   135               #   140 Thr Phe Thr Leu Gln Gly Gln Val Phe Glu Hi #s Gly Asn Tyr Thr Arg 145                 1 #50                 1 #55                 1 #60 Trp Val Arg Leu Glu Asn Ala Glu Pro Lys Le #u Ile Ile Ser Trp Ala                 165   #               170   #               175 Leu Ser Asn Arg Thr Ile Asn Lys Gly Pro Al #a Tyr Thr Ala Asn Met             180       #           185       #           190 Asp Phe Asp Pro Gly Asn Asn Thr Leu Thr Le #u His Pro Val Leu Ile         195           #       200           #       205 Thr Asp Ala Gly Ile Phe Gln Cys Val Ile As #p Gln Gln Thr Asn Leu     210               #   215               #   220 Thr Leu Thr Ile Asn Phe Thr Val Ser Glu As #n Pro Pro Ile Val Ala 225                 2 #30                 2 #35                 2 #40 His Leu Asp Ile His Lys Thr Ile Ser Arg Th #r Ile Ala Ile Cys Ser                 245   #               250   #               255 Cys Leu Leu Ile Ala Val Ile Ala Val Leu Cy #s Cys Leu Arg Gln Leu             260       #           265       #           270 Asn Val Asn Gly Arg Gly Asn Ser Glu Met Il #e         275           #       280 <210> SEQ ID NO 24 <211> LENGTH: 135 <212> TYPE: PRT <213> ORGANISM: CELO Virus <220> FEATURE: <223> OTHER INFORMATION: Position: 41958..42365 /note #= ORF11 <400> SEQUENCE: 24 Met Leu Leu Leu Thr Val Val Leu Leu Val Gl #y Val Thr Leu Ala Ala   1               5  #                 10  #                 15 Asp His Pro Thr Leu Tyr Ala Pro Lys Gly Gl #y Ser Ile Glu Leu Gly              20      #             25      #             30 Val Gly Ala Lys Gln Lys Gly Gln Tyr Lys Ph #e Glu Trp Arg Phe Gly          35          #         40          #         45 Asn Leu Lys Ile Val Ile Ala Glu Met Ser Se #r Thr Asn Gln Leu Glu      50              #     55              #     60 Ile Lys Phe Pro Asp Asn Gly Phe Gln Asn Ar #g Ser Glu Phe Asn Pro  65                  # 70                  # 75                  # 80 Thr Lys His Asn Leu Thr Ile His Asn Ala Se #r Tyr Glu Asp Ser Gly                  85  #                 90  #                 95 Thr Tyr Ser Leu His Gln Glu Glu Asn Asp Gl #y Thr Glu His Thr Asp             100       #           105       #           110 Asn Phe Lys Val Ile Val Gln Gly Met Ser Le #u Tyr Thr Tyr Leu Gln         115           #       120           #       125 Tyr Ala Leu Ile Ser Pro Ile     130               #   135 <210> SEQ ID NO 25 <211> LENGTH: 1326 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(1326) <400> SEQUENCE: 25 atg gaa aga acc ccg aaa aga gct cat ggc tt #t cgc agc acc aag cct       48 Met Glu Arg Thr Pro Lys Arg Ala His Gly Ph #e Arg Ser Thr Lys Pro   1               5  #                 10  #                 15 gtc aag aga acg gca gaa gtc atg atg gaa ga #g gag gag gaa gaa gtg       96 Val Lys Arg Thr Ala Glu Val Met Met Glu Gl #u Glu Glu Glu Glu Val              20      #             25      #             30 gaa gtg gtc gcc ccg ggc cga ggc gcg act cg #c aag aag gtc agc cgc      144 Glu Val Val Ala Pro Gly Arg Gly Ala Thr Ar #g Lys Lys Val Ser Arg          35          #         40          #         45 cgc gag gag tcc cca tcc ccc gta agg cga gt #t acc cgc cgg cgg gaa      192 Arg Glu Glu Ser Pro Ser Pro Val Arg Arg Va #l Thr Arg Arg Arg Glu      50              #     55              #     60 acc gtt gtc gat gac gaa gaa aac gcc agc ga #c gag gaa tcc ccg gag      240 Thr Val Val Asp Asp Glu Glu Asn Ala Ser As #p Glu Glu Ser Pro Glu  65                  # 70                  # 75                  # 80 gcc cct ctg tca gac ccc gtg gtc tac ggc gc #g caa cgc gcc atg gcc      288 Ala Pro Leu Ser Asp Pro Val Val Tyr Gly Al #a Gln Arg Ala Met Ala                  85  #                 90  #                 95 acc gtc gcc agc atc tgc gaa gct ctc gac ct #a cag tgg cag gga gcc      336 Thr Val Ala Ser Ile Cys Glu Ala Leu Asp Le #u Gln Trp Gln Gly Ala             100       #           105       #           110 agc gtg cgc ccc gac gac tcc att tgg acc aa #a atg ggg ggt aca tac      384 Ser Val Arg Pro Asp Asp Ser Ile Trp Thr Ly #s Met Gly Gly Thr Tyr         115           #       120           #       125 gtt cgc aaa aag cat ccc gaa ttt cgc ctg ac #c ttt tct agc tac gac      432 Val Arg Lys Lys His Pro Glu Phe Arg Leu Th #r Phe Ser Ser Tyr Asp     130               #   135               #   140 tct ttc aac gct cag gta ggg cgg ttc ctg gc #a gcc gtt atc tac agc      480 Ser Phe Asn Ala Gln Val Gly Arg Phe Leu Al #a Ala Val Ile Tyr Ser 145                 1 #50                 1 #55                 1 #60 cgc gcg ggt ctg gag ccc aag ttc gtg ccc gg #a ggg gcg cac gtt tgg      528 Arg Ala Gly Leu Glu Pro Lys Phe Val Pro Gl #y Gly Ala His Val Trp                 165   #               170   #               175 cgc cat ggc tgg ttc cca gcg ctc cag gag cc #c ttc ccg aaa tgc atg      576 Arg His Gly Trp Phe Pro Ala Leu Gln Glu Pr #o Phe Pro Lys Cys Met             180       #           185       #           190 cac ggt gtg gac atg gtg acg aaa cct cgt ac #c gtg gag ttg aac ccg      624 His Gly Val Asp Met Val Thr Lys Pro Arg Th #r Val Glu Leu Asn Pro         195           #       200           #       205 tct agc gag gcg gga aag agg gct ctg gcc ga #a cag aac ggc gta atc      672 Ser Ser Glu Ala Gly Lys Arg Ala Leu Ala Gl #u Gln Asn Gly Val Ile     210               #   215               #   220 gag aag aac cgg ttt gga cga cag gtg gtg gt #g ctc agg ttc gac gcg      720 Glu Lys Asn Arg Phe Gly Arg Gln Val Val Va #l Leu Arg Phe Asp Ala 225                 2 #30                 2 #35                 2 #40 aac gcg gtg tgc tac aag gat cag gag cac ag #c ggc ttc cct cat ccc      768 Asn Ala Val Cys Tyr Lys Asp Gln Glu His Se #r Gly Phe Pro His Pro                 245   #               250   #               255 cac gcg cac ggc agt tgc gcc atg gtc ttt tc #c gac gcc gcc aag gcg      816 His Ala His Gly Ser Cys Ala Met Val Phe Se #r Asp Ala Ala Lys Ala             260       #           265       #           270 gtc agc gcg atg cgt cac gac ata gac tgg ac #g aag gcg ctt tac ccc      864 Val Ser Ala Met Arg His Asp Ile Asp Trp Th #r Lys Ala Leu Tyr Pro         275           #       280           #       285 aac gcg gac aag cgc cgg gca gag gaa tgt gt #c ctc atc tca acc aat      912 Asn Ala Asp Lys Arg Arg Ala Glu Glu Cys Va #l Leu Ile Ser Thr Asn     290               #   295               #   300 tgc aac tgc aac tac gcc tcc gat cga gcc at #t tca ggg aga cag ttc      960 Cys Asn Cys Asn Tyr Ala Ser Asp Arg Ala Il #e Ser Gly Arg Gln Phe 305                 3 #10                 3 #15                 3 #20 tgt aaa atg act cct tat aag ctc aac ggc ac #a gac gac att act cgc     1008 Cys Lys Met Thr Pro Tyr Lys Leu Asn Gly Th #r Asp Asp Ile Thr Arg                 325   #               330   #               335 gac atg gtc gag agc agg ccc gat atg aag gc #t cac aag aaa aac ccg     1056 Asp Met Val Glu Ser Arg Pro Asp Met Lys Al #a His Lys Lys Asn Pro             340       #           345       #           350 cat acc atg gtg ttc acc tgc tgc aac ccg ca #g gcg gcg tcg ggc gga     1104 His Thr Met Val Phe Thr Cys Cys Asn Pro Gl #n Ala Ala Ser Gly Gly         355           #       360           #       365 gca ggc cgc ggt ctg aag aag acc gaa aaa ac #c tgc gcc tgg cgt ctg     1152 Ala Gly Arg Gly Leu Lys Lys Thr Glu Lys Th #r Cys Ala Trp Arg Leu     370               #   375               #   380 tcg gcc atg gat ctg cgc tac gcg tac gtc tt #t gct acg gag ctg ttt     1200 Ser Ala Met Asp Leu Arg Tyr Ala Tyr Val Ph #e Ala Thr Glu Leu Phe 385                 3 #90                 3 #95                 4 #00 act gcc gtg atg ggt tct tca gag ccc aca ca #t gtg cct gag ttc cgt     1248 Thr Ala Val Met Gly Ser Ser Glu Pro Thr Hi #s Val Pro Glu Phe Arg                 405   #               410   #               415 tgg aac gag tcg tac gcc ttt aaa acg gag gt #g ttg gcg cca gtc tcg     1296 Trp Asn Glu Ser Tyr Ala Phe Lys Thr Glu Va #l Leu Ala Pro Val Ser             420       #           425       #           430 ccc atc gcc agt gac gac ccg ttc gct taa   #                   #         1326 Pro Ile Ala Ser Asp Asp Pro Phe Ala         435           #       440 <210> SEQ ID NO 26 <211> LENGTH: 441 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position: 21899..23224/Product: # E2a DBP <400> SEQUENCE: 26 Met Glu Arg Thr Pro Lys Arg Ala His Gly Ph #e Arg Ser Thr Lys Pro   1               5  #                 10  #                 15 Val Lys Arg Thr Ala Glu Val Met Met Glu Gl #u Glu Glu Glu Glu Val              20      #             25      #             30 Glu Val Val Ala Pro Gly Arg Gly Ala Thr Ar #g Lys Lys Val Ser Arg          35          #         40          #         45 Arg Glu Glu Ser Pro Ser Pro Val Arg Arg Va #l Thr Arg Arg Arg Glu      50              #     55              #     60 Thr Val Val Asp Asp Glu Glu Asn Ala Ser As #p Glu Glu Ser Pro Glu  65                  # 70                  # 75                  # 80 Ala Pro Leu Ser Asp Pro Val Val Tyr Gly Al #a Gln Arg Ala Met Ala                  85  #                 90  #                 95 Thr Val Ala Ser Ile Cys Glu Ala Leu Asp Le #u Gln Trp Gln Gly Ala             100       #           105       #           110 Ser Val Arg Pro Asp Asp Ser Ile Trp Thr Ly #s Met Gly Gly Thr Tyr         115           #       120           #       125 Val Arg Lys Lys His Pro Glu Phe Arg Leu Th #r Phe Ser Ser Tyr Asp     130               #   135               #   140 Ser Phe Asn Ala Gln Val Gly Arg Phe Leu Al #a Ala Val Ile Tyr Ser 145                 1 #50                 1 #55                 1 #60 Arg Ala Gly Leu Glu Pro Lys Phe Val Pro Gl #y Gly Ala His Val Trp                 165   #               170   #               175 Arg His Gly Trp Phe Pro Ala Leu Gln Glu Pr #o Phe Pro Lys Cys Met             180       #           185       #           190 His Gly Val Asp Met Val Thr Lys Pro Arg Th #r Val Glu Leu Asn Pro         195           #       200           #       205 Ser Ser Glu Ala Gly Lys Arg Ala Leu Ala Gl #u Gln Asn Gly Val Ile     210               #   215               #   220 Glu Lys Asn Arg Phe Gly Arg Gln Val Val Va #l Leu Arg Phe Asp Ala 225                 2 #30                 2 #35                 2 #40 Asn Ala Val Cys Tyr Lys Asp Gln Glu His Se #r Gly Phe Pro His Pro                 245   #               250   #               255 His Ala His Gly Ser Cys Ala Met Val Phe Se #r Asp Ala Ala Lys Ala             260       #           265       #           270 Val Ser Ala Met Arg His Asp Ile Asp Trp Th #r Lys Ala Leu Tyr Pro         275           #       280           #       285 Asn Ala Asp Lys Arg Arg Ala Glu Glu Cys Va #l Leu Ile Ser Thr Asn     290               #   295               #   300 Cys Asn Cys Asn Tyr Ala Ser Asp Arg Ala Il #e Ser Gly Arg Gln Phe 305                 3 #10                 3 #15                 3 #20 Cys Lys Met Thr Pro Tyr Lys Leu Asn Gly Th #r Asp Asp Ile Thr Arg                 325   #               330   #               335 Asp Met Val Glu Ser Arg Pro Asp Met Lys Al #a His Lys Lys Asn Pro             340       #           345       #           350 His Thr Met Val Phe Thr Cys Cys Asn Pro Gl #n Ala Ala Ser Gly Gly         355           #       360           #       365 Ala Gly Arg Gly Leu Lys Lys Thr Glu Lys Th #r Cys Ala Trp Arg Leu     370               #   375               #   380 Ser Ala Met Asp Leu Arg Tyr Ala Tyr Val Ph #e Ala Thr Glu Leu Phe 385                 3 #90                 3 #95                 4 #00 Thr Ala Val Met Gly Ser Ser Glu Pro Thr Hi #s Val Pro Glu Phe Arg                 405   #               410   #               415 Trp Asn Glu Ser Tyr Ala Phe Lys Thr Glu Va #l Leu Ala Pro Val Ser             420       #           425       #           430 Pro Ile Ala Ser Asp Asp Pro Phe Ala         435           #       440 <210> SEQ ID NO 27 <211> LENGTH: 3366 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(3366) <400> SEQUENCE: 27 atg ctc atc gcc aaa aac gtc acc gga gaa tg #g gtc tgg atc acc agc       48 Met Leu Ile Ala Lys Asn Val Thr Gly Glu Tr #p Val Trp Ile Thr Ser   1               5  #                 10  #                 15 cgc act ccg gtt caa cag tgt ccc acc tgc gg #c cga cac tgg gtc aga       96 Arg Thr Pro Val Gln Gln Cys Pro Thr Cys Gl #y Arg His Trp Val Arg              20      #             25      #             30 cga cac tcg tgc aac gaa cgc cgc tct gcc tt #c tac tac cac gcc gtc      144 Arg His Ser Cys Asn Glu Arg Arg Ser Ala Ph #e Tyr Tyr His Ala Val          35          #         40          #         45 cag gga tcg ggc agc gat ttg tgg cag cac gt #c cac ttc tcc tgt cca      192 Gln Gly Ser Gly Ser Asp Leu Trp Gln His Va #l His Phe Ser Cys Pro      50              #     55              #     60 gcc caa cac ccc cac ata cgt cag ttg tac at #c acc tac gat atc gag      240 Ala Gln His Pro His Ile Arg Gln Leu Tyr Il #e Thr Tyr Asp Ile Glu  65                  # 70                  # 75                  # 80 acg tat acc gtg ttc gaa aag aaa ggc aag cg #c atg cat ccg ttt atg      288 Thr Tyr Thr Val Phe Glu Lys Lys Gly Lys Ar #g Met His Pro Phe Met                  85  #                 90  #                 95 ttg tgc ttc atg ctc agc gga gac ccc cag ct #g gtc tcc cgc gcc gaa      336 Leu Cys Phe Met Leu Ser Gly Asp Pro Gln Le #u Val Ser Arg Ala Glu             100       #           105       #           110 cgc tta gca cgg cag gac gac cgt ctc aaa gc #c ctc gac gaa ggc ttc      384 Arg Leu Ala Arg Gln Asp Asp Arg Leu Lys Al #a Leu Asp Glu Gly Phe         115           #       120           #       125 tat tgg cta gac agc cat ccg ggc gag gtt gc #c aga agg ttt cgc aac      432 Tyr Trp Leu Asp Ser His Pro Gly Glu Val Al #a Arg Arg Phe Arg Asn     130               #   135               #   140 ttc agg tcc cgt ctg caa ata gaa ttt gcc ca #a aat cta gtc gac cgc      480 Phe Arg Ser Arg Leu Gln Ile Glu Phe Ala Gl #n Asn Leu Val Asp Arg 145                 1 #50                 1 #55                 1 #60 tac gcg gct gcc aac cga gat tat tgc gac ca #g cta gtc aag gac gga      528 Tyr Ala Ala Ala Asn Arg Asp Tyr Cys Asp Gl #n Leu Val Lys Asp Gly                 165   #               170   #               175 aag tac ggc tcc gtt cac aaa ata ccg tac ga #g ctc ttc gag aaa ccc      576 Lys Tyr Gly Ser Val His Lys Ile Pro Tyr Gl #u Leu Phe Glu Lys Pro             180       #           185       #           190 acc tcc ccc ctc tcc ctc ccg gat aac ttt ta #t tcc gta gac atc gta      624 Thr Ser Pro Leu Ser Leu Pro Asp Asn Phe Ty #r Ser Val Asp Ile Val         195           #       200           #       205 gtg cta ggt cac aac ata tgt aag ttc gat ga #a ctc ctc tta gcc acg      672 Val Leu Gly His Asn Ile Cys Lys Phe Asp Gl #u Leu Leu Leu Ala Thr     210               #   215               #   220 gaa ctc gtc gag cgc agg gac cta ttc ccg ga #a gcg tgc aaa tgt gat      720 Glu Leu Val Glu Arg Arg Asp Leu Phe Pro Gl #u Ala Cys Lys Cys Asp 225                 2 #30                 2 #35                 2 #40 cga tcc ttc atg cct cgc gtc ggt cgc ctt ct #g ttc aat gat atc att      768 Arg Ser Phe Met Pro Arg Val Gly Arg Leu Le #u Phe Asn Asp Ile Ile                 245   #               250   #               255 ttc cgc atg cca aac ccc aac tac gtg aag aa #a gac gcc tcc cgc gta      816 Phe Arg Met Pro Asn Pro Asn Tyr Val Lys Ly #s Asp Ala Ser Arg Val             260       #           265       #           270 gaa cgc tgg tct cgc ggg atc gtg tcc cat ca #g gat gcg cgc tcg gta      864 Glu Arg Trp Ser Arg Gly Ile Val Ser His Gl #n Asp Ala Arg Ser Val         275           #       280           #       285 ttt gtg cgg ttc atg gtg cga gac act cta ca #g ctc acc agc ggg gcc      912 Phe Val Arg Phe Met Val Arg Asp Thr Leu Gl #n Leu Thr Ser Gly Ala     290               #   295               #   300 aaa ctc tcc aaa gcc gcg gca gcc tac gcg ct #a gac ctc tgc aag gga      960 Lys Leu Ser Lys Ala Ala Ala Ala Tyr Ala Le #u Asp Leu Cys Lys Gly 305                 3 #10                 3 #15                 3 #20 cat tgc cca tac gag gcc atc aac gaa ttc at #t tcc acg ggg cgc ttt     1008 His Cys Pro Tyr Glu Ala Ile Asn Glu Phe Il #e Ser Thr Gly Arg Phe                 325   #               330   #               335 cac gcg gac gcc gac ggc ttt cct gtc gaa ag #g tac tgg gaa gac cca     1056 His Ala Asp Ala Asp Gly Phe Pro Val Glu Ar #g Tyr Trp Glu Asp Pro             340       #           345       #           350 tcc gtc atc gct gaa cag aag aat cta tgg ca #g aaa gaa cac ccg ggc     1104 Ser Val Ile Ala Glu Gln Lys Asn Leu Trp Gl #n Lys Glu His Pro Gly         355           #       360           #       365 cag cag tac gac atc gtc caa gcg tgc ctc ga #a tac tgc atg cag gac     1152 Gln Gln Tyr Asp Ile Val Gln Ala Cys Leu Gl #u Tyr Cys Met Gln Asp     370               #   375               #   380 gtc cgc gtc acc caa aag ctg gcc cac acg tt #a cac gac agc tac gac     1200 Val Arg Val Thr Gln Lys Leu Ala His Thr Le #u His Asp Ser Tyr Asp 385                 3 #90                 3 #95                 4 #00 gcc tat ttc caa cga gaa cta ggg atg gaa gg #c cat ttt aac atc ttc     1248 Ala Tyr Phe Gln Arg Glu Leu Gly Met Glu Gl #y His Phe Asn Ile Phe                 405   #               410   #               415 gtg cgg ccc acc atc ccc agc aac act cat gc #c ttt tgg aag caa ctt     1296 Val Arg Pro Thr Ile Pro Ser Asn Thr His Al #a Phe Trp Lys Gln Leu             420       #           425       #           430 acc ttt tcc aat tac gtc cgc gaa cag cgt gc #g aca tgc cct ccc tcc     1344 Thr Phe Ser Asn Tyr Val Arg Glu Gln Arg Al #a Thr Cys Pro Pro Ser         435           #       440           #       445 gtc ccc gaa ccc ccc aaa aag aaa ggt cga ac #c aaa aag aaa aaa caa     1392 Val Pro Glu Pro Pro Lys Lys Lys Gly Arg Th #r Lys Lys Lys Lys Gln     450               #   455               #   460 ccc tcc ccc gac tac gtg gcc gaa gtc tac gc #c ccc cac cgc ccc atg     1440 Pro Ser Pro Asp Tyr Val Ala Glu Val Tyr Al #a Pro His Arg Pro Met 465                 4 #70                 4 #75                 4 #80 ttc aaa tac ata cgc caa gcg ctc cgc ggc gg #a cga tgc tac ccc aac     1488 Phe Lys Tyr Ile Arg Gln Ala Leu Arg Gly Gl #y Arg Cys Tyr Pro Asn                 485   #               490   #               495 gtg ctc gga cct tac ctg aaa ccc gtc tac gt #c ttt gac atc tgc ggc     1536 Val Leu Gly Pro Tyr Leu Lys Pro Val Tyr Va #l Phe Asp Ile Cys Gly             500       #           505       #           510 atg tac gct tcc gcc ctc acc cac ccc atg cc #c cac gga atg ccc cta     1584 Met Tyr Ala Ser Ala Leu Thr His Pro Met Pr #o His Gly Met Pro Leu         515           #       520           #       525 gat cca aaa ttt acc gcg cag cac gtg gag ga #g ctc aac cgg ctg ctg     1632 Asp Pro Lys Phe Thr Ala Gln His Val Glu Gl #u Leu Asn Arg Leu Leu     530               #   535               #   540 acc aac gaa tcg cat ctg agc tac ttc gat gc #g cgt atc aag cct tcc     1680 Thr Asn Glu Ser His Leu Ser Tyr Phe Asp Al #a Arg Ile Lys Pro Ser 545                 5 #50                 5 #55                 5 #60 atc ctg aaa ata gaa gcc tac cct ccc ccg cc #c gaa atg tta gac cca     1728 Ile Leu Lys Ile Glu Ala Tyr Pro Pro Pro Pr #o Glu Met Leu Asp Pro                 565   #               570   #               575 ctc cct ccc atc tgc tcc cgg agg gga ggc ag #a ctg gtc tgg acc aac     1776 Leu Pro Pro Ile Cys Ser Arg Arg Gly Gly Ar #g Leu Val Trp Thr Asn             580       #           585       #           590 gag gct ctc tac gac gag gtg gtc acc gtc at #a gat atc ctc acg ctg     1824 Glu Ala Leu Tyr Asp Glu Val Val Thr Val Il #e Asp Ile Leu Thr Leu         595           #       600           #       605 cac aac cgg gga tgg cga gtc cag gtc ctc ca #t gac gag atg aac att     1872 His Asn Arg Gly Trp Arg Val Gln Val Leu Hi #s Asp Glu Met Asn Ile     610               #   615               #   620 gtt ttt ccg gaa tgg aaa acg cta tgt gcc ga #c tac gtc acg aaa aac     1920 Val Phe Pro Glu Trp Lys Thr Leu Cys Ala As #p Tyr Val Thr Lys Asn 625                 6 #30                 6 #35                 6 #40 atc ctc gcc aaa gaa aaa gcc gat cgc gag aa #g aac gaa gtg att cga     1968 Ile Leu Ala Lys Glu Lys Ala Asp Arg Glu Ly #s Asn Glu Val Ile Arg                 645   #               650   #               655 tcc atc tcc aaa atg ctg agc aac gcg ctg ta #c ggt gcg ttt gcc acc     2016 Ser Ile Ser Lys Met Leu Ser Asn Ala Leu Ty #r Gly Ala Phe Ala Thr             660       #           665       #           670 aac atg gac acc acg cgc atc atc ttt gaa ca #g gac ctc tcg gaa gca     2064 Asn Met Asp Thr Thr Arg Ile Ile Phe Glu Gl #n Asp Leu Ser Glu Ala         675           #       680           #       685 gat aag aaa aac atc tac gaa ggc act gaa at #c gtc aaa cac gtc acg     2112 Asp Lys Lys Asn Ile Tyr Glu Gly Thr Glu Il #e Val Lys His Val Thr     690               #   695               #   700 ctg ctc aat gac gac tcg ttc aac gga acg ga #a gtc acc ctc gaa aac     2160 Leu Leu Asn Asp Asp Ser Phe Asn Gly Thr Gl #u Val Thr Leu Glu Asn 705                 7 #10                 7 #15                 7 #20 gcg cct aac ccc ttc agt gag gag agt cta cg #a caa cag ttc cgc tac     2208 Ala Pro Asn Pro Phe Ser Glu Glu Ser Leu Ar #g Gln Gln Phe Arg Tyr                 725   #               730   #               735 gca gac gac ccc gaa cag gaa gag ccc gaa gc #a gaa gag gat ggg gaa     2256 Ala Asp Asp Pro Glu Gln Glu Glu Pro Glu Al #a Glu Glu Asp Gly Glu             740       #           745       #           750 gaa gaa gga gac gac agc gat cgc gag agt gc #c cgt aag ccg aaa aac     2304 Glu Glu Gly Asp Asp Ser Asp Arg Glu Ser Al #a Arg Lys Pro Lys Asn         755           #       760           #       765 gca ctt acc gaa gac gat cct ctc gtc gcc gt #a gac ctg gaa gtc gag     2352 Ala Leu Thr Glu Asp Asp Pro Leu Val Ala Va #l Asp Leu Glu Val Glu     770               #   775               #   780 gcg acc ctc gcg acg ggc cct tat ata ccc ga #g ggg gag cta agc tcc     2400 Ala Thr Leu Ala Thr Gly Pro Tyr Ile Pro Gl #u Gly Glu Leu Ser Ser 785                 7 #90                 7 #95                 8 #00 gcc cac tac gct cgc gct aac gag acc cgg tt #t aaa cct atg cgt ctc     2448 Ala His Tyr Ala Arg Ala Asn Glu Thr Arg Ph #e Lys Pro Met Arg Leu                 805   #               810   #               815 ctc gaa gcc aca cca gaa gcc cta acc gtg ct #c cat ctg gaa agc ctg     2496 Leu Glu Ala Thr Pro Glu Ala Leu Thr Val Le #u His Leu Glu Ser Leu             820       #           825       #           830 gac aag cag gtg gca aac aaa aga tac gcc ac #g caa atc gcc tgc ttc     2544 Asp Lys Gln Val Ala Asn Lys Arg Tyr Ala Th #r Gln Ile Ala Cys Phe         835           #       840           #       845 gtg ctg ggc tgg tcg agg gcc ttc ttc agc ga #g tgg tgt gac atc ctg     2592 Val Leu Gly Trp Ser Arg Ala Phe Phe Ser Gl #u Trp Cys Asp Ile Leu     850               #   855               #   860 tac gga ccg gac aga gga gtg cac atc ctg cg #a agg gag gag ccg cgc     2640 Tyr Gly Pro Asp Arg Gly Val His Ile Leu Ar #g Arg Glu Glu Pro Arg 865                 8 #70                 8 #75                 8 #80 agc ctc tat ggc gat acc gac agc ctg ttc gt #c aca gaa aca ggc tat     2688 Ser Leu Tyr Gly Asp Thr Asp Ser Leu Phe Va #l Thr Glu Thr Gly Tyr                 885   #               890   #               895 cat cgc atg aaa agc cgc ggc gcg cac cga at #c aaa aca gaa tcc act     2736 His Arg Met Lys Ser Arg Gly Ala His Arg Il #e Lys Thr Glu Ser Thr             900       #           905       #           910 cga ctg act ttc gat cca gaa aat ccc ggc ct #c tac tgg gcc tgc gat     2784 Arg Leu Thr Phe Asp Pro Glu Asn Pro Gly Le #u Tyr Trp Ala Cys Asp         915           #       920           #       925 tgc gac atc aag tgc aaa gcc tgc gga agt ga #c acg tac agc tcg gaa     2832 Cys Asp Ile Lys Cys Lys Ala Cys Gly Ser As #p Thr Tyr Ser Ser Glu     930               #   935               #   940 acc atc ttc cta gcg cca aaa ctg tac gga ct #g aaa aac tca atc tgc     2880 Thr Ile Phe Leu Ala Pro Lys Leu Tyr Gly Le #u Lys Asn Ser Ile Cys 945                 9 #50                 9 #55                 9 #60 gtc aac gaa cag tgc cgc acg gta gga ccc gg #g aaa atc aga tcg aag     2928 Val Asn Glu Gln Cys Arg Thr Val Gly Pro Gl #y Lys Ile Arg Ser Lys                 965   #               970   #               975 gga cac agg cag tcc gaa ctc atc tac gac ac #g ctg ctg cgc tgt tgg     2976 Gly His Arg Gln Ser Glu Leu Ile Tyr Asp Th #r Leu Leu Arg Cys Trp             980       #           985       #           990 cgt aga cac gag gac gtg caa ttc gga gcg ca #g agc aac atc cca gag     3024 Arg Arg His Glu Asp Val Gln Phe Gly Ala Gl #n Ser Asn Ile Pro Glu         995           #      1000            #     1005 cta cac acg cgg aga acc atc ttt aaa acc ac #g ctt ctg aac aag gtc     3072 Leu His Thr Arg Arg Thr Ile Phe Lys Thr Th #r Leu Leu Asn Lys Val    1010               #  1015                # 1020 agt cgc tac gac cct ttc acc att cac aac ga #g cag ctc acg cga gtg     3120 Ser Arg Tyr Asp Pro Phe Thr Ile His Asn Gl #u Gln Leu Thr Arg Val 1025               1030  #               1035   #              1040 ctg cgt ccg tgg aag gac ctc acc cta tac ga #g cac ggg gac tac ctg     3168 Leu Arg Pro Trp Lys Asp Leu Thr Leu Tyr Gl #u His Gly Asp Tyr Leu                1045   #              1050    #             1055 tac ccc tac gac aat gag cac cca aat ccc cg #c acg aca gga gac gta     3216 Tyr Pro Tyr Asp Asn Glu His Pro Asn Pro Ar #g Thr Thr Gly Asp Val            1060       #          1065        #         1070 cga ccc gtc cca atc gtc ggg cac gaa gac cc #c ctc gca ccc cta cga     3264 Arg Pro Val Pro Ile Val Gly His Glu Asp Pr #o Leu Ala Pro Leu Arg        1075           #      1080            #     1085 tgg gaa ccc tac gcg ttc cta tcc gaa gag ga #a tgc ggg caa gtt cac     3312 Trp Glu Pro Tyr Ala Phe Leu Ser Glu Glu Gl #u Cys Gly Gln Val His    1090               #  1095                # 1100 gac cta ctc ttc gca gat gat agc tcc cag ga #a gcg gaa agc ctg gga     3360 Asp Leu Leu Phe Ala Asp Asp Ser Ser Gln Gl #u Ala Glu Ser Leu Gly 1105               1110  #               1115   #              1120 gta tga                 #                   #                   #         3366 Val <210> SEQ ID NO 28 <211> LENGTH: 1121 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position: 6501..9866/Product:  #E2b pol <400> SEQUENCE: 28 Met Leu Ile Ala Lys Asn Val Thr Gly Glu Tr #p Val Trp Ile Thr Ser   1               5  #                 10  #                 15 Arg Thr Pro Val Gln Gln Cys Pro Thr Cys Gl #y Arg His Trp Val Arg              20      #             25      #             30 Arg His Ser Cys Asn Glu Arg Arg Ser Ala Ph #e Tyr Tyr His Ala Val          35          #         40          #         45 Gln Gly Ser Gly Ser Asp Leu Trp Gln His Va #l His Phe Ser Cys Pro      50              #     55              #     60 Ala Gln His Pro His Ile Arg Gln Leu Tyr Il #e Thr Tyr Asp Ile Glu  65                  # 70                  # 75                  # 80 Thr Tyr Thr Val Phe Glu Lys Lys Gly Lys Ar #g Met His Pro Phe Met                  85  #                 90  #                 95 Leu Cys Phe Met Leu Ser Gly Asp Pro Gln Le #u Val Ser Arg Ala Glu             100       #           105       #           110 Arg Leu Ala Arg Gln Asp Asp Arg Leu Lys Al #a Leu Asp Glu Gly Phe         115           #       120           #       125 Tyr Trp Leu Asp Ser His Pro Gly Glu Val Al #a Arg Arg Phe Arg Asn     130               #   135               #   140 Phe Arg Ser Arg Leu Gln Ile Glu Phe Ala Gl #n Asn Leu Val Asp Arg 145                 1 #50                 1 #55                 1 #60 Tyr Ala Ala Ala Asn Arg Asp Tyr Cys Asp Gl #n Leu Val Lys Asp Gly                 165   #               170   #               175 Lys Tyr Gly Ser Val His Lys Ile Pro Tyr Gl #u Leu Phe Glu Lys Pro             180       #           185       #           190 Thr Ser Pro Leu Ser Leu Pro Asp Asn Phe Ty #r Ser Val Asp Ile Val         195           #       200           #       205 Val Leu Gly His Asn Ile Cys Lys Phe Asp Gl #u Leu Leu Leu Ala Thr     210               #   215               #   220 Glu Leu Val Glu Arg Arg Asp Leu Phe Pro Gl #u Ala Cys Lys Cys Asp 225                 2 #30                 2 #35                 2 #40 Arg Ser Phe Met Pro Arg Val Gly Arg Leu Le #u Phe Asn Asp Ile Ile                 245   #               250   #               255 Phe Arg Met Pro Asn Pro Asn Tyr Val Lys Ly #s Asp Ala Ser Arg Val             260       #           265       #           270 Glu Arg Trp Ser Arg Gly Ile Val Ser His Gl #n Asp Ala Arg Ser Val         275           #       280           #       285 Phe Val Arg Phe Met Val Arg Asp Thr Leu Gl #n Leu Thr Ser Gly Ala     290               #   295               #   300 Lys Leu Ser Lys Ala Ala Ala Ala Tyr Ala Le #u Asp Leu Cys Lys Gly 305                 3 #10                 3 #15                 3 #20 His Cys Pro Tyr Glu Ala Ile Asn Glu Phe Il #e Ser Thr Gly Arg Phe                 325   #               330   #               335 His Ala Asp Ala Asp Gly Phe Pro Val Glu Ar #g Tyr Trp Glu Asp Pro             340       #           345       #           350 Ser Val Ile Ala Glu Gln Lys Asn Leu Trp Gl #n Lys Glu His Pro Gly         355           #       360           #       365 Gln Gln Tyr Asp Ile Val Gln Ala Cys Leu Gl #u Tyr Cys Met Gln Asp     370               #   375               #   380 Val Arg Val Thr Gln Lys Leu Ala His Thr Le #u His Asp Ser Tyr Asp 385                 3 #90                 3 #95                 4 #00 Ala Tyr Phe Gln Arg Glu Leu Gly Met Glu Gl #y His Phe Asn Ile Phe                 405   #               410   #               415 Val Arg Pro Thr Ile Pro Ser Asn Thr His Al #a Phe Trp Lys Gln Leu             420       #           425       #           430 Thr Phe Ser Asn Tyr Val Arg Glu Gln Arg Al #a Thr Cys Pro Pro Ser         435           #       440           #       445 Val Pro Glu Pro Pro Lys Lys Lys Gly Arg Th #r Lys Lys Lys Lys Gln     450               #   455               #   460 Pro Ser Pro Asp Tyr Val Ala Glu Val Tyr Al #a Pro His Arg Pro Met 465                 4 #70                 4 #75                 4 #80 Phe Lys Tyr Ile Arg Gln Ala Leu Arg Gly Gl #y Arg Cys Tyr Pro Asn                 485   #               490   #               495 Val Leu Gly Pro Tyr Leu Lys Pro Val Tyr Va #l Phe Asp Ile Cys Gly             500       #           505       #           510 Met Tyr Ala Ser Ala Leu Thr His Pro Met Pr #o His Gly Met Pro Leu         515           #       520           #       525 Asp Pro Lys Phe Thr Ala Gln His Val Glu Gl #u Leu Asn Arg Leu Leu     530               #   535               #   540 Thr Asn Glu Ser His Leu Ser Tyr Phe Asp Al #a Arg Ile Lys Pro Ser 545                 5 #50                 5 #55                 5 #60 Ile Leu Lys Ile Glu Ala Tyr Pro Pro Pro Pr #o Glu Met Leu Asp Pro                 565   #               570   #               575 Leu Pro Pro Ile Cys Ser Arg Arg Gly Gly Ar #g Leu Val Trp Thr Asn             580       #           585       #           590 Glu Ala Leu Tyr Asp Glu Val Val Thr Val Il #e Asp Ile Leu Thr Leu         595           #       600           #       605 His Asn Arg Gly Trp Arg Val Gln Val Leu Hi #s Asp Glu Met Asn Ile     610               #   615               #   620 Val Phe Pro Glu Trp Lys Thr Leu Cys Ala As #p Tyr Val Thr Lys Asn 625                 6 #30                 6 #35                 6 #40 Ile Leu Ala Lys Glu Lys Ala Asp Arg Glu Ly #s Asn Glu Val Ile Arg                 645   #               650   #               655 Ser Ile Ser Lys Met Leu Ser Asn Ala Leu Ty #r Gly Ala Phe Ala Thr             660       #           665       #           670 Asn Met Asp Thr Thr Arg Ile Ile Phe Glu Gl #n Asp Leu Ser Glu Ala         675           #       680           #       685 Asp Lys Lys Asn Ile Tyr Glu Gly Thr Glu Il #e Val Lys His Val Thr     690               #   695               #   700 Leu Leu Asn Asp Asp Ser Phe Asn Gly Thr Gl #u Val Thr Leu Glu Asn 705                 7 #10                 7 #15                 7 #20 Ala Pro Asn Pro Phe Ser Glu Glu Ser Leu Ar #g Gln Gln Phe Arg Tyr                 725   #               730   #               735 Ala Asp Asp Pro Glu Gln Glu Glu Pro Glu Al #a Glu Glu Asp Gly Glu             740       #           745       #           750 Glu Glu Gly Asp Asp Ser Asp Arg Glu Ser Al #a Arg Lys Pro Lys Asn         755           #       760           #       765 Ala Leu Thr Glu Asp Asp Pro Leu Val Ala Va #l Asp Leu Glu Val Glu     770               #   775               #   780 Ala Thr Leu Ala Thr Gly Pro Tyr Ile Pro Gl #u Gly Glu Leu Ser Ser 785                 7 #90                 7 #95                 8 #00 Ala His Tyr Ala Arg Ala Asn Glu Thr Arg Ph #e Lys Pro Met Arg Leu                 805   #               810   #               815 Leu Glu Ala Thr Pro Glu Ala Leu Thr Val Le #u His Leu Glu Ser Leu             820       #           825       #           830 Asp Lys Gln Val Ala Asn Lys Arg Tyr Ala Th #r Gln Ile Ala Cys Phe         835           #       840           #       845 Val Leu Gly Trp Ser Arg Ala Phe Phe Ser Gl #u Trp Cys Asp Ile Leu     850               #   855               #   860 Tyr Gly Pro Asp Arg Gly Val His Ile Leu Ar #g Arg Glu Glu Pro Arg 865                 8 #70                 8 #75                 8 #80 Ser Leu Tyr Gly Asp Thr Asp Ser Leu Phe Va #l Thr Glu Thr Gly Tyr                 885   #               890   #               895 His Arg Met Lys Ser Arg Gly Ala His Arg Il #e Lys Thr Glu Ser Thr             900       #           905       #           910 Arg Leu Thr Phe Asp Pro Glu Asn Pro Gly Le #u Tyr Trp Ala Cys Asp         915           #       920           #       925 Cys Asp Ile Lys Cys Lys Ala Cys Gly Ser As #p Thr Tyr Ser Ser Glu     930               #   935               #   940 Thr Ile Phe Leu Ala Pro Lys Leu Tyr Gly Le #u Lys Asn Ser Ile Cys 945                 9 #50                 9 #55                 9 #60 Val Asn Glu Gln Cys Arg Thr Val Gly Pro Gl #y Lys Ile Arg Ser Lys                 965   #               970   #               975 Gly His Arg Gln Ser Glu Leu Ile Tyr Asp Th #r Leu Leu Arg Cys Trp             980       #           985       #           990 Arg Arg His Glu Asp Val Gln Phe Gly Ala Gl #n Ser Asn Ile Pro Glu         995           #      1000            #     1005 Leu His Thr Arg Arg Thr Ile Phe Lys Thr Th #r Leu Leu Asn Lys Val    1010               #  1015                # 1020 Ser Arg Tyr Asp Pro Phe Thr Ile His Asn Gl #u Gln Leu Thr Arg Val 1025                1030 #                1035  #               1040 Leu Arg Pro Trp Lys Asp Leu Thr Leu Tyr Gl #u His Gly Asp Tyr Leu                1045   #              1050    #             1055 Tyr Pro Tyr Asp Asn Glu His Pro Asn Pro Ar #g Thr Thr Gly Asp Val            1060       #          1065        #         1070 Arg Pro Val Pro Ile Val Gly His Glu Asp Pr #o Leu Ala Pro Leu Arg        1075           #      1080            #     1085 Trp Glu Pro Tyr Ala Phe Leu Ser Glu Glu Gl #u Cys Gly Gln Val His    1090               #  1095                # 1100 Asp Leu Leu Phe Ala Asp Asp Ser Ser Gln Gl #u Ala Glu Ser Leu Gly 1105                1110 #                1115  #               1120 Val <210> SEQ ID NO 29 <211> LENGTH: 1728 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(1728) <400> SEQUENCE: 29 atg caa ctc cga gac ctc gcg ccg cga tcg cc #g aac gtc gcc gcg ccg       48 Met Gln Leu Arg Asp Leu Ala Pro Arg Ser Pr #o Asn Val Ala Ala Pro   1               5  #                 10  #                 15 ccc tac aac gga ttg ccg ccg ccg cac ctt ct #c ctc ggg tac caa gct       96 Pro Tyr Asn Gly Leu Pro Pro Pro His Leu Le #u Leu Gly Tyr Gln Ala              20      #             25      #             30 atg cac cgc gcg ctc aac gat tac ctt ttc ga #c aac cgc gtt ttt atg      144 Met His Arg Ala Leu Asn Asp Tyr Leu Phe As #p Asn Arg Val Phe Met          35          #         40          #         45 cag ata ggt tac gat agc cca ccc caa aga cc #c aga cgc ctc ttt tgg      192 Gln Ile Gly Tyr Asp Ser Pro Pro Gln Arg Pr #o Arg Arg Leu Phe Trp      50              #     55              #     60 acc tgt ctg acc gac tgc tcc tac gcc gtc aa #t gta ggg cag tac atg      240 Thr Cys Leu Thr Asp Cys Ser Tyr Ala Val As #n Val Gly Gln Tyr Met  65                  # 70                  # 75                  # 80 cga ttt ctc gat ctc gac aac ttt cac ggt ac #g ttc acg cag atg cac      288 Arg Phe Leu Asp Leu Asp Asn Phe His Gly Th #r Phe Thr Gln Met His                  85  #                 90  #                 95 aac gcc gta ctc atg gac cgc gtg gcc gcg ga #c atg ggc cgg gcg cat      336 Asn Ala Val Leu Met Asp Arg Val Ala Ala As #p Met Gly Arg Ala His             100       #           105       #           110 ctg cga ggt agg gga atc gac gta ggc cgt ca #c gga caa gtg ttg ccg      384 Leu Arg Gly Arg Gly Ile Asp Val Gly Arg Hi #s Gly Gln Val Leu Pro         115           #       120           #       125 cag ctc gac gcc gaa cac cac agc cta ctg tc #g ggc aac gga gcg ggt      432 Gln Leu Asp Ala Glu His His Ser Leu Leu Se #r Gly Asn Gly Ala Gly     130               #   135               #   140 ggc ttg caa gaa ggc gtc ctc atg cga acg gc #c tct gcc gcc gac gcc      480 Gly Leu Gln Glu Gly Val Leu Met Arg Thr Al #a Ser Ala Ala Asp Ala 145                 1 #50                 1 #55                 1 #60 gaa ctg ctc gcc gcc atc cgc caa cta aga gt #c gcc ctc tgc cac tat      528 Glu Leu Leu Ala Ala Ile Arg Gln Leu Arg Va #l Ala Leu Cys His Tyr                 165   #               170   #               175 cta ttc tgc tac gca tat gat cta ttt caa ac #g gaa gaa aga tat cgg      576 Leu Phe Cys Tyr Ala Tyr Asp Leu Phe Gln Th #r Glu Glu Arg Tyr Arg             180       #           185       #           190 ttc tta cct gga tcc gat gtg ttc ctt gaa cc #a aac tgg ctc tcc tac      624 Phe Leu Pro Gly Ser Asp Val Phe Leu Glu Pr #o Asn Trp Leu Ser Tyr         195           #       200           #       205 ttc gcg gaa gcc ttc gcg gag cta gac acc ca #g caa ctg gtg cgg gat      672 Phe Ala Glu Ala Phe Ala Glu Leu Asp Thr Gl #n Gln Leu Val Arg Asp     210               #   215               #   220 gcc gag cgc aag ttt cga gga aga cgg gac gt #a gag gaa cct acg gaa      720 Ala Glu Arg Lys Phe Arg Gly Arg Arg Asp Va #l Glu Glu Pro Thr Glu 225                 2 #30                 2 #35                 2 #40 aca atg gcg aga tgt ttc atg agc act cta gc #g agc gac gcc gtt tcc      768 Thr Met Ala Arg Cys Phe Met Ser Thr Leu Al #a Ser Asp Ala Val Ser                 245   #               250   #               255 tta gca gga acg ggt ctg tca gga ggc gcc at #c acc ctc tgc agc cgg      816 Leu Ala Gly Thr Gly Leu Ser Gly Gly Ala Il #e Thr Leu Cys Ser Arg             260       #           265       #           270 cgg gta acc gac cgc acc ggc ctg cgc cct ag #a gac cgc cac ggc aga      864 Arg Val Thr Asp Arg Thr Gly Leu Arg Pro Ar #g Asp Arg His Gly Arg         275           #       280           #       285 gcc atc acc gcg tcc gaa gcg cgc cgc att ag #g ccc cgt gcc gtg cgg      912 Ala Ile Thr Ala Ser Glu Ala Arg Arg Ile Ar #g Pro Arg Ala Val Arg     290               #   295               #   300 gcc ttc gta gac cgc ctg ccc cgc gtc acg cg #g cgg cga cgg aga ccc      960 Ala Phe Val Asp Arg Leu Pro Arg Val Thr Ar #g Arg Arg Arg Arg Pro 305                 3 #10                 3 #15                 3 #20 ccc tcc ccc gcg ccc cct ccc gaa gaa ata ga #a gaa gcc gcc atg gaa     1008 Pro Ser Pro Ala Pro Pro Pro Glu Glu Ile Gl #u Glu Ala Ala Met Glu                 325   #               330   #               335 gta gaa gaa cca gaa gag gag gaa gaa gag ct #g tta gac gag gtg att     1056 Val Glu Glu Pro Glu Glu Glu Glu Glu Glu Le #u Leu Asp Glu Val Ile             340       #           345       #           350 cgc aca gcg ctc gaa gcc atc ggg gca ctg ca #a gac gag ctc agc ggg     1104 Arg Thr Ala Leu Glu Ala Ile Gly Ala Leu Gl #n Asp Glu Leu Ser Gly         355           #       360           #       365 gcc gcc cgg aga cac gaa ctc ttc agg ttt gc #c aac gac ttc tac cgc     1152 Ala Ala Arg Arg His Glu Leu Phe Arg Phe Al #a Asn Asp Phe Tyr Arg     370               #   375               #   380 atg ctc ctg acc gcg cgc gac gcg gga ctc at #g gga gag tcg ttc ctg     1200 Met Leu Leu Thr Ala Arg Asp Ala Gly Leu Me #t Gly Glu Ser Phe Leu 385                 3 #90                 3 #95                 4 #00 cgc aag tgg gtg ctg tac ttc ttc tta gcc ga #a cat atc gcc tct aca     1248 Arg Lys Trp Val Leu Tyr Phe Phe Leu Ala Gl #u His Ile Ala Ser Thr                 405   #               410   #               415 ctc tac tac ctg tac agc cac ttc atc gcc aa #c cgc gag ttc cgc cgg     1296 Leu Tyr Tyr Leu Tyr Ser His Phe Ile Ala As #n Arg Glu Phe Arg Arg             420       #           425       #           430 tac gtc gac gtc ctg acc tta caa gta ctc gt #c gtg gga tgg gac gtc     1344 Tyr Val Asp Val Leu Thr Leu Gln Val Leu Va #l Val Gly Trp Asp Val         435           #       440           #       445 aac gcg cag cag gtt ttt aaa cgc ata tgg ag #c gag caa tcc aac ccc     1392 Asn Ala Gln Gln Val Phe Lys Arg Ile Trp Se #r Glu Gln Ser Asn Pro     450               #   455               #   460 gcc acc ata ttc gaa acc ctg tgg gaa cgt at #a tta cgc gat ttt ctt     1440 Ala Thr Ile Phe Glu Thr Leu Trp Glu Arg Il #e Leu Arg Asp Phe Leu 465                 4 #70                 4 #75                 4 #80 atg atg gtc gaa cgg acg ggt caa ttc gaa gg #c atg gac gat gcg gac     1488 Met Met Val Glu Arg Thr Gly Gln Phe Glu Gl #y Met Asp Asp Ala Asp                 485   #               490   #               495 caa caa ctg ttt ctc tct gat att caa tac ag #a gac cgc tcc ggt gac     1536 Gln Gln Leu Phe Leu Ser Asp Ile Gln Tyr Ar #g Asp Arg Ser Gly Asp             500       #           505       #           510 atc gaa gaa gtg ctg aag cag ctc aac ctc ag #c gaa gag ctg atc gat     1584 Ile Glu Glu Val Leu Lys Gln Leu Asn Leu Se #r Glu Glu Leu Ile Asp         515           #       520           #       525 agc atc gac atc agt ttc cgc atc aaa ttt aa #a ggc atc gta gcc atc     1632 Ser Ile Asp Ile Ser Phe Arg Ile Lys Phe Ly #s Gly Ile Val Ala Ile     530               #   535               #   540 gct acc aac gag gag atc aaa gcc aac ctc ag #a cgc gtg ctc cgc cac     1680 Ala Thr Asn Glu Glu Ile Lys Ala Asn Leu Ar #g Arg Val Leu Arg His 545                 5 #50                 5 #55                 5 #60 cgc cgc gaa gac atc gaa gcg gcg gcg cga cg #a ggt cag cct ctg taa     1728 Arg Arg Glu Asp Ile Glu Ala Ala Ala Arg Ar #g Gly Gln Pro Leu                 565   #               570   #               575 <210> SEQ ID NO 30 <211> LENGTH: 575 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position: 10269..11996/Product: # E2b pTP <400> SEQUENCE: 30 Met Gln Leu Arg Asp Leu Ala Pro Arg Ser Pr #o Asn Val Ala Ala Pro   1               5  #                 10  #                 15 Pro Tyr Asn Gly Leu Pro Pro Pro His Leu Le #u Leu Gly Tyr Gln Ala              20      #             25      #             30 Met His Arg Ala Leu Asn Asp Tyr Leu Phe As #p Asn Arg Val Phe Met          35          #         40          #         45 Gln Ile Gly Tyr Asp Ser Pro Pro Gln Arg Pr #o Arg Arg Leu Phe Trp      50              #     55              #     60 Thr Cys Leu Thr Asp Cys Ser Tyr Ala Val As #n Val Gly Gln Tyr Met  65                  # 70                  # 75                  # 80 Arg Phe Leu Asp Leu Asp Asn Phe His Gly Th #r Phe Thr Gln Met His                  85  #                 90  #                 95 Asn Ala Val Leu Met Asp Arg Val Ala Ala As #p Met Gly Arg Ala His             100       #           105       #           110 Leu Arg Gly Arg Gly Ile Asp Val Gly Arg Hi #s Gly Gln Val Leu Pro         115           #       120           #       125 Gln Leu Asp Ala Glu His His Ser Leu Leu Se #r Gly Asn Gly Ala Gly     130               #   135               #   140 Gly Leu Gln Glu Gly Val Leu Met Arg Thr Al #a Ser Ala Ala Asp Ala 145                 1 #50                 1 #55                 1 #60 Glu Leu Leu Ala Ala Ile Arg Gln Leu Arg Va #l Ala Leu Cys His Tyr                 165   #               170   #               175 Leu Phe Cys Tyr Ala Tyr Asp Leu Phe Gln Th #r Glu Glu Arg Tyr Arg             180       #           185       #           190 Phe Leu Pro Gly Ser Asp Val Phe Leu Glu Pr #o Asn Trp Leu Ser Tyr         195           #       200           #       205 Phe Ala Glu Ala Phe Ala Glu Leu Asp Thr Gl #n Gln Leu Val Arg Asp     210               #   215               #   220 Ala Glu Arg Lys Phe Arg Gly Arg Arg Asp Va #l Glu Glu Pro Thr Glu 225                 2 #30                 2 #35                 2 #40 Thr Met Ala Arg Cys Phe Met Ser Thr Leu Al #a Ser Asp Ala Val Ser                 245   #               250   #               255 Leu Ala Gly Thr Gly Leu Ser Gly Gly Ala Il #e Thr Leu Cys Ser Arg             260       #           265       #           270 Arg Val Thr Asp Arg Thr Gly Leu Arg Pro Ar #g Asp Arg His Gly Arg         275           #       280           #       285 Ala Ile Thr Ala Ser Glu Ala Arg Arg Ile Ar #g Pro Arg Ala Val Arg     290               #   295               #   300 Ala Phe Val Asp Arg Leu Pro Arg Val Thr Ar #g Arg Arg Arg Arg Pro 305                 3 #10                 3 #15                 3 #20 Pro Ser Pro Ala Pro Pro Pro Glu Glu Ile Gl #u Glu Ala Ala Met Glu                 325   #               330   #               335 Val Glu Glu Pro Glu Glu Glu Glu Glu Glu Le #u Leu Asp Glu Val Ile             340       #           345       #           350 Arg Thr Ala Leu Glu Ala Ile Gly Ala Leu Gl #n Asp Glu Leu Ser Gly         355           #       360           #       365 Ala Ala Arg Arg His Glu Leu Phe Arg Phe Al #a Asn Asp Phe Tyr Arg     370               #   375               #   380 Met Leu Leu Thr Ala Arg Asp Ala Gly Leu Me #t Gly Glu Ser Phe Leu 385                 3 #90                 3 #95                 4 #00 Arg Lys Trp Val Leu Tyr Phe Phe Leu Ala Gl #u His Ile Ala Ser Thr                 405   #               410   #               415 Leu Tyr Tyr Leu Tyr Ser His Phe Ile Ala As #n Arg Glu Phe Arg Arg             420       #           425       #           430 Tyr Val Asp Val Leu Thr Leu Gln Val Leu Va #l Val Gly Trp Asp Val         435           #       440           #       445 Asn Ala Gln Gln Val Phe Lys Arg Ile Trp Se #r Glu Gln Ser Asn Pro     450               #   455               #   460 Ala Thr Ile Phe Glu Thr Leu Trp Glu Arg Il #e Leu Arg Asp Phe Leu 465                 4 #70                 4 #75                 4 #80 Met Met Val Glu Arg Thr Gly Gln Phe Glu Gl #y Met Asp Asp Ala Asp                 485   #               490   #               495 Gln Gln Leu Phe Leu Ser Asp Ile Gln Tyr Ar #g Asp Arg Ser Gly Asp             500       #           505       #           510 Ile Glu Glu Val Leu Lys Gln Leu Asn Leu Se #r Glu Glu Leu Ile Asp         515           #       520           #       525 Ser Ile Asp Ile Ser Phe Arg Ile Lys Phe Ly #s Gly Ile Val Ala Ile     530               #   535               #   540 Ala Thr Asn Glu Glu Ile Lys Ala Asn Leu Ar #g Arg Val Leu Arg His 545                 5 #50                 5 #55                 5 #60 Arg Arg Glu Asp Ile Glu Ala Ala Ala Arg Ar #g Gly Gln Pro Leu                 565   #               570   #               575 <210> SEQ ID NO 31 <211> LENGTH: 1320 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(1320) <400> SEQUENCE: 31 atg agc acc caa atc ccc gca cga cag gag ac #g tac gac ccg tcc caa       48 Met Ser Thr Gln Ile Pro Ala Arg Gln Glu Th #r Tyr Asp Pro Ser Gln   1               5  #                 10  #                 15 tcg tcg ggc acg aag acc ccc tcg cac ccc ta #c gat ggg aac cct acg       96 Ser Ser Gly Thr Lys Thr Pro Ser His Pro Ty #r Asp Gly Asn Pro Thr              20      #             25      #             30 cgt tcc tat ccg aag agg aat gcg ggc aag tt #c acg acc tac tct tcg      144 Arg Ser Tyr Pro Lys Arg Asn Ala Gly Lys Ph #e Thr Thr Tyr Ser Ser          35          #         40          #         45 cag atg ata gct ccc agg aag cgg aaa gcc tg #g gag tat gag gaa gaa      192 Gln Met Ile Ala Pro Arg Lys Arg Lys Ala Tr #p Glu Tyr Glu Glu Glu      50              #     55              #     60 gag tac gaa gcc tcg cgg gac ttc tac cag cg #c gtc acc agc tgg tac      240 Glu Tyr Glu Ala Ser Arg Asp Phe Tyr Gln Ar #g Val Thr Ser Trp Tyr  65                  # 70                  # 75                  # 80 gac gga gct gtc gac cta gca ccg cag ctc tt #c cgc gag caa cac ttc      288 Asp Gly Ala Val Asp Leu Ala Pro Gln Leu Ph #e Arg Glu Gln His Phe                  85  #                 90  #                 95 ccc tcc tac gac gag ttc tac agc cta ggg gg #c gtt aat gag aag ttt      336 Pro Ser Tyr Asp Glu Phe Tyr Ser Leu Gly Gl #y Val Asn Glu Lys Phe             100       #           105       #           110 ctc gaa gcc cac gaa gaa gtt aaa gcc cag ga #a cag atg gac agt cgc      384 Leu Glu Ala His Glu Glu Val Lys Ala Gln Gl #u Gln Met Asp Ser Arg         115           #       120           #       125 tac ctc caa cac gga cag ctg ccg tcc atc aa #c atg ggc aag cag ccc      432 Tyr Leu Gln His Gly Gln Leu Pro Ser Ile As #n Met Gly Lys Gln Pro     130               #   135               #   140 atc atc ggg gtc atc tac gga ccc acc gga tc #c ggc aag tcg cat ctg      480 Ile Ile Gly Val Ile Tyr Gly Pro Thr Gly Se #r Gly Lys Ser His Leu 145                 1 #50                 1 #55                 1 #60 ctg cgg gcg ctc atc tcg tgc aac atg ttg ga #c ccg atc ccc gaa acg      528 Leu Arg Ala Leu Ile Ser Cys Asn Met Leu As #p Pro Ile Pro Glu Thr                 165   #               170   #               175 gtc atc ttc atc act ccg gaa aag aac atg at #t cca ccc atc gaa cag      576 Val Ile Phe Ile Thr Pro Glu Lys Asn Met Il #e Pro Pro Ile Glu Gln             180       #           185       #           190 acg tcc tgg aac ctg cag ctg gtc gag gcc aa #t ttc gac tgc agg gaa      624 Thr Ser Trp Asn Leu Gln Leu Val Glu Ala As #n Phe Asp Cys Arg Glu         195           #       200           #       205 gac ggc acc atc gcc cct aag aca agc acg tt #c cgt ccc gaa ttt atg      672 Asp Gly Thr Ile Ala Pro Lys Thr Ser Thr Ph #e Arg Pro Glu Phe Met     210               #   215               #   220 gag atg act tac gag gag gcc acc gca ccc ga #a cat ctc aac atc gac      720 Glu Met Thr Tyr Glu Glu Ala Thr Ala Pro Gl #u His Leu Asn Ile Asp 225                 2 #30                 2 #35                 2 #40 cat cca gac aac att tac gtg aaa gtc tcc aa #g cgg gga ccc gtc gcc      768 His Pro Asp Asn Ile Tyr Val Lys Val Ser Ly #s Arg Gly Pro Val Ala                 245   #               250   #               255 att atc atg gac gag tgc atg gat aag ctc tg #t tca ggc tcc agc gtc      816 Ile Ile Met Asp Glu Cys Met Asp Lys Leu Cy #s Ser Gly Ser Ser Val             260       #           265       #           270 tct gtc ctc ttt cac gcc ctt cct tct aag ct #c ttt gct cgc tct gcc      864 Ser Val Leu Phe His Ala Leu Pro Ser Lys Le #u Phe Ala Arg Ser Ala         275           #       280           #       285 cac tgt aca gcc ttc tac att ttc gta gtc tt #g cac aac atg gca ccg      912 His Cys Thr Ala Phe Tyr Ile Phe Val Val Le #u His Asn Met Ala Pro     290               #   295               #   300 cgc acc gcg ata gga aac gtt ccc acc ctc aa #a gtg aac gcg aaa atg      960 Arg Thr Ala Ile Gly Asn Val Pro Thr Leu Ly #s Val Asn Ala Lys Met 305                 3 #10                 3 #15                 3 #20 cac atc cta tcc tgt cat att ccc caa ttc ca #g ttc gct agg ttc ctc     1008 His Ile Leu Ser Cys His Ile Pro Gln Phe Gl #n Phe Ala Arg Phe Leu                 325   #               330   #               335 tat gcg ttc gca cac aac atc tcg aag gac ct #c gtt gtc ctt ctc aaa     1056 Tyr Ala Phe Ala His Asn Ile Ser Lys Asp Le #u Val Val Leu Leu Lys             340       #           345       #           350 gct tac ttt tcc ttc ctg cag cag aac cag cg #g ttc agc tgg gtc atg     1104 Ala Tyr Phe Ser Phe Leu Gln Gln Asn Gln Ar #g Phe Ser Trp Val Met         355           #       360           #       365 tac act ccg gac cca gta tcc gag tcc ttt ag #g tgg tgc agt ata gat     1152 Tyr Thr Pro Asp Pro Val Ser Glu Ser Phe Ar #g Trp Cys Ser Ile Asp     370               #   375               #   380 cag cag tac tcg atc atc cct ctc aat gtt aa #c att cag gag aga ttc     1200 Gln Gln Tyr Ser Ile Ile Pro Leu Asn Val As #n Ile Gln Glu Arg Phe 385                 3 #90                 3 #95                 4 #00 ctg aaa aca gcc aaa tct atc atc aaa ttt ag #c gaa aca cat aga aag     1248 Leu Lys Thr Ala Lys Ser Ile Ile Lys Phe Se #r Glu Thr His Arg Lys                 405   #               410   #               415 cag tta gag aga aac ccc aaa cta acc gat ct #c gaa aaa ctt tct ccc     1296 Gln Leu Glu Arg Asn Pro Lys Leu Thr Asp Le #u Glu Lys Leu Ser Pro             420       #           425       #           430 cca gga acg ttt cag gaa act taa      #                   #              1320 Pro Gly Thr Phe Gln Glu Thr         435 <210> SEQ ID NO 32 <211> LENGTH: 439 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position: 5366..6685/Product:IV #a2 <400> SEQUENCE: 32 Met Ser Thr Gln Ile Pro Ala Arg Gln Glu Th #r Tyr Asp Pro Ser Gln   1               5  #                 10  #                   # 15 Ser Ser Gly Thr Lys Thr Pro Ser His Pro Ty #r Asp Gly Asn Pro Thr              20      #             25      #             30 Arg Ser Tyr Pro Lys Arg Asn Ala Gly Lys Ph #e Thr Thr Tyr Ser Ser          35          #         40          #         45 Gln Met Ile Ala Pro Arg Lys Arg Lys Ala Tr #p Glu Tyr Glu Glu Glu      50              #     55              #     60 Glu Tyr Glu Ala Ser Arg Asp Phe Tyr Gln Ar #g Val Thr Ser Trp Tyr  65                  # 70                  # 75                  # 80 Asp Gly Ala Val Asp Leu Ala Pro Gln Leu Ph #e Arg Glu Gln His Phe                  85  #                 90  #                 95 Pro Ser Tyr Asp Glu Phe Tyr Ser Leu Gly Gl #y Val Asn Glu Lys Phe             100       #           105       #           110 Leu Glu Ala His Glu Glu Val Lys Ala Gln Gl #u Gln Met Asp Ser Arg         115           #       120           #       125 Tyr Leu Gln His Gly Gln Leu Pro Ser Ile As #n Met Gly Lys Gln Pro     130               #   135               #   140 Ile Ile Gly Val Ile Tyr Gly Pro Thr Gly Se #r Gly Lys Ser His Leu 145                 1 #50                 1 #55                 1 #60 Leu Arg Ala Leu Ile Ser Cys Asn Met Leu As #p Pro Ile Pro Glu Thr                 165   #               170   #               175 Val Ile Phe Ile Thr Pro Glu Lys Asn Met Il #e Pro Pro Ile Glu Gln             180       #           185       #           190 Thr Ser Trp Asn Leu Gln Leu Val Glu Ala As #n Phe Asp Cys Arg Glu         195           #       200           #       205 Asp Gly Thr Ile Ala Pro Lys Thr Ser Thr Ph #e Arg Pro Glu Phe Met     210               #   215               #   220 Glu Met Thr Tyr Glu Glu Ala Thr Ala Pro Gl #u His Leu Asn Ile Asp 225                 2 #30                 2 #35                 2 #40 His Pro Asp Asn Ile Tyr Val Lys Val Ser Ly #s Arg Gly Pro Val Ala                 245   #               250   #               255 Ile Ile Met Asp Glu Cys Met Asp Lys Leu Cy #s Ser Gly Ser Ser Val             260       #           265       #           270 Ser Val Leu Phe His Ala Leu Pro Ser Lys Le #u Phe Ala Arg Ser Ala         275           #       280           #       285 His Cys Thr Ala Phe Tyr Ile Phe Val Val Le #u His Asn Met Ala Pro     290               #   295               #   300 Arg Thr Ala Ile Gly Asn Val Pro Thr Leu Ly #s Val Asn Ala Lys Met 305                 3 #10                 3 #15                 3 #20 His Ile Leu Ser Cys His Ile Pro Gln Phe Gl #n Phe Ala Arg Phe Leu                 325   #               330   #               335 Tyr Ala Phe Ala His Asn Ile Ser Lys Asp Le #u Val Val Leu Leu Lys             340       #           345       #           350 Ala Tyr Phe Ser Phe Leu Gln Gln Asn Gln Ar #g Phe Ser Trp Val Met         355           #       360           #       365 Tyr Thr Pro Asp Pro Val Ser Glu Ser Phe Ar #g Trp Cys Ser Ile Asp     370               #   375               #   380 Gln Gln Tyr Ser Ile Ile Pro Leu Asn Val As #n Ile Gln Glu Arg Phe 385                 3 #90                 3 #95                 4 #00 Leu Lys Thr Ala Lys Ser Ile Ile Lys Phe Se #r Glu Thr His Arg Lys                 405   #               410   #               415 Gln Leu Glu Arg Asn Pro Lys Leu Thr Asp Le #u Glu Lys Leu Ser Pro             420       #           425       #           430 Pro Gly Thr Phe Gln Glu Thr         435 <210> SEQ ID NO 33 <211> LENGTH: 633 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(633) <400> SEQUENCE: 33 atg cta gaa gcc gaa ggt tac aat gct ccg gt #a gcc atc tac gcc att       48 Met Leu Glu Ala Glu Gly Tyr Asn Ala Pro Va #l Ala Ile Tyr Ala Ile   1               5  #                 10  #                 15 tat ctg tgg atg tct gcc atg agc att agt cg #c ctg tgc cat tat act       96 Tyr Leu Trp Met Ser Ala Met Ser Ile Ser Ar #g Leu Cys His Tyr Thr              20      #             25      #             30 aac acg ctc tat gtc gta gga gaa cct tcc tc #t gcc gca gat ata ttc      144 Asn Thr Leu Tyr Val Val Gly Glu Pro Ser Se #r Ala Ala Asp Ile Phe          35          #         40          #         45 act gca tcc atc ctc aga tta ttc caa ttt gt #c ctc act gcc aac att      192 Thr Ala Ser Ile Leu Arg Leu Phe Gln Phe Va #l Leu Thr Ala Asn Ile      50              #     55              #     60 aac gcg ttc gac ttt ggc cag tac gcc aga ca #g caa gat tta gtc aag      240 Asn Ala Phe Asp Phe Gly Gln Tyr Ala Arg Gl #n Gln Asp Leu Val Lys  65                  # 70                  # 75                  # 80 atg ctt tat ttc ccc tgc aca gct cat tgt aa #c acg ttc aaa gat ccc      288 Met Leu Tyr Phe Pro Cys Thr Ala His Cys As #n Thr Phe Lys Asp Pro                  85  #                 90  #                 95 gtt gct aac cag ctg ctg aaa ggc agg tca tt #c acc aca atg acc cgc      336 Val Ala Asn Gln Leu Leu Lys Gly Arg Ser Ph #e Thr Thr Met Thr Arg             100       #           105       #           110 gac ggt ctc gtg gac atc agt gag aaa aaa tg #c ctc gtc cgc tta tat      384 Asp Gly Leu Val Asp Ile Ser Glu Lys Lys Cy #s Leu Val Arg Leu Tyr         115           #       120           #       125 cag ctc ccc cat ccc gaa cat ctg ccc act gc #t ccc gac gaa cat atc      432 Gln Leu Pro His Pro Glu His Leu Pro Thr Al #a Pro Asp Glu His Ile     130               #   135               #   140 att att agg ttc tac gaa ccc gcc aac ggc tg #c ggg ttc ttt ctg gga      480 Ile Ile Arg Phe Tyr Glu Pro Ala Asn Gly Cy #s Gly Phe Phe Leu Gly 145                 1 #50                 1 #55                 1 #60 gag ctc tcc cgc tac att cat cgc ata cac ca #a tta cag gca gat aat      528 Glu Leu Ser Arg Tyr Ile His Arg Ile His Gl #n Leu Gln Ala Asp Asn                 165   #               170   #               175 gac aac gac gcc ttg cgc gct ctc cta tgc ga #g aac aaa gga atg ctc      576 Asp Asn Asp Ala Leu Arg Ala Leu Leu Cys Gl #u Asn Lys Gly Met Leu             180       #           185       #           190 tgt tcc cgc tcg tgg acc tcc cca tgc aat gc #t tgt cac tca tca cat      624 Cys Ser Arg Ser Trp Thr Ser Pro Cys Asn Al #a Cys His Ser Ser His         195           #       200           #       205 gac ata taa               #                   #                   #        633 Asp Ile     210 <210> SEQ ID NO 34 <211> LENGTH: 210 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position: 4462..5094/note=OR #F12 <400> SEQUENCE: 34 Met Leu Glu Ala Glu Gly Tyr Asn Ala Pro Va #l Ala Ile Tyr Ala Ile   1               5  #                 10  #                 15 Tyr Leu Trp Met Ser Ala Met Ser Ile Ser Ar #g Leu Cys His Tyr Thr              20      #             25      #             30 Asn Thr Leu Tyr Val Val Gly Glu Pro Ser Se #r Ala Ala Asp Ile Phe          35          #         40          #         45 Thr Ala Ser Ile Leu Arg Leu Phe Gln Phe Va #l Leu Thr Ala Asn Ile      50              #     55              #     60 Asn Ala Phe Asp Phe Gly Gln Tyr Ala Arg Gl #n Gln Asp Leu Val Lys  65                  # 70                  # 75                  # 80 Met Leu Tyr Phe Pro Cys Thr Ala His Cys As #n Thr Phe Lys Asp Pro                  85  #                 90  #                 95 Val Ala Asn Gln Leu Leu Lys Gly Arg Ser Ph #e Thr Thr Met Thr Arg             100       #           105       #           110 Asp Gly Leu Val Asp Ile Ser Glu Lys Lys Cy #s Leu Val Arg Leu Tyr         115           #       120           #       125 Gln Leu Pro His Pro Glu His Leu Pro Thr Al #a Pro Asp Glu His Ile     130               #   135               #   140 Ile Ile Arg Phe Tyr Glu Pro Ala Asn Gly Cy #s Gly Phe Phe Leu Gly 145                 1 #50                 1 #55                 1 #60 Glu Leu Ser Arg Tyr Ile His Arg Ile His Gl #n Leu Gln Ala Asp Asn                 165   #               170   #               175 Asp Asn Asp Ala Leu Arg Ala Leu Leu Cys Gl #u Asn Lys Gly Met Leu             180       #           185       #           190 Cys Ser Arg Ser Trp Thr Ser Pro Cys Asn Al #a Cys His Ser Ser His         195           #       200           #       205 Asp Ile     210 <210> SEQ ID NO 35 <211> LENGTH: 1020 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(1020) <400> SEQUENCE: 35 atg aca acg acg cct tgc gcg ctc tcc tat gc #g aga aca aag gaa tgc       48 Met Thr Thr Thr Pro Cys Ala Leu Ser Tyr Al #a Arg Thr Lys Glu Cys   1               5  #                 10  #                 15 tct gtt ccc gct cgt gga cct ccc cat gca at #g ctt gtc act cat cac       96 Ser Val Pro Ala Arg Gly Pro Pro His Ala Me #t Leu Val Thr His His              20      #             25      #             30 atg aca tat aat tct ctc cca cag tgc acc aa #g agg cga cgc gag tct      144 Met Thr Tyr Asn Ser Leu Pro Gln Cys Thr Ly #s Arg Arg Arg Glu Ser          35          #         40          #         45 cag tcg tct tta agt agc gaa gag gag caa at #a gca tcc tgc att cca      192 Gln Ser Ser Leu Ser Ser Glu Glu Glu Gln Il #e Ala Ser Cys Ile Pro      50              #     55              #     60 gac acc cct tca ccc tgc tta ttt ccg tcc ac #g tcc ccc atg gat cag      240 Asp Thr Pro Ser Pro Cys Leu Phe Pro Ser Th #r Ser Pro Met Asp Gln  65                  # 70                  # 75                  # 80 ttg gtt gaa cgg ttg ttt gtc gaa ggt gta gc #a cac gaa gtc cag tgg      288 Leu Val Glu Arg Leu Phe Val Glu Gly Val Al #a His Glu Val Gln Trp                  85  #                 90  #                 95 aac ttc ccg tcc aag aac ctc ata ccc acc ta #c gaa cga gag cgt gta      336 Asn Phe Pro Ser Lys Asn Leu Ile Pro Thr Ty #r Glu Arg Glu Arg Val             100       #           105       #           110 ctc gaa gcc ctc aag gaa cgg ttc gga ccc gg #a cag agc ctc att aac      384 Leu Glu Ala Leu Lys Glu Arg Phe Gly Pro Gl #y Gln Ser Leu Ile Asn         115           #       120           #       125 cag tta ccc tcc gaa gag ccc gac acc ctc aa #g gct gcg ttc tac aac      432 Gln Leu Pro Ser Glu Glu Pro Asp Thr Leu Ly #s Ala Ala Phe Tyr Asn     130               #   135               #   140 gtc tgc gac aac tgg ttc cat cag atg atg ga #a gcc gaa ggc tac gag      480 Val Cys Asp Asn Trp Phe His Gln Met Met Gl #u Ala Glu Gly Tyr Glu 145                 1 #50                 1 #55                 1 #60 gga aaa gtg gca gct aac gcc atc ctc cga tg #g ctc cga gga gaa cta      528 Gly Lys Val Ala Ala Asn Ala Ile Leu Arg Tr #p Leu Arg Gly Glu Leu                 165   #               170   #               175 aac acc ctc gtg ctc tgc gga gga aga ctt tc #c aac gcc aag agt ctc      576 Asn Thr Leu Val Leu Cys Gly Gly Arg Leu Se #r Asn Ala Lys Ser Leu             180       #           185       #           190 ttt aat gcc tta tgc gcg tgt ttc ccg ctc gc #g atc tcc gac agc cga      624 Phe Asn Ala Leu Cys Ala Cys Phe Pro Leu Al #a Ile Ser Asp Ser Arg         195           #       200           #       205 atc aac tcc ata cta tca ctg ggc gaa atc gc #a ccc cac gcc tct cta      672 Ile Asn Ser Ile Leu Ser Leu Gly Glu Ile Al #a Pro His Ala Ser Leu     210               #   215               #   220 tac tgt ctg ccc ttc gta gac gag aag ccg ga #c ccg ttg atg ctg cac      720 Tyr Cys Leu Pro Phe Val Asp Glu Lys Pro As #p Pro Leu Met Leu His 225                 2 #30                 2 #35                 2 #40 ttt atg gaa ggc aat gct gcc acc tgc agg ct #g aat aag aaa acg ttc      768 Phe Met Glu Gly Asn Ala Ala Thr Cys Arg Le #u Asn Lys Lys Thr Phe                 245   #               250   #               255 cac atc ccc tcg acc ccc atg cta atc cac tg #c gcg gac ctc tcg ctc      816 His Ile Pro Ser Thr Pro Met Leu Ile His Cy #s Ala Asp Leu Ser Leu             260       #           265       #           270 gcc aac gag ttc acg gcg cgg aac acg gtc gt #c ttc ttc ctc aca gga      864 Ala Asn Glu Phe Thr Ala Arg Asn Thr Val Va #l Phe Phe Leu Thr Gly         275           #       280           #       285 gac cac acc aag acc cct cca tgc tac cac cc #g cgc aaa gag cta cgc      912 Asp His Thr Lys Thr Pro Pro Cys Tyr His Pr #o Arg Lys Glu Leu Arg     290               #   295               #   300 gac ttt gtt gct aat gct gcc gct tgt gct tg #c tta atg aca ctg cat      960 Asp Phe Val Ala Asn Ala Ala Ala Cys Ala Cy #s Leu Met Thr Leu His 305                 3 #10                 3 #15                 3 #20 tgc aaa cgc gat aat aaa ctc tgt aac ccc tg #t ata cgt acc cct ctt     1008 Cys Lys Arg Asp Asn Lys Leu Cys Asn Pro Cy #s Ile Arg Thr Pro Leu                 325   #               330   #               335 caa aat cag taa             #                   #                   #     1020 Gln Asn Gln <210> SEQ ID NO 36 <211> LENGTH: 339 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position: 3549..4568/note=OR #F13 <400> SEQUENCE: 36 Met Thr Thr Thr Pro Cys Ala Leu Ser Tyr Al #a Arg Thr Lys Glu Cys   1               5  #                 10  #                 15 Ser Val Pro Ala Arg Gly Pro Pro His Ala Me #t Leu Val Thr His His              20      #             25      #             30 Met Thr Tyr Asn Ser Leu Pro Gln Cys Thr Ly #s Arg Arg Arg Glu Ser          35          #         40          #         45 Gln Ser Ser Leu Ser Ser Glu Glu Glu Gln Il #e Ala Ser Cys Ile Pro      50              #     55              #     60 Asp Thr Pro Ser Pro Cys Leu Phe Pro Ser Th #r Ser Pro Met Asp Gln  65                  # 70                  # 75                  # 80 Leu Val Glu Arg Leu Phe Val Glu Gly Val Al #a His Glu Val Gln Trp                  85  #                 90  #                 95 Asn Phe Pro Ser Lys Asn Leu Ile Pro Thr Ty #r Glu Arg Glu Arg Val             100       #           105       #           110 Leu Glu Ala Leu Lys Glu Arg Phe Gly Pro Gl #y Gln Ser Leu Ile Asn         115           #       120           #       125 Gln Leu Pro Ser Glu Glu Pro Asp Thr Leu Ly #s Ala Ala Phe Tyr Asn     130               #   135               #   140 Val Cys Asp Asn Trp Phe His Gln Met Met Gl #u Ala Glu Gly Tyr Glu 145                 1 #50                 1 #55                 1 #60 Gly Lys Val Ala Ala Asn Ala Ile Leu Arg Tr #p Leu Arg Gly Glu Leu                 165   #               170   #               175 Asn Thr Leu Val Leu Cys Gly Gly Arg Leu Se #r Asn Ala Lys Ser Leu             180       #           185       #           190 Phe Asn Ala Leu Cys Ala Cys Phe Pro Leu Al #a Ile Ser Asp Ser Arg         195           #       200           #       205 Ile Asn Ser Ile Leu Ser Leu Gly Glu Ile Al #a Pro His Ala Ser Leu     210               #   215               #   220 Tyr Cys Leu Pro Phe Val Asp Glu Lys Pro As #p Pro Leu Met Leu His 225                 2 #30                 2 #35                 2 #40 Phe Met Glu Gly Asn Ala Ala Thr Cys Arg Le #u Asn Lys Lys Thr Phe                 245   #               250   #               255 His Ile Pro Ser Thr Pro Met Leu Ile His Cy #s Ala Asp Leu Ser Leu             260       #           265       #           270 Ala Asn Glu Phe Thr Ala Arg Asn Thr Val Va #l Phe Phe Leu Thr Gly         275           #       280           #       285 Asp His Thr Lys Thr Pro Pro Cys Tyr His Pr #o Arg Lys Glu Leu Arg     290               #   295               #   300 Asp Phe Val Ala Asn Ala Ala Ala Cys Ala Cy #s Leu Met Thr Leu His 305                 3 #10                 3 #15                 3 #20 Cys Lys Arg Asp Asn Lys Leu Cys Asn Pro Cy #s Ile Arg Thr Pro Leu                 325   #               330   #               335 Gln Asn Gln <210> SEQ ID NO 37 <211> LENGTH: 483 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(483) <400> SEQUENCE: 37 atg tac ccc ttc aag cac tcg ccc cac tgc at #t acg gac gaa gag tgt       48 Met Tyr Pro Phe Lys His Ser Pro His Cys Il #e Thr Asp Glu Glu Cys   1               5  #                 10  #                 15 gac ctc cag ctc agg tca ttc tgc agc tgg at #a aga gtt att gag atg       96 Asp Leu Gln Leu Arg Ser Phe Cys Ser Trp Il #e Arg Val Ile Glu Met              20      #             25      #             30 cga tgt acc gac tgg act atc cag tac atc tg #c agc tgc gag aca ccc      144 Arg Cys Thr Asp Trp Thr Ile Gln Tyr Ile Cy #s Ser Cys Glu Thr Pro          35          #         40          #         45 cgt tcc ctc ttt tgt tta tcc ctc atc cga gt #g ctt aca gct cac tgg      192 Arg Ser Leu Phe Cys Leu Ser Leu Ile Arg Va #l Leu Thr Ala His Trp      50              #     55              #     60 gcc aaa acg gtc gtc aat ttc gtt gct caa ca #c gac cac cag ccc caa      240 Ala Lys Thr Val Val Asn Phe Val Ala Gln Hi #s Asp His Gln Pro Gln  65                  # 70                  # 75                  # 80 ctc cct ctt aat ctc atc tta tac aca tat gc #t act cac tgc agg tta      288 Leu Pro Leu Asn Leu Ile Leu Tyr Thr Tyr Al #a Thr His Cys Arg Leu                  85  #                 90  #                 95 tgc aac ttg aac cct gcc ctc gaa caa ata ta #t aca gca gta acc gtt      336 Cys Asn Leu Asn Pro Ala Leu Glu Gln Ile Ty #r Thr Ala Val Thr Val             100       #           105       #           110 gcg cgg cgc caa ggc gcc tac acg cga ctg ga #a gga caa aca ctc tat      384 Ala Arg Arg Gln Gly Ala Tyr Thr Arg Leu Gl #u Gly Gln Thr Leu Tyr         115           #       120           #       125 gtc tgt ctt cca agg gac atc gta aac tat cc #c tgc ata gct tgc ttt      432 Val Cys Leu Pro Arg Asp Ile Val Asn Tyr Pr #o Cys Ile Ala Cys Phe     130               #   135               #   140 tac cac ctg ctt ctg cgg ctc cca gtc gca at #t aac ttc cac gtg ata      480 Tyr His Leu Leu Leu Arg Leu Pro Val Ala Il #e Asn Phe His Val Ile 145                 1 #50                 1 #55                 1 #60 tga                   #                   #                   #            483 <210> SEQ ID NO 38 <211> LENGTH: 160 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position: 2892..3374/note=OR #F14 <400> SEQUENCE: 38 Met Tyr Pro Phe Lys His Ser Pro His Cys Il #e Thr Asp Glu Glu Cys   1               5  #                 10  #                 15 Asp Leu Gln Leu Arg Ser Phe Cys Ser Trp Il #e Arg Val Ile Glu Met              20      #             25      #             30 Arg Cys Thr Asp Trp Thr Ile Gln Tyr Ile Cy #s Ser Cys Glu Thr Pro          35          #         40          #         45 Arg Ser Leu Phe Cys Leu Ser Leu Ile Arg Va #l Leu Thr Ala His Trp      50              #     55              #     60 Ala Lys Thr Val Val Asn Phe Val Ala Gln Hi #s Asp His Gln Pro Gln  65                  # 70                  # 75                  # 80 Leu Pro Leu Asn Leu Ile Leu Tyr Thr Tyr Al #a Thr His Cys Arg Leu                  85  #                 90  #                 95 Cys Asn Leu Asn Pro Ala Leu Glu Gln Ile Ty #r Thr Ala Val Thr Val             100       #           105       #           110 Ala Arg Arg Gln Gly Ala Tyr Thr Arg Leu Gl #u Gly Gln Thr Leu Tyr         115           #       120           #       125 Val Cys Leu Pro Arg Asp Ile Val Asn Tyr Pr #o Cys Ile Ala Cys Phe     130               #   135               #   140 Tyr His Leu Leu Leu Arg Leu Pro Val Ala Il #e Asn Phe His Val Ile 145                 1 #50                 1 #55                 1 #60 <210> SEQ ID NO 39 <211> LENGTH: 324 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(324) <400> SEQUENCE: 39 atg gtc gcg agc tgc cac acg ctc aca atc at #a cct aaa gaa gca cgc       48 Met Val Ala Ser Cys His Thr Leu Thr Ile Il #e Pro Lys Glu Ala Arg   1               5  #                 10  #                 15 agt aac tgt tac aga gcg tac agc agg gcc tc #t tgc tgg tgc tgc ctt       96 Ser Asn Cys Tyr Arg Ala Tyr Ser Arg Ala Se #r Cys Trp Cys Cys Leu              20      #             25      #             30 cgc aca gac aat gtc cgt atg tgt cgt cgt cc #c cct caa aat ctg ctt      144 Arg Thr Asp Asn Val Arg Met Cys Arg Arg Pr #o Pro Gln Asn Leu Leu          35          #         40          #         45 gca agc gta cag cga agt cga ctt cgt cgc aa #g ggt cct atc aac ggg      192 Ala Ser Val Gln Arg Ser Arg Leu Arg Arg Ly #s Gly Pro Ile Asn Gly      50              #     55              #     60 aac cag ggg tca gcc att cca aca cag agc gc #t gat tgc ggt cta cag      240 Asn Gln Gly Ser Ala Ile Pro Thr Gln Ser Al #a Asp Cys Gly Leu Gln  65                  # 70                  # 75                  # 80 cac cca tac ctg tgg acc cga aac ccg acg cc #c cgc ggt ctg tct cgc      288 His Pro Tyr Leu Trp Thr Arg Asn Pro Thr Pr #o Arg Gly Leu Ser Arg                  85  #                 90  #                 95 cta gct gcg tca gtt ccg aca gct ccg gaa cc #a taa                 #      324 Leu Ala Ala Ser Val Pro Thr Ala Pro Glu Pr #o             100       #           105 <210> SEQ ID NO 40 <211> LENGTH: 107 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position:1191..1514/note=ORF15 <400> SEQUENCE: 40 Met Val Ala Ser Cys His Thr Leu Thr Ile Il #e Pro Lys Glu Ala Arg   1               5  #                 10  #                 15 Ser Asn Cys Tyr Arg Ala Tyr Ser Arg Ala Se #r Cys Trp Cys Cys Leu              20      #             25      #             30 Arg Thr Asp Asn Val Arg Met Cys Arg Arg Pr #o Pro Gln Asn Leu Leu          35          #         40          #         45 Ala Ser Val Gln Arg Ser Arg Leu Arg Arg Ly #s Gly Pro Ile Asn Gly      50              #     55              #     60 Asn Gln Gly Ser Ala Ile Pro Thr Gln Ser Al #a Asp Cys Gly Leu Gln  65                  # 70                  # 75                  # 80 His Pro Tyr Leu Trp Thr Arg Asn Pro Thr Pr #o Arg Gly Leu Ser Arg                  85  #                 90  #                 95 Leu Ala Ala Ser Val Pro Thr Ala Pro Glu Pr #o             100       #           105 <210> SEQ ID NO 41 <211> LENGTH: 417 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(417) <400> SEQUENCE: 41 atg tat tac ttc cac ctc cgc gtg acc ttg at #g gag cct aac ttg gcc       48 Met Tyr Tyr Phe His Leu Arg Val Thr Leu Me #t Glu Pro Asn Leu Ala   1               5  #                 10  #                 15 gta ttc cat gat ctg aaa ttg acg gtg ata aa #t gcc tgg gaa agt tta       96 Val Phe His Asp Leu Lys Leu Thr Val Ile As #n Ala Trp Glu Ser Leu              20      #             25      #             30 act gtt gag atg ctg tcc cac tat agt gta ga #t tac ctg ttc cga ttg      144 Thr Val Glu Met Leu Ser His Tyr Ser Val As #p Tyr Leu Phe Arg Leu          35          #         40          #         45 gag gag ttt gcg ggg gta tat tca gct tct at #t ttt ttg ccc acg cat      192 Glu Glu Phe Ala Gly Val Tyr Ser Ala Ser Il #e Phe Leu Pro Thr His      50              #     55              #     60 aag gtt gat tgg act ttc ttg aaa agg gcg gt #g gct tta ctg cgc gaa      240 Lys Val Asp Trp Thr Phe Leu Lys Arg Ala Va #l Ala Leu Leu Arg Glu  65                  # 70                  # 75                  # 80 tgt att tgg agg aga ttt gaa tgt aca cag gt #t ccg cga ggg gtg gct      288 Cys Ile Trp Arg Arg Phe Glu Cys Thr Gln Va #l Pro Arg Gly Val Ala                  85  #                 90  #                 95 tct att tac gcg gtg cgc aat acg tgg acc cc #c tcc gcc aat agg gtg      336 Ser Ile Tyr Ala Val Arg Asn Thr Trp Thr Pr #o Ser Ala Asn Arg Val             100       #           105       #           110 gcc cgt cac ttt gta aaa cgc ggg gca ttg gt #t ggc atg cag ccc tgt      384 Ala Arg His Phe Val Lys Arg Gly Ala Leu Va #l Gly Met Gln Pro Cys         115           #       120           #       125 tta cac gaa tgt acc tat gag cgg gat gcc tg #t                   #        417 Leu His Glu Cys Thr Tyr Glu Arg Asp Ala Cy #s     130               #   135 <210> SEQ ID NO 42 <211> LENGTH: 139 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position:39286..39705/note=ORF1 #6 <400> SEQUENCE: 42 Met Tyr Tyr Phe His Leu Arg Val Thr Leu Me #t Glu Pro Asn Leu Ala   1               5  #                 10  #                 15 Val Phe His Asp Leu Lys Leu Thr Val Ile As #n Ala Trp Glu Ser Leu              20      #             25      #             30 Thr Val Glu Met Leu Ser His Tyr Ser Val As #p Tyr Leu Phe Arg Leu          35          #         40          #         45 Glu Glu Phe Ala Gly Val Tyr Ser Ala Ser Il #e Phe Leu Pro Thr His      50              #     55              #     60 Lys Val Asp Trp Thr Phe Leu Lys Arg Ala Va #l Ala Leu Leu Arg Glu  65                  # 70                  # 75                  # 80 Cys Ile Trp Arg Arg Phe Glu Cys Thr Gln Va #l Pro Arg Gly Val Ala                  85  #                 90  #                 95 Ser Ile Tyr Ala Val Arg Asn Thr Trp Thr Pr #o Ser Ala Asn Arg Val             100       #           105       #           110 Ala Arg His Phe Val Lys Arg Gly Ala Leu Va #l Gly Met Gln Pro Cys         115           #       120           #       125 Leu His Glu Cys Thr Tyr Glu Arg Asp Ala Cy #s     130               #   135 <210> SEQ ID NO 43 <211> LENGTH: 540 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(540) <400> SEQUENCE: 43 atg cct ttg tat ttg tgc ttt ggg gcc gcc gc #c ccg gtt tcg att ttg       48 Met Pro Leu Tyr Leu Cys Phe Gly Ala Ala Al #a Pro Val Ser Ile Leu   1               5  #                 10  #                 15 tgg cgg gaa gaa ctc ttc tgg gga ttc gtg gc #t gcg gtc aag agg agg       96 Trp Arg Glu Glu Leu Phe Trp Gly Phe Val Al #a Ala Val Lys Arg Arg              20      #             25      #             30 tgg cac act gta tat gca cgg acc aat gtg ga #c att cag tat ccg atg      144 Trp His Thr Val Tyr Ala Arg Thr Asn Val As #p Ile Gln Tyr Pro Met          35          #         40          #         45 gcg tat tgt gtc ggt atc caa tcc ctg tct cc #a tgc aaa tgt cat gtg      192 Ala Tyr Cys Val Gly Ile Gln Ser Leu Ser Pr #o Cys Lys Cys His Val      50              #     55              #     60 acc gtg gtg gtg tgt ctg acc ttt ctg gat ct #g cgc atg tcc gct att      240 Thr Val Val Val Cys Leu Thr Phe Leu Asp Le #u Arg Met Ser Ala Ile  65                  # 70                  # 75                  # 80 aat gaa gcc acg aaa ata atg cgc gcg ttt tt #c aaa acc ttt ttc tac      288 Asn Glu Ala Thr Lys Ile Met Arg Ala Phe Ph #e Lys Thr Phe Phe Tyr                  85  #                 90  #                 95 cac cac ggg aaa gtc ccg cgt ggg cgg tgg tt #t aaa ttg tac aga aat      336 His His Gly Lys Val Pro Arg Gly Arg Trp Ph #e Lys Leu Tyr Arg Asn             100       #           105       #           110 gat tgg tgt aag gat cct aat tta aca gtg gg #t aat tac att gtg gca      384 Asp Trp Cys Lys Asp Pro Asn Leu Thr Val Gl #y Asn Tyr Ile Val Ala         115           #       120           #       125 tcg ggg gcg tta cct ttg atg ctg ggg tgg gc #g cgg tct acg ggg ttg      432 Ser Gly Ala Leu Pro Leu Met Leu Gly Trp Al #a Arg Ser Thr Gly Leu     130               #   135               #   140 cgg ttc agc aca ttt aca tat tca gat gag gc #t ctg tgg agt cat aga      480 Arg Phe Ser Thr Phe Thr Tyr Ser Asp Glu Al #a Leu Trp Ser His Arg 145                 1 #50                 1 #55                 1 #60 cgg aga gat agg agg ctt gcc cgt cgg cgg ga #a aag ctt gaa aat aaa      528 Arg Arg Asp Arg Arg Leu Ala Arg Arg Arg Gl #u Lys Leu Glu Asn Lys                 165   #               170   #               175 gta tca ggt tga             #                   #                   #      540 Val Ser Gly <210> SEQ ID NO 44 <211> LENGTH: 179 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position:38717..39256/note=ORF1 #7 <400> SEQUENCE: 44 Met Pro Leu Tyr Leu Cys Phe Gly Ala Ala Al #a Pro Val Ser Ile Leu   1               5  #                 10  #                 15 Trp Arg Glu Glu Leu Phe Trp Gly Phe Val Al #a Ala Val Lys Arg Arg              20      #             25      #             30 Trp His Thr Val Tyr Ala Arg Thr Asn Val As #p Ile Gln Tyr Pro Met          35          #         40          #         45 Ala Tyr Cys Val Gly Ile Gln Ser Leu Ser Pr #o Cys Lys Cys His Val      50              #     55              #     60 Thr Val Val Val Cys Leu Thr Phe Leu Asp Le #u Arg Met Ser Ala Ile  65                  # 70                  # 75                  # 80 Asn Glu Ala Thr Lys Ile Met Arg Ala Phe Ph #e Lys Thr Phe Phe Tyr                  85  #                 90  #                 95 His His Gly Lys Val Pro Arg Gly Arg Trp Ph #e Lys Leu Tyr Arg Asn             100       #           105       #           110 Asp Trp Cys Lys Asp Pro Asn Leu Thr Val Gl #y Asn Tyr Ile Val Ala         115           #       120           #       125 Ser Gly Ala Leu Pro Leu Met Leu Gly Trp Al #a Arg Ser Thr Gly Leu     130               #   135               #   140 Arg Phe Ser Thr Phe Thr Tyr Ser Asp Glu Al #a Leu Trp Ser His Arg 145                 1 #50                 1 #55                 1 #60 Arg Arg Asp Arg Arg Leu Ala Arg Arg Arg Gl #u Lys Leu Glu Asn Lys                 165   #               170   #               175 Val Ser Gly <210> SEQ ID NO 45 <211> LENGTH: 609 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(609) <400> SEQUENCE: 45 atg tct gcc cta tct tcg tgc ttt aat ggg tc #g gat tcc aga tgg gat       48 Met Ser Ala Leu Ser Ser Cys Phe Asn Gly Se #r Asp Ser Arg Trp Asp   1               5  #                 10  #                 15 ccg cca tat cct aag gct gac gtc agg cgc tt #g atg ggc acc tat tcg       96 Pro Pro Tyr Pro Lys Ala Asp Val Arg Arg Le #u Met Gly Thr Tyr Ser              20      #             25      #             30 ccg gat ttt cct tcg tgg ccc aag tta att gt #a tgg tgg aat gag act      144 Pro Asp Phe Pro Ser Trp Pro Lys Leu Ile Va #l Trp Trp Asn Glu Thr          35          #         40          #         45 ttt ttg act ttt tcg gac ggc ccc tgg gtt gt #c agt caa atg cgg cgg      192 Phe Leu Thr Phe Ser Asp Gly Pro Trp Val Va #l Ser Gln Met Arg Arg      50              #     55              #     60 ctc ggg gta ttg gat ggt aaa gat agc ggg ga #g ctc att att ctg gtt      240 Leu Gly Val Leu Asp Gly Lys Asp Ser Gly Gl #u Leu Ile Ile Leu Val  65                  # 70                  # 75                  # 80 cag gac atg tat ccc gat gtg tgt ccg ctt at #t aat agg gcg cgc tat      288 Gln Asp Met Tyr Pro Asp Val Cys Pro Leu Il #e Asn Arg Ala Arg Tyr                  85  #                 90  #                 95 gac ggc aca tat aaa tgg acc agt gaa atg at #g aga aag att ttg cgt      336 Asp Gly Thr Tyr Lys Trp Thr Ser Glu Met Me #t Arg Lys Ile Leu Arg             100       #           105       #           110 atg cat acc att atg acg cca gag tcc ccg gt #c att ctg ttg gac tgg      384 Met His Thr Ile Met Thr Pro Glu Ser Pro Va #l Ile Leu Leu Asp Trp         115           #       120           #       125 acc aat cag ctg aga gat att tgt aag aag gt #a gac gcc ctt ttg tgg      432 Thr Asn Gln Leu Arg Asp Ile Cys Lys Lys Va #l Asp Ala Leu Leu Trp     130               #   135               #   140 ggg cag gat gtg agg ggg ccg gcc tat tac gc #a gtc agg acc act gct      480 Gly Gln Asp Val Arg Gly Pro Ala Tyr Tyr Al #a Val Arg Thr Thr Ala 145                 1 #50                 1 #55                 1 #60 cat ttt ttt acg gag ttc aag gac cat cga at #t cat tgc ata ggg atg      528 His Phe Phe Thr Glu Phe Lys Asp His Arg Il #e His Cys Ile Gly Met                 165   #               170   #               175 tcg cta ggg ggc act gta tgc gcg gct ttg tc #c cgc caa ctt cta gtc      576 Ser Leu Gly Gly Thr Val Cys Ala Ala Leu Se #r Arg Gln Leu Leu Val             180       #           185       #           190 cgg aca gag ggt caa aaa agg ttg gcc gca ta #g                   #        609 Arg Thr Glu Gly Gln Lys Arg Leu Ala Ala         195           #       200 <210> SEQ ID NO 46 <211> LENGTH: 202 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position:35536..36144/note=ORF1 #8 <400> SEQUENCE: 46 Met Ser Ala Leu Ser Ser Cys Phe Asn Gly Se #r Asp Ser Arg Trp Asp   1               5  #                 10  #                 15 Pro Pro Tyr Pro Lys Ala Asp Val Arg Arg Le #u Met Gly Thr Tyr Ser              20      #             25      #             30 Pro Asp Phe Pro Ser Trp Pro Lys Leu Ile Va #l Trp Trp Asn Glu Thr          35          #         40          #         45 Phe Leu Thr Phe Ser Asp Gly Pro Trp Val Va #l Ser Gln Met Arg Arg      50              #     55              #     60 Leu Gly Val Leu Asp Gly Lys Asp Ser Gly Gl #u Leu Ile Ile Leu Val  65                  # 70                  # 75                  # 80 Gln Asp Met Tyr Pro Asp Val Cys Pro Leu Il #e Asn Arg Ala Arg Tyr                  85  #                 90  #                 95 Asp Gly Thr Tyr Lys Trp Thr Ser Glu Met Me #t Arg Lys Ile Leu Arg             100       #           105       #           110 Met His Thr Ile Met Thr Pro Glu Ser Pro Va #l Ile Leu Leu Asp Trp         115           #       120           #       125 Thr Asn Gln Leu Arg Asp Ile Cys Lys Lys Va #l Asp Ala Leu Leu Trp     130               #   135               #   140 Gly Gln Asp Val Arg Gly Pro Ala Tyr Tyr Al #a Val Arg Thr Thr Ala 145                 1 #50                 1 #55                 1 #60 His Phe Phe Thr Glu Phe Lys Asp His Arg Il #e His Cys Ile Gly Met                 165   #               170   #               175 Ser Leu Gly Gly Thr Val Cys Ala Ala Leu Se #r Arg Gln Leu Leu Val             180       #           185       #           190 Arg Thr Glu Gly Gln Lys Arg Leu Ala Ala         195           #       200 <210> SEQ ID NO 47 <211> LENGTH: 1362 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(1362) <400> SEQUENCE: 47 atg cgc ggc ttt gtc ccg cca act tct agt cc #g gac aga ggg tca aaa       48 Met Arg Gly Phe Val Pro Pro Thr Ser Ser Pr #o Asp Arg Gly Ser Lys   1               5  #                 10  #                 15 aag gtt ggc cgc ata gtg gcg cta gat ccc cc #a ttg gaa agt ttc cag       96 Lys Val Gly Arg Ile Val Ala Leu Asp Pro Pr #o Leu Glu Ser Phe Gln              20      #             25      #             30 ggt tat agg atg gac tta cac aca aaa ggg tt #a aac ctt ttg ctg tct      144 Gly Tyr Arg Met Asp Leu His Thr Lys Gly Le #u Asn Leu Leu Leu Ser          35          #         40          #         45 tcc ggt ggt cat tgg tca gcc aat agg gat gc #g gat agt gtt atc tct      192 Ser Gly Gly His Trp Ser Ala Asn Arg Asp Al #a Asp Ser Val Ile Ser      50              #     55              #     60 agg gat gac gcg gat tac gta gtg gtg att gc #g tct agt att ggt tcg      240 Arg Asp Asp Ala Asp Tyr Val Val Val Ile Al #a Ser Ser Ile Gly Ser  65                  # 70                  # 75                  # 80 tac ggt ttt gat cga cca ata gga gac gag ta #t ata cgg agc gat ctg      288 Tyr Gly Phe Asp Arg Pro Ile Gly Asp Glu Ty #r Ile Arg Ser Asp Leu                  85  #                 90  #                 95 act ggt caa aaa cat gag gct tgc gag tca cg #t gct tgg tgg aaa ggt      336 Thr Gly Gln Lys His Glu Ala Cys Glu Ser Ar #g Ala Trp Trp Lys Gly             100       #           105       #           110 caa atc tgt gca tgg tct tat tct ggg agg cg #c cat tgt gaa gat gta      384 Gln Ile Cys Ala Trp Ser Tyr Ser Gly Arg Ar #g His Cys Glu Asp Val         115           #       120           #       125 cat att ccc ttt gat ttc ctc cga tcg gat gg #a ctg tgt tat cac att      432 His Ile Pro Phe Asp Phe Leu Arg Ser Asp Gl #y Leu Cys Tyr His Ile     130               #   135               #   140 atg gcg cct ttg acc ttt atg aag gcc ctg ga #t act cac cag gct gac      480 Met Ala Pro Leu Thr Phe Met Lys Ala Leu As #p Thr His Gln Ala Asp 145                 1 #50                 1 #55                 1 #60 cag cta ctg agc atg cac gga agt gtt cct tc #c gcg tgg tca gcc tac      528 Gln Leu Leu Ser Met His Gly Ser Val Pro Se #r Ala Trp Ser Ala Tyr                 165   #               170   #               175 gtc acg ggg cgt gat tac agt cag cca act ca #g tac tac acg gaa gag      576 Val Thr Gly Arg Asp Tyr Ser Gln Pro Thr Gl #n Tyr Tyr Thr Glu Glu             180       #           185       #           190 gta gct gat tgg agg atg ctt tta cga gag ga #t gac atg gca tct tcc      624 Val Ala Asp Trp Arg Met Leu Leu Arg Glu As #p Asp Met Ala Ser Ser         195           #       200           #       205 tat ttg ctg ttg gtg gtg aca gag ggc aat gc #c gcg gag ttg tgg act      672 Tyr Leu Leu Leu Val Val Thr Glu Gly Asn Al #a Ala Glu Leu Trp Thr     210               #   215               #   220 tat gac cct tat tat act aaa aca ata ggg at #g gaa cac ggg tat tcg      720 Tyr Asp Pro Tyr Tyr Thr Lys Thr Ile Gly Me #t Glu His Gly Tyr Ser 225                 2 #30                 2 #35                 2 #40 gtc aga tgg tat ttt att agg gat agg aat gt #g ggc gag gct ccc att      768 Val Arg Trp Tyr Phe Ile Arg Asp Arg Asn Va #l Gly Glu Ala Pro Ile                 245   #               250   #               255 gtt tta tat gct agg ggc ggg ggt gta tta aa #a ttt att aga ctg tac      816 Val Leu Tyr Ala Arg Gly Gly Gly Val Leu Ly #s Phe Ile Arg Leu Tyr             260       #           265       #           270 aag ggg cgt ggc act ctg acg tca cta ggg gc #g agg gca atg acg aca      864 Lys Gly Arg Gly Thr Leu Thr Ser Leu Gly Al #a Arg Ala Met Thr Thr         275           #       280           #       285 cag gaa gtg acg gag ttt acg tgt ttc cgg ac #t cac acc tat tac ttt      912 Gln Glu Val Thr Glu Phe Thr Cys Phe Arg Th #r His Thr Tyr Tyr Phe     290               #   295               #   300 acc gga act aag aag tac gat tgc cat cca gg #c ggg cac cgc ttt gat      960 Thr Gly Thr Lys Lys Tyr Asp Cys His Pro Gl #y Gly His Arg Phe Asp 305                 3 #10                 3 #15                 3 #20 gtc cct aga tgg cgc tct cat atc aat gtt tc #t gcg cac cat ctt cct     1008 Val Pro Arg Trp Arg Ser His Ile Asn Val Se #r Ala His His Leu Pro                 325   #               330   #               335 gtc ccg ccc aaa tgt ggc tgt ttg aag ttc cc #c aaa ttg ttt aag gat     1056 Val Pro Pro Lys Cys Gly Cys Leu Lys Phe Pr #o Lys Leu Phe Lys Asp             340       #           345       #           350 tat gtc ata ttt gat cac ccg aat gta gtg gg #c agg gcc gga gaa tat     1104 Tyr Val Ile Phe Asp His Pro Asn Val Val Gl #y Arg Ala Gly Glu Tyr         355           #       360           #       365 gtt agt tta ggg ccc tgg agt acc ggg tta ca #g gcc gta gtg acc ttt     1152 Val Ser Leu Gly Pro Trp Ser Thr Gly Leu Gl #n Ala Val Val Thr Phe     370               #   375               #   380 aaa cct caa cct cga cgt cac cga gtg gtc ct #g gct acg tac tgg gat     1200 Lys Pro Gln Pro Arg Arg His Arg Val Val Le #u Ala Thr Tyr Trp Asp 385                 3 #90                 3 #95                 4 #00 gcc tgt tca aac acc aag agg cgt gtc ggc at #t gac gtc aga acg gac     1248 Ala Cys Ser Asn Thr Lys Arg Arg Val Gly Il #e Asp Val Arg Thr Asp                 405   #               410   #               415 cgg aag aat cac atg gtt tgg ctc aag gcg ga #c aag cct gtg tcc aga     1296 Arg Lys Asn His Met Val Trp Leu Lys Ala As #p Lys Pro Val Ser Arg             420       #           425       #           430 gag atg tgg ttt gta tcg gaa gtg gac gtc gt #t cga gtc tac gtc acg     1344 Glu Met Trp Phe Val Ser Glu Val Asp Val Va #l Arg Val Tyr Val Thr         435           #       440           #       445 tgg ctc tcc ccc gaa taa          #                   #                   #1362 Trp Leu Ser Pro Glu     450 <210> SEQ ID NO 48 <211> LENGTH: 453 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position:34238..35599/note=ORF1 #9 <400> SEQUENCE: 48 Met Arg Gly Phe Val Pro Pro Thr Ser Ser Pr #o Asp Arg Gly Ser Lys   1               5  #                 10  #                 15 Lys Val Gly Arg Ile Val Ala Leu Asp Pro Pr #o Leu Glu Ser Phe Gln              20      #             25      #             30 Gly Tyr Arg Met Asp Leu His Thr Lys Gly Le #u Asn Leu Leu Leu Ser          35          #         40          #         45 Ser Gly Gly His Trp Ser Ala Asn Arg Asp Al #a Asp Ser Val Ile Ser      50              #     55              #     60 Arg Asp Asp Ala Asp Tyr Val Val Val Ile Al #a Ser Ser Ile Gly Ser  65                  # 70                  # 75                  # 80 Tyr Gly Phe Asp Arg Pro Ile Gly Asp Glu Ty #r Ile Arg Ser Asp Leu                  85  #                 90  #                 95 Thr Gly Gln Lys His Glu Ala Cys Glu Ser Ar #g Ala Trp Trp Lys Gly             100       #           105       #           110 Gln Ile Cys Ala Trp Ser Tyr Ser Gly Arg Ar #g His Cys Glu Asp Val         115           #       120           #       125 His Ile Pro Phe Asp Phe Leu Arg Ser Asp Gl #y Leu Cys Tyr His Ile     130               #   135               #   140 Met Ala Pro Leu Thr Phe Met Lys Ala Leu As #p Thr His Gln Ala Asp 145                 1 #50                 1 #55                 1 #60 Gln Leu Leu Ser Met His Gly Ser Val Pro Se #r Ala Trp Ser Ala Tyr                 165   #               170   #               175 Val Thr Gly Arg Asp Tyr Ser Gln Pro Thr Gl #n Tyr Tyr Thr Glu Glu             180       #           185       #           190 Val Ala Asp Trp Arg Met Leu Leu Arg Glu As #p Asp Met Ala Ser Ser         195           #       200           #       205 Tyr Leu Leu Leu Val Val Thr Glu Gly Asn Al #a Ala Glu Leu Trp Thr     210               #   215               #   220 Tyr Asp Pro Tyr Tyr Thr Lys Thr Ile Gly Me #t Glu His Gly Tyr Ser 225                 2 #30                 2 #35                 2 #40 Val Arg Trp Tyr Phe Ile Arg Asp Arg Asn Va #l Gly Glu Ala Pro Ile                 245   #               250   #               255 Val Leu Tyr Ala Arg Gly Gly Gly Val Leu Ly #s Phe Ile Arg Leu Tyr             260       #           265       #           270 Lys Gly Arg Gly Thr Leu Thr Ser Leu Gly Al #a Arg Ala Met Thr Thr         275           #       280           #       285 Gln Glu Val Thr Glu Phe Thr Cys Phe Arg Th #r His Thr Tyr Tyr Phe     290               #   295               #   300 Thr Gly Thr Lys Lys Tyr Asp Cys His Pro Gl #y Gly His Arg Phe Asp 305                 3 #10                 3 #15                 3 #20 Val Pro Arg Trp Arg Ser His Ile Asn Val Se #r Ala His His Leu Pro                 325   #               330   #               335 Val Pro Pro Lys Cys Gly Cys Leu Lys Phe Pr #o Lys Leu Phe Lys Asp             340       #           345       #           350 Tyr Val Ile Phe Asp His Pro Asn Val Val Gl #y Arg Ala Gly Glu Tyr         355           #       360           #       365 Val Ser Leu Gly Pro Trp Ser Thr Gly Leu Gl #n Ala Val Val Thr Phe     370               #   375               #   380 Lys Pro Gln Pro Arg Arg His Arg Val Val Le #u Ala Thr Tyr Trp Asp 385                 3 #90                 3 #95                 4 #00 Ala Cys Ser Asn Thr Lys Arg Arg Val Gly Il #e Asp Val Arg Thr Asp                 405   #               410   #               415 Arg Lys Asn His Met Val Trp Leu Lys Ala As #p Lys Pro Val Ser Arg             420       #           425       #           430 Glu Met Trp Phe Val Ser Glu Val Asp Val Va #l Arg Val Tyr Val Thr         435           #       440           #       445 Trp Leu Ser Pro Glu     450 <210> SEQ ID NO 49 <211> LENGTH: 816 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(816) <400> SEQUENCE: 49 atg gag aga ctg aac gag tac cgc ata aat ag #a gcc gtg gct agc ttg       48 Met Glu Arg Leu Asn Glu Tyr Arg Ile Asn Ar #g Ala Val Ala Ser Leu   1               5  #                 10  #                 15 cgg tgt ttc gat aat gat ctg atg agg cga tt #g cat agt tct gtc acg       96 Arg Cys Phe Asp Asn Asp Leu Met Arg Arg Le #u His Ser Ser Val Thr              20      #             25      #             30 gtg cta gtg acg gta cgc agc gca aag ttt gt #g tgt ttc aaa cgg cga      144 Val Leu Val Thr Val Arg Ser Ala Lys Phe Va #l Cys Phe Lys Arg Arg          35          #         40          #         45 gac tac gta ctc atg aat tgc ata gtc cgg at #t gtg agt gcc ctt cac      192 Asp Tyr Val Leu Met Asn Cys Ile Val Arg Il #e Val Ser Ala Leu His      50              #     55              #     60 ctg aac cgg gca gag aag acc gcc ctg ctg ca #c tac ctc tca cgt agg      240 Leu Asn Arg Ala Glu Lys Thr Ala Leu Leu Hi #s Tyr Leu Ser Arg Arg  65                  # 70                  # 75                  # 80 ttg ctt ttt att aca cct ggg atg aag tac ga #c ttg gaa ccg tgg atg      288 Leu Leu Phe Ile Thr Pro Gly Met Lys Tyr As #p Leu Glu Pro Trp Met                  85  #                 90  #                 95 ctt gct cgc agg aag aca gat ttt aag ttt tt #c acc aca ggc ttt ctg      336 Leu Ala Arg Arg Lys Thr Asp Phe Lys Phe Ph #e Thr Thr Gly Phe Leu             100       #           105       #           110 att gcg gag aag ata tcc gta aag atg gct ct #c cgc tcg atg agc ttt      384 Ile Ala Glu Lys Ile Ser Val Lys Met Ala Le #u Arg Ser Met Ser Phe         115           #       120           #       125 gag gtg tcc ttt tcg caa gtg cct tcg tct gt #t cct ttt gtg cgg tct      432 Glu Val Ser Phe Ser Gln Val Pro Ser Ser Va #l Pro Phe Val Arg Ser     130               #   135               #   140 ccg gtt gtt ctc atg aat gcg tgt cgc gtg ac #c gtg acg gcc acc atc      480 Pro Val Val Leu Met Asn Ala Cys Arg Val Th #r Val Thr Ala Thr Ile 145                 1 #50                 1 #55                 1 #60 atg gtg gaa act att tct cgc agc agc gcc gt #g acc caa ccc gtc tgc      528 Met Val Glu Thr Ile Ser Arg Ser Ser Ala Va #l Thr Gln Pro Val Cys                 165   #               170   #               175 ctg aga agc atg ctc cgc gtg atg gtg tcg cc #g gaa ctg tgg ccg atc      576 Leu Arg Ser Met Leu Arg Val Met Val Ser Pr #o Glu Leu Trp Pro Ile             180       #           185       #           190 gtg tcg cag gga ctg tgt tac ttc ccc ggt ta #c cgt cgg ttg tcc tac      624 Val Ser Gln Gly Leu Cys Tyr Phe Pro Gly Ty #r Arg Arg Leu Ser Tyr         195           #       200           #       205 gct aac gtc gaa gag tgg gta ttt cat gtg ca #c ggg aag tac ggg gag      672 Ala Asn Val Glu Glu Trp Val Phe His Val Hi #s Gly Lys Tyr Gly Glu     210               #   215               #   220 tct cat ccc gag tgt ttc gga cag tgc aaa ca #g tgt tcg acg cgg caa      720 Ser His Pro Glu Cys Phe Gly Gln Cys Lys Gl #n Cys Ser Thr Arg Gln 225                 2 #30                 2 #35                 2 #40 cct ctc tct ctg ttc tgt tct gct cag ttg gc #t tat ctg cgc aat gtg      768 Pro Leu Ser Leu Phe Cys Ser Ala Gln Leu Al #a Tyr Leu Arg Asn Val                 245   #               250   #               255 ttt atg gaa cga cgc gcg aga gtc gct ggt ga #a cgt ccg tat agc taa      816 Phe Met Glu Arg Arg Ala Arg Val Ala Gly Gl #u Arg Pro Tyr Ser             260       #           265       #           270 <210> SEQ ID NO 50 <211> LENGTH: 271 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position:32892..33707/note=ORF2 #0 <400> SEQUENCE: 50 Met Glu Arg Leu Asn Glu Tyr Arg Ile Asn Ar #g Ala Val Ala Ser Leu   1               5  #                 10  #                 15 Arg Cys Phe Asp Asn Asp Leu Met Arg Arg Le #u His Ser Ser Val Thr              20      #             25      #             30 Val Leu Val Thr Val Arg Ser Ala Lys Phe Va #l Cys Phe Lys Arg Arg          35          #         40          #         45 Asp Tyr Val Leu Met Asn Cys Ile Val Arg Il #e Val Ser Ala Leu His      50              #     55              #     60 Leu Asn Arg Ala Glu Lys Thr Ala Leu Leu Hi #s Tyr Leu Ser Arg Arg  65                  # 70                  # 75                  # 80 Leu Leu Phe Ile Thr Pro Gly Met Lys Tyr As #p Leu Glu Pro Trp Met                  85  #                 90  #                 95 Leu Ala Arg Arg Lys Thr Asp Phe Lys Phe Ph #e Thr Thr Gly Phe Leu             100       #           105       #           110 Ile Ala Glu Lys Ile Ser Val Lys Met Ala Le #u Arg Ser Met Ser Phe         115           #       120           #       125 Glu Val Ser Phe Ser Gln Val Pro Ser Ser Va #l Pro Phe Val Arg Ser     130               #   135               #   140 Pro Val Val Leu Met Asn Ala Cys Arg Val Th #r Val Thr Ala Thr Ile 145                 1 #50                 1 #55                 1 #60 Met Val Glu Thr Ile Ser Arg Ser Ser Ala Va #l Thr Gln Pro Val Cys                 165   #               170   #               175 Leu Arg Ser Met Leu Arg Val Met Val Ser Pr #o Glu Leu Trp Pro Ile             180       #           185       #           190 Val Ser Gln Gly Leu Cys Tyr Phe Pro Gly Ty #r Arg Arg Leu Ser Tyr         195           #       200           #       205 Ala Asn Val Glu Glu Trp Val Phe His Val Hi #s Gly Lys Tyr Gly Glu     210               #   215               #   220 Ser His Pro Glu Cys Phe Gly Gln Cys Lys Gl #n Cys Ser Thr Arg Gln 225                 2 #30                 2 #35                 2 #40 Pro Leu Ser Leu Phe Cys Ser Ala Gln Leu Al #a Tyr Leu Arg Asn Val                 245   #               250   #               255 Phe Met Glu Arg Arg Ala Arg Val Ala Gly Gl #u Arg Pro Tyr Ser             260       #           265       #           270 <210> SEQ ID NO 51 <211> LENGTH: 324 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(324) <400> SEQUENCE: 51 atg tgc acg gga agt acg ggg agt ctc atc cc #g agt gtt tcg gac agt       48 Met Cys Thr Gly Ser Thr Gly Ser Leu Ile Pr #o Ser Val Ser Asp Ser   1               5  #                 10  #                 15 gca aac agt gtt cga cgc ggc aac ctc tct ct #c tgt tct gtt ctg ctc       96 Ala Asn Ser Val Arg Arg Gly Asn Leu Ser Le #u Cys Ser Val Leu Leu              20      #             25      #             30 agt tgg ctt atc tgc gca atg tgt tta tgg aa #c gac gcg cga gag tcg      144 Ser Trp Leu Ile Cys Ala Met Cys Leu Trp As #n Asp Ala Arg Glu Ser          35          #         40          #         45 ctg gtg aac gtc cgt ata gct aat tac gtg tt #t gat ttt gca gtg ttg      192 Leu Val Asn Val Arg Ile Ala Asn Tyr Val Ph #e Asp Phe Ala Val Leu      50              #     55              #     60 tgg acg cta ttg gcg cga gtt ctt ggc cct cc #t ggt cgc cct gtc cta      240 Trp Thr Leu Leu Ala Arg Val Leu Gly Pro Pr #o Gly Arg Pro Val Leu  65                  # 70                  # 75                  # 80 cag cag cat cat cct gtg cag ctt cct gtt cc #t aca gaa cca tct gtc      288 Gln Gln His His Pro Val Gln Leu Pro Val Pr #o Thr Glu Pro Ser Val                  85  #                 90  #                 95 ttc gtt aaa ctt tgt aat cag cgt gtt cgt tt #g tag                 #      324 Phe Val Lys Leu Cys Asn Gln Arg Val Arg Le #u             100       #           105 <210> SEQ ID NO 52 <211> LENGTH: 107 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position:32735..33058/note=ORF2 #1 <400> SEQUENCE: 52 Met Cys Thr Gly Ser Thr Gly Ser Leu Ile Pr #o Ser Val Ser Asp Ser   1               5  #                 10  #                 15 Ala Asn Ser Val Arg Arg Gly Asn Leu Ser Le #u Cys Ser Val Leu Leu              20      #             25      #             30 Ser Trp Leu Ile Cys Ala Met Cys Leu Trp As #n Asp Ala Arg Glu Ser          35          #         40          #         45 Leu Val Asn Val Arg Ile Ala Asn Tyr Val Ph #e Asp Phe Ala Val Leu      50              #     55              #     60 Trp Thr Leu Leu Ala Arg Val Leu Gly Pro Pr #o Gly Arg Pro Val Leu  65                  # 70                  # 75                  # 80 Gln Gln His His Pro Val Gln Leu Pro Val Pr #o Thr Glu Pro Ser Val                  85  #                 90  #                 95 Phe Val Lys Leu Cys Asn Gln Arg Val Arg Le #u             100       #           105 <210> SEQ ID NO 53 <211> LENGTH: 618 <212> TYPE: DNA <213> ORGANISM: CELO VIRUS <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)..(618) <400> SEQUENCE: 53 atg aac gac gag cag atc ctg gag atg gtg ct #g cag cac cag cag cgc       48 Met Asn Asp Glu Gln Ile Leu Glu Met Val Le #u Gln His Gln Gln Arg   1               5  #                 10  #                 15 cgc caa cag gaa gcg gag cgc gag gag gaa gt #t ggg gat gac atg gaa       96 Arg Gln Gln Glu Ala Glu Arg Glu Glu Glu Va #l Gly Asp Asp Met Glu              20      #             25      #             30 gac gac gaa gat gat gac ggt ctt cag atg cc #g acg ccg ctt cat gcc      144 Asp Asp Glu Asp Asp Asp Gly Leu Gln Met Pr #o Thr Pro Leu His Ala          35          #         40          #         45 tat cag cta ctg tgt tac gat tct ttc gaa ct #t cat ttc ggg gga tgc      192 Tyr Gln Leu Leu Cys Tyr Asp Ser Phe Glu Le #u His Phe Gly Gly Cys      50              #     55              #     60 gct tgc cac ggg tta cct ttg cat cgt atg gg #g tta tcg gct tgc cac      240 Ala Cys His Gly Leu Pro Leu His Arg Met Gl #y Leu Ser Ala Cys His  65                  # 70                  # 75                  # 80 ctg gct cct tcc gat ttg gcc act tat gtt tg #g gcc agg ttg gag gat      288 Leu Ala Pro Ser Asp Leu Ala Thr Tyr Val Tr #p Ala Arg Leu Glu Asp                  85  #                 90  #                 95 gac ttg aat gtg gca ggg gtg tac ttc gtg gc #t atg tgg gcg tca ccg      336 Asp Leu Asn Val Ala Gly Val Tyr Phe Val Al #a Met Trp Ala Ser Pro             100       #           105       #           110 ggg ttt agc gat ttc tct cca gta ttt atg ca #g cga ccg atc ggg aac      384 Gly Phe Ser Asp Phe Ser Pro Val Phe Met Gl #n Arg Pro Ile Gly Asn         115           #       120           #       125 gtg tgc ggg atg tta att cac gtg gac ctg ca #c agc agg cta cca ttc      432 Val Cys Gly Met Leu Ile His Val Asp Leu Hi #s Ser Arg Leu Pro Phe     130               #   135               #   140 cta att gcg gtg tcg cgc ttg ggg gag gcg gg #t ggc agc ccc tgt ctg      480 Leu Ile Ala Val Ser Arg Leu Gly Glu Ala Gl #y Gly Ser Pro Cys Leu 145                 1 #50                 1 #55                 1 #60 tat atg agg aaa att gat gtt gat ttg gac ac #g cag cgc gta cat ttt      528 Tyr Met Arg Lys Ile Asp Val Asp Leu Asp Th #r Gln Arg Val His Phe                 165   #               170   #               175 tat aca gaa gat tgg ttc agt gag ttt gcg aa #t ctg ctg tat tac tgg      576 Tyr Thr Glu Asp Trp Phe Ser Glu Phe Ala As #n Leu Leu Tyr Tyr Trp             180       #           185       #           190 caa atg agc gaa tgg aaa cat tta gcg gag cg #t atg caa taa              # 618 Gln Met Ser Glu Trp Lys His Leu Ala Glu Ar #g Met Gln         195           #       200           #       205 <210> SEQ ID NO 54 <211> LENGTH: 205 <212> TYPE: PRT <213> ORGANISM: CELO VIRUS <220> FEATURE: <223> OTHER INFORMATION: Position:31812..32429/note=ORF2 #2 <400> SEQUENCE: 54 Met Asn Asp Glu Gln Ile Leu Glu Met Val Le #u Gln His Gln Gln Arg   1               5  #                 10  #                 15 Arg Gln Gln Glu Ala Glu Arg Glu Glu Glu Va #l Gly Asp Asp Met Glu              20      #             25      #             30 Asp Asp Glu Asp Asp Asp Gly Leu Gln Met Pr #o Thr Pro Leu His Ala          35          #         40          #         45 Tyr Gln Leu Leu Cys Tyr Asp Ser Phe Glu Le #u His Phe Gly Gly Cys      50              #     55              #     60 Ala Cys His Gly Leu Pro Leu His Arg Met Gl #y Leu Ser Ala Cys His  65                  # 70                  # 75                  # 80 Leu Ala Pro Ser Asp Leu Ala Thr Tyr Val Tr #p Ala Arg Leu Glu Asp                  85  #                 90  #                 95 Asp Leu Asn Val Ala Gly Val Tyr Phe Val Al #a Met Trp Ala Ser Pro             100       #           105       #           110 Gly Phe Ser Asp Phe Ser Pro Val Phe Met Gl #n Arg Pro Ile Gly Asn         115           #       120           #       125 Val Cys Gly Met Leu Ile His Val Asp Leu Hi #s Ser Arg Leu Pro Phe     130               #   135               #   140 Leu Ile Ala Val Ser Arg Leu Gly Glu Ala Gl #y Gly Ser Pro Cys Leu 145                 1 #50                 1 #55                 1 #60 Tyr Met Arg Lys Ile Asp Val Asp Leu Asp Th #r Gln Arg Val His Phe                 165   #               170   #               175 Tyr Thr Glu Asp Trp Phe Ser Glu Phe Ala As #n Leu Leu Tyr Tyr Trp             180       #           185       #           190 Gln Met Ser Glu Trp Lys His Leu Ala Glu Ar #g Met Gln         195           #       200           #       205 

What is claimed is:
 1. A recombinant fowl adenovirus type 1 (CELO) virus comprising the left and right inverted terminal repeats and the packaging signal of the CELO virus genome, wherein said CELO virus genome contains a deletion of all or part of, an insertion in, or a mutation in, one or more non-essential regions of the CELO virus genome selected from the group consisting of: (a) nucleotides from about 794 to about 1,330 of SEQ ID NO:1; and (b) nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1.
 2. The CELO virus of claim 1, wherein said deletion, insertion or mutation occurs within nucleotides from about 794 to about 1,330 of SEQ ID NO:1.
 3. The CELO virus of claim 2, wherein said CELO virus contains a deletion of nucleotides from about 794 to about 1,330 of SEQ ID NO:1.
 4. The CELO virus of claim 1, wherein said deletion, insertion or mutation occurs within nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1.
 5. The CELO virus of claim 4, wherein said CELO virus contains a deletion of nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1.
 6. The CELO virus of claim 1, wherein said deletion, insertion or mutation occurs within nucleotides from about 794 to about 1,330 and nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1.
 7. The CELO virus of claim 6, wherein said CELO virus contains a deletion of nucleotides from about 794 to about 1,330 and nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1.
 8. The CELO virus of claim 1, wherein said CELO virus genome comprises nucleotides 1 to 43,804 in SEQ ID NO:1.
 9. The CELO virus of claim 1, wherein said CELO virus contains foreign DNA.
 10. The CELO virus of claim 9, wherein said foreign DNA codes a protein.
 11. The CELO virus of claim 9, wherein said foreign DNA is inserted in a deleted section.
 12. The CELO virus of claim 10, wherein said foreign DNA codes for a therapeutically active protein.
 13. The CELO virus of claim 12, wherein said foreign DNA codes for an immunostimulatory protein.
 14. The CELO virus of claim 13, wherein said foreign DNA codes for a cytokine.
 15. The CELO virus of claim 12, wherein said foreign DNA codes for a protein selected from the group consisting of IL-1, IL-2, IL-6, IL-12, GM-CSF, an interferon, IκB, a glucocorticoid receptor, a catalase, manganese superoxide dismutase, glutathione peroxidase, LIP, LAP, ADF, Bcl-2, adenovirus E1B19K, Mcl-2, BAX, IRF-2, ICE protease, cJun, TAM-67, adenovirus E1A, p53, factor VIII, factor IX, erythropoietin, cystic fibrosis transmembrane regulator, dystrophin, globin, the LDL receptor and β-glucuronidase.
 16. The CELO virus of claim 9, wherein said foreign DNA codes for a tumor antigen or an immunogenic fragment thereof.
 17. The CELO virus of claim 9, wherein said foreign DNA codes for an antigen from a human pathogen.
 18. The CELO virus of claim 9, wherein said foreign DNA codes for an antigen from an animal pathogen.
 19. The CELO virus of claim 18, wherein said foreign DNA codes for an antigen from a bird pathogen.
 20. The CELO virus of claim 9, wherein said foreign DNA codes for a ligand for mammalian cells.
 21. The CELO virus of claim 9, wherein said CELO virus contains said foreign DNA on a section comprising nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1, which contains the fibre 1 gene.
 22. The CELO virus of claim 9, wherein said CELO virus contains said foreign DNA in the region of the reading frame at nucleotide 794 of SEQ ID NO:1 which codes for dUTPase.
 23. The CELO virus of claim 1, wherein said left terminal repeat comprises nucleotides 1 to 68 in SEQ ID NO:1, said packaging signal comprises nucleotides 70 to 200 in SEQ ID NO:1, and said right terminal repeat comprises nucleotides 43,734 to 43,804 in SEQ ID NO:1.
 24. A host cell comprising the CELO virus of claim
 1. 25. A host cell comprising the CELO virus of claim
 9. 26. A method for producing a protein comprising culturing the host cell of claim 25 under conditions such that said protein is expressed, and recovering said protein.
 27. A recombinant fowl adenovirus type 1 (CELO) virus comprising the left and right inverted terminal repeats and the packaging signal of the CELO virus genome, wherein said CELO virus contains a deletion of part of, an insertion in, or a mutation in, a non-essential region of the CELO virus genome consisting of nucleotides from about 31,800 to about 43,734 of SEQ ID NO:1.
 28. The CELO virus of claim 27, wherein said CELO virus further contains a deletion, insertion or mutation within nucleotides from about 794 to about 1,330 of SEQ ID NO:1.
 29. The CELO virus of claim 28, wherein said CELO virus contains a deletion of nucleotides from about 794 to about 1,330 of SEQ ID NO:1.
 30. The CELO virus of claim 27, wherein said CELO virus further contains a deletion, insertion or mutation within nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1.
 31. The CELO virus of claim 30, wherein said CELO virus contains a deletion of nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1.
 32. The CELO virus of claim 27, wherein said CELO virus further contains a deletion, insertion or mutation within nucleotides from about 794 to about 1,330 and nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1.
 33. The CELO virus of claim 32, wherein said CELO virus contains a deletion of nucleotides from about 794 to about 1,330 and nucleotides from about 28,114 to about 30,495 of SEQ ID NO:1.
 34. The CELO virus of claim 27, wherein said CELO virus genome comprises nucleotides 1 to 43,804 in SEQ ID NO:1.
 35. The CELO virus of claim 27, wherein said CELO virus contains foreign DNA.
 36. The CELO virus of claim 35, wherein said foreign DNA codes a protein.
 37. The CELO virus of claim 35, wherein said foreign DNA is inserted in a deleted section.
 38. The CELO virus of claim 36, wherein said foreign DNA codes for a therapeutically active protein.
 39. The CELO virus of claim 38, wherein said foreign DNA codes for an immunostimulatory protein.
 40. The CELO virus of claim 39, wherein said foreign DNA codes for a cytokine.
 41. The CELO virus of claim 38, wherein said foreign DNA codes for a protein selected from the group consisting of IL-1, IL-2, IL-6, IL-12, GM-CSF, an interferon, IκB, a glucocorticoid receptor, a catalase, manganese superoxide dismutase, glutathione peroxidase, LIP, LAP, ADF, Bcl-2, adenovirus E1B19K, Mcl-2, BAX, IRF-2, ICE protease, cjun, TAM-67, adenovirus E1A, p53, factor VIII, factor IX, erythropoietin, cystic fibrosis transmembrane regulator, dystrophin, globin, the LDL receptor and β-glucuronidase.
 42. The CELO virus of claim 35, wherein said foreign DNA codes for a tumor antigen or an immunogenic fragment thereof.
 43. The CELO virus of claim 35, wherein said foreign DNA codes for an antigen from a human pathogen.
 44. The CELO virus of claim 35, wherein said foreign DNA codes for an antigen from an animal pathogen.
 45. The CELO virus of claim 44, wherein said foreign DNA codes for an antigen from a bird pathogen.
 46. The CELO virus of claim 35, wherein said foreign DNA codes for a ligand for mammalian cells.
 47. The CELO virus of claim 35, wherein said CELO virus contains said foreign DNA at about the FseI cutting site which is located at position 35,693 of SEQ ID NO:1.
 48. The CELO virus of claim 27, wherein said left terminal repeat comprises nucleotides 1 to 68 in SEQ ID NO:1, said packaging signal comprises nucleotides 70 to 200 in SEQ ID NO:1, and said right terminal repeat comprises nucleotides 43,734 to 43,804 in SEQ ID NO:1.
 49. A host cell comprising the CELO virus of claim
 27. 50. A host cell comprising the CELO virus of claim
 35. 51. A method for producing a protein comprising culturing the host cell of claim 50 under conditions such that said protein is expressed, and recovering said protein.
 52. A recombinant fowl adenovirus type 1 (CELO) virus comprising the left and right inverted terminal repeats and the packaging signal of the CELO virus genome, wherein said CELO virus genome contains a deletion of nucleotides within the region from about 201 to about 5,000 of SEQ ID NO:1.
 53. The CELO virus of claim 52, wherein said CELO virus genome comprises nucleotides 1 to 43,804 in SEQ ID NO:1.
 54. The CELO virus of claim 52, wherein said CELO virus contains foreign DNA.
 55. The CELO virus of claim 54, wherein said foreign DNA codes a protein.
 56. The CELO virus of claim 54, wherein said foreign DNA is inserted in the deleted section.
 57. The CELO virus of claim 55, wherein said foreign DNA codes for a therapeutically active protein.
 58. The CELO virus of claim 57, wherein said foreign DNA codes for an immunostimulatory protein.
 59. The CELO virus of claim 58, wherein said foreign DNA codes for a cytokine.
 60. The CELO virus of claim 57, wherein said foreign DNA codes for a protein selected from the group consisting of IL-1, IL-2, IL-6, IL- 12, GM-CSF, an interferon, IκB, a glucocorticoid receptor, a catalase, manganese superoxide dismutase, glutathione peroxidase, LIP, LAP, ADF, Bcl-2, adenovirus E1B19K, Mcl-2, BAX, IRF-2, ICE protease, cjun, TAM-67, adenovirus E1A, p53, factor VIII, factor IX, erythropoietin, cystic fibrosis transmembrane regulator, dystrophin, globin, the LDL receptor and β-glucuronidase.
 61. The CELO virus of claim 54, wherein said foreign DNA codes for a tumor antigen or an immunogenic fragment thereof.
 62. The CELO virus of claim 54, wherein said foreign DNA codes for an antigen from a human pathogen.
 63. The CELO virus of claim 54, wherein said foreign DNA codes for an antigen from an animal pathogen.
 64. The CELO virus of claim 63, wherein said foreign DNA codes for an antigen from a bird pathogen.
 65. The CELO virus of claim 54, wherein said foreign DNA codes for a ligand for mammalian cells.
 66. The CELO virus of claim 52, wherein said left terminal repeat comprises nucleotides 1 to 68 in SEQ ID NO:1, said packaging signal comprises nucleotides 70 to 200 in SEQ ID NO:1, and said right terminal repeat comprises nucleotides 43,734 to 43,804 in SEQ ID NO:1.
 67. A host cell comprising the CELO virus of claim
 52. 68. A host cell comprising the CELO virus of claim
 54. 69. A method for producing of a protein comprising culturing the host cell of claim 68 under conditions such that said protein is expressed, and recovering said protein. 